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Chapter 1   1.1 Imidazole-2-thiones and their applications Imidazole-2-thiones I, the cyclic analogues of thiourea, despite being known over a century, hold a significant importance in chemistry till date due to their ample use in both chemical and pharmaceutical industries. Much of the research on applications of imidazole-2-thiones is driven by their coordination properties. For example, the bacteriostatic activities[1] of imidazole-2-thiones have been related to their metal binding abilities and this is the same reason why they are also used in gravimetric[2] and spectrophotometric titration[3] for a wide series of metals. Barring these, medical implications of imidazole-2-thiones include thyrotoxic activity[4], central nervous system depressant and anti-convulsant activity.[5] Furthermore it is also used in metal finishing, electroplating industries where it helps to stop metal corrosion.[6]  Due to this sustained utility, the synthetic protocol for the imidazole-2-thiones have also gone through a significant evolution.[7, 8] Nowadays they are readily obtained by a single-pot reaction protocol where the corresponding imidazolium salts are treated with a base to generate the imidazole-2-ylidene, which is then in situ trapped as the imidazole-2-thione by reacting with elemental sulfur (Scheme 1).[9, 10]  
 Scheme 1: Synthesis of imidazole-2-thiones 
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Apart from all the industrial and medicinal applications, in synthetic chemistry imidazole-2-thiones also act as a potent source for the corresponding imidazole-2-ylidenes II (via reductive desulfurization) and imidazolium salts III (via oxidative desulfurization) (Figure 1). In the reductive desulfurization process,[11] under thermal conditions and in presence of a metal as reducing agent, sulfur is transformed into a metal sulfide. On the other hand, i.e. during the oxidative desulfurization,[12] H2O2 is used as the oxidant to remove sulfur and form the bisulfate (hydrogensulfate) anion. The imidazolium salts obtained by the oxidative desulfurization can also be converted into the corresponding imidazole-2-ylidene by means of deprotonation by a base.[10] 
 Figure 1: Examples for the use of imidazole-2-thiones in synthetic chemistry. Imidazolium salts III can become ionic liquids [8, 13] given that suitable substituents and counter anions are employed. This also offers the opportunity to access halogen-free and functionalized ionic liquids, which are also sometimes called as task-specific ionic liquids (introduced by Davis).[14]  
 Figure 2: Selected examples of functionalized ionic liquids. 
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Some selected examples of functionalized ionic liquids are listed in Figure 2. These task-specific ionic liquids ȋTSILsȌ, also known as ǲdesigner solventsǳ,[15] provide a diverse combination of cations and anions, which enables to design ionic liquids suitable for catalyzing a wide spectrum of chemical reactions. Those ionic liquids containing carboxylic acid (IV) are supreme for catalyzing acetalization of aldehydes.[16] Ionic liquids V fall into a special class of ionic liquids which contains a phosphorus-containing alkyl chain on the ring N-atom and are useful as lubricants for an aluminium-on-steal system.[17] Presence of a nitrile group on the side chain enables ionic liquids VI to act as catalysts in Heck, Suzuki and Stille coupling along with charge transfer complexes formation.[18] Compound class VII, which were recently developed by the Streubel group,[19, 20] fall into a unique category of ionic liquids containing a phosphinoyl functionality in the backbone and are completely halogen free. The catalytic utilities of VII are yet to be explored.  1.2 Backbone functionalization of imidazole-2-ylidenes  The first ever example of backbone functionalization of an imidazole-2-ylidene without touching the C2-center, was published by Arduengo in 1999,[21] where he showed the backbone chlorination (and bromination)[22] using CCl4 (and CBr4) as the chlorinating (and brominating) agents (Figure 3).  
 Figure 3: Backbone substitution of imidazole-2-ylidenes. 
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Introduction of two strongly electron withdrawing halogen atoms in the backbone diminishes the air and moisture sensitivity of VIII to an significant extent.[21, 22] Following this report, the chemistry of backbone substitution of imidazole-2-thione kick-started and examples of backbone-deuteration IX,[23] -silylation X[24]-XI[25] were published. These compounds created a quest for obtaining the versatility in the backbone substitution, especially for the inclusion of phosphorus containing functional groups. The first breakthrough came with the work of Gates in 2009, in which a sterically demanding NHC XII reacted with a phosphaalkene to access the backbone phosphanyl substituted imidazole-2-ylidene XIII (Scheme 2).[26] During the course of the reaction, an abnormal form of the NHC (IMes) is believed to be formed, which then attacks the electrophilic P-center in the phosphaalkene to give a zwitterionic structure.  
 Scheme 2: First reported example of backbone substitution of imidazole-2-ylidene.[26] This zwitterionic form in the next step converts to XIII via an intramolecular proton transfer.  One year later, Bertrand[27] reported a more versatile and flexible route for a backbone phosphanylation of an imidazole-2-ylidene. They could show that the imidazolium salt XV, obtained by reacting the sterically protected NHC XIV with an electrophile (E-X), undergoes an intramolecular transfer of the  
 Scheme 3: Examples of backbone phosphanylation of imidazole-2-ylidene.[27] 
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electrophile from the C2 to the C4 position in the presence of a bulky and non-nucleophilic base e.g. KHMDS (Scheme 3). The treatment of XV with the base creates again an intermediate, abnormal NHC,[28] which thereafter undergoes intramolecular shift of the electrophile to isomerize to the more stable analogue XVI. This protocol also provides access to the disubstituted imidazole-2-ylidene, and therefore can be used to fine-tune the σ-donating and Ɏ-accepting properties of the backbone functionalized NHCs. In the same manner compound XVIII, which represents a less sterically demanding version of XIII and XVI, was recently reported by the group of Ruiz.[29] This synthetic protocol proves that sterically demanding group on the N-center is not necessary to achieve backbone phosphanylation. Furthermore, they also garnered evidences for the utilization of this backbone phosphanylated imidazole-2-ylidene XVIII as a bidentate ligand (Scheme 4).[30] 
 Scheme 4: Synthesis of backbone phosphanylated bidentate imidazole-2-ylidene XIX.[29, 30] The borane adduct of imidazole-2-ylidenes were also recently employed by Curran and co-workers for the purpose of backbone P-substitution. They could use the borane adduct XX in a salt with a wide range of electrophiles to get access to the backbone functionalized borane adducts XXI (Scheme 5).[31] Moreover, it was also possible to achieve the backbone bis-substitution along this synthetic protocol. They also reported the way to remove the protection at the C2-center of the NHC, so that the NHC can again be regenerated, if necessary. Compound XXI, upon treatment with methyltriflate or I2 gets converted into the corresponding imidazolium salt which can be used for the generation of the NHC again at a later stage. This synthetic pathway also works very well with most of the substitution patterns at the backbone carbon center but has some inbuilt drawbacks when the backbone phosphanylation is concerned. The protocol is limited to the use of PV-centers only as electrophiles and not so ǲfunctional group tolerantǳ in the context of phosphanylation. Against this 
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background, the use of imidazole-2-thiones for the purpose of backbone phosphanylation of imidazole-2-ylidenes becomes very promising. 
 Scheme 5: Use of borane adducts of imidazole-2-ylidenes for backbone functionalization.[31]  1.3 Imidazole-2-thiones and backbone phosphanylation  The backbone phosphanylation of imidazole-2-thiones were reported first by Streubel and co-workers in 2012.[10] The final compound XXIII was obtained by treating the imidazole-2-thione XXII first with nBuLi to generate the lithiated intermediate which reacted in situ with a chloro-(diorgano)phosphane (Scheme 6). This particular approach to backbone phosphanylation is extremely selective, functional group tolerant, high yielding and a single-pot reaction. Therefore, it could be explored to create a wider spectrum of substitution patterns, using different chlorophosphanes and different alkyl/aryl groups on the N-center of the imidazole-2-thione. Later on, further reactions of these backbone phosphanylated imidazole-2-thiones were also studied in detail and reported by the Streubel group. 
 Scheme 6: Backbone phosphanylation of  imidazole-2-thiones.[10] 
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Compound XXIII can further be phosphanylated in the backbone, but the conversion of the backbone PIII-center into a PV-center is required prior to that (Scheme 7).[32] The oxidation of the backbone PIII-center makes the remaining vinylic proton (in compound XXIV) acidic enough which enables the second phosphanylation. Compounds XXV have been further oxidized to get access to the backbone PV/PV-substituted imidazole-2-thione, and, hereafter, coordination properties of XXIII-XXV were investigated.  
 Scheme 7: Introduction of a second phosphanyl group in the backbone of imidazole-2-thiones.[32]  The main reason why these studies stand out in the chemistry of backbone phosphanylation of imidazole-2-ylidenes is the likelihood of these backbone phosphanylated imidazole-2-thiones to act as starting materials for the generation of corresponding NHCs. Both the reductive and oxidative pathways of desulfurizing the C2-center of the thione were explored in the Streubel group in recent years. In case of reductive desulfurization in the presence of an alkali metal, these backbone phosphanylated imidazole-2-thiones gave access to first examples of imidazolium phosphanide zwitterions XXVI (Scheme 8).[33] Under these harsh reductive conditions the backbone P-C bond was also cleaved along with the C=S bond to produce these zwitterions. But in the case of oxidative desulfurization the scenario is different, i.e., compounds XXVI, upon treatment with aq. solution of hydrogen peroxide, gives an easy access to backbone phosphinoyl substituted imidazolium salts XXVII (Scheme 8).[19, 20, 34] These imidazolium salts were also successfully employed to synthesize the corresponding backbone P-substituted imidazole-2-ylidenes XXVIII.[20, 34] This new pathway enables also to fine-tune the σ-donating and Ɏ-accepting properties of NHCs by means of careful choice of suitable P-containing substituents in the imidazole backbone.
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 Scheme 8: Synthesis of backbone P-substituted imidazole-2-ylidene complexes and an imidazolium phosphanide zwitterion.[19, 33] Having such a prudent protocol also helped to explore the possibilities of introducing more than one imidazole-2-thione moiety in the backbone phosphorus center. Use of a dichlorophosphane permits the synthesis of the bis(imidazole-2-thione-4-yl)phosphanes XXIX (Scheme 9).[35] Compounds XXIX were later subjected to oxidation, complexation, acid-induced P-N bond cleavage[35, 36] and oxidative desulfurization,[34] respectively. The bis-imidazolium salts obtained from the oxidative desulfurization reactions of XXIX gave access to first examples of phosphanyl bridged bis-imidazole-2-ylidenes and their metal complexes.[34] These bis(imidazole-2-thione-4-yl)-phosphanes XXIX were also successfully employed recently in the chemistry of low-coordinated phosphorus chemistry.[36] With such a wide spread reactivity spectrum and applicability of these bis(imidazole-2-thione-4-yl)phosphanes are bound to draw more attentions in synthesis.   
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 Scheme 9: Synthesis of bis(imidazole-2-thione-4-yl)phosphanes XXIX.[35]  1.4 An imidazole-2-thione based tricyclic 1,4-dihydro-1,4-diphosphinine by-product   Taking a closer look at the synthetic protocols for compounds XXIX, one can see that the reaction outcome is not always straightforward as in the case of XIII, and the outcome is related to the nature of R and R’. Backbone phosphanylation of 1,3-dimethylimidazole-2-thione using dimethyl-amino-dichlorophosphane as the electrophile produces the tricyclic compound XXX[37] (Scheme 10) as minor product along with XXIX. The limited solubility of compound XXX helped in its first isolation as it precipitates out of the reaction mixture as white powder during the course of the reaction. It is formed as a mixture of two stereoisomers (cis and trans), the latter is due to a substantial inversion barrier at the two P-centers. As compound XXX was formed in the reaction mixture only as the minor product (yield: up to 4%), and together with the limited solubility, studies on the chemistry of compound XXX were hold back substantially. In particular, the pathway of formation of compound XXX was not understood, and its chemistry was not investigated, too. Compound XXX contains the  
 Scheme 10: Synthesis of imidazole-2-thione based tricyclic 1,4-dihydro-1,4-diphosphinine XXX.[37] 
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1,4-dihydro-1,4-diphosphinine motif, a six-membered heterocyclic compound with two 33-phosphorus centers;   represents the coordination number of P and the number of valence electrons involved in bonding. The first derivative related to XXX was reported in 1964 by Mann and co-workers.[38] They showed that the 1,4-dihydro-1,4-diphosphinine XXXI (Figure 4) (R = Et, Ph), condensed to two benzene rings, could easily be obtained via a stepwise ring closure using dichlorophosphane as the source of phosphorus. Later on, Uchida[39] added a further simplification to the synthetic protocol of XXXI. The synthesis of the monocyclic compound XXXII was reported by Märkl [40] where the six-membered ring was constructed by reacting di(ethinyl)phosphane with a primary phosphane. This synthetic protocol proved to be really convenient and leads to wide combination of substituents on the phosphorus. The idea of a formal replacement of the benzene rings in compound XXXI by other structural motifs has been established for the following units:  tetrafluorobenzene,[41] thiophene,[42] xylene[43] and tetrathiafulvalene[44] systems have already been reported. Compound XXXIII (X = O, S), reported by Becher,[45] presents an unique synthetic pathway to the 1,4-dihydro-1,4-diphosphinine ring where elimination of volatile trimethylchlorosilane drives the cyclization. In this context, compound XXXIV was synthesized via thermal fusion of the corresponding backbone dichlorophosphanyl substituted 1-methyl-2-(alkyl)-imidazole and PCl3 using pyridine as base.  
 Figure 4: Some literature known examples of 1,4-dihydro-1,4-diphosphinines. XXXIV also includes another different heterocyclic structural motif.[46] Furthermore, Märkl had also envisaged the 1,4-dihydro-1,4-diphosphinines as the probable starting for obtaining the 1,4-diphosphinines under thermal elimination condition. But this remained to be experimentally established till today.[40] 
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1.5 Phosphinines and diphosphinines  Phosphinines, also previously termed phosphabenzenes, are P-analogues of benzene and their synthesis in 1966 by Märkl[47] has been a real landmark in the chemistry of low-coordinated P-chemistry. They possess planar, six-membered, aromatic heterocyclic ring with a σ2ɉ3-phosphorus atom in the ring. Due to the incorporation of the P-atom in the benzene ring the -conjugation within the ring is perturbed and, therefore, the aromaticity is diminished. The aromaticity of phosphinine is ~ 88 % of the aromaticity[48] of benzene, but this slight reduction does not fully  
 Figure 5: Benzene and its hetero-analogues.[49] reflect the effect of the inclusion of the P-atom in the ring. When the molecular orbitals of phosphinine are compared to pyridine, the first substantial difference is the change in the nature of lone pair. The lone pair in phosphinine has little to no nucleophilic character left due to its occupation in a less directional and more diffused HOMO-2 orbital (Figure 5).[49] In fact the LUMO in phosphinine has a large coefficient on the phosphorus atom and is much lower in energy compared to that of pyridine. And this is why phosphinine is a much weaker σ-donor and much stronger Ɏ-acceptor ligand compared to pyridine. The first synthesis of phosphinines was the thermal reaction between a formal PH3 source and a pyrylium salt, as described by Märkl,[50] and compound XXXV (Figure 6) remained the most easily accessible derivative for long time.  The most important illustrative example of this series though is the synthesis of the parent compound XXXVI which used a base-induced dehydrohalogenation
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reaction starting from 1-bromo-phospha-cyclohexadiene.[51] In contrast, a [4+2]-cycloaddition reaction between 1,3-cyclopentadiene and tBuCP[52] was used for synthesis of compound XXXVII. Phosphinines can also be derived via thermal elimination of a small molecule which leads to aromatization, e.g., 1-benzyl-1,2-dihydro-phospha-naphthalene loses a molecule of toluene upon heating at 260-300°C to produce compound XXXVIII.[53] Another illustrative synthetic route is the reaction between ethyldiazoacetate with a phosphole sulfide as addition of the carbene at the C2-C3 bond of the phosphole creates a bicyclic derivative in the first step which, under thermal conditions, subsequently rearranges to compound XXXIX.[54] Finally, compound XL was synthesized via a [4+2]-cycloaddition reaction between an 1,3-azaphosphinine and an alkyne, followed by elimination of a nitrile unit.[55] There are several more synthetic routes available to phosphinines as their chemistry has seen an enormous development since the first report by Märkl, and is still developing. 
 Figure 6: Some selected examples of 23-phosphinines XXXV-XL, derived from different synthetic protocols. In case of diphosphinines, three possible regioisomers can be envisaged, i.e. 1,2-diphosphinine, 1,3-diphosphinine and 1,4-diphosphinine (Figure 7). The chemistry of these diphosphinines is still largely underdeveloped mainly due to their high reactivity and instability. 
 Figure 7: Regioisomers of σ3ɉ3-diphosphinines. 
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In the case of 1,2-diphosphinines, a single report came from Bickelhaupt and co-workers.[56] Upon treatment of compound XLI with hydrogen chloride a cyclic intermediate XLII was formed, instead of the originally targeted bis-dichlorophosphane derivative. This cyclic intermediate could be converted to the ͳɉ5,ʹɉ3-diphosphinine XLIII (Scheme 11) upon reduction with Mg. The final compound though could not be isolated and purified, and was exclusively evidenced via 31P NMR spectroscopy, i.e., compound XLIII shows two doublets at 94.5 and -129 ppm, respectively, with a large 1JP,P coupling constant of 469 Hz.  
 Scheme 11: Synthesis of the only known example of 1,2-diphosphinine XLIII.[56] Comparatively well-known are 1ɉ3,3ɉ3-diphosphinines and the first example was reported by Zenneck and co-workers in 1995.[57] Compound XLIV was synthesized via an iron(0)-catalyzed regiospecific [2+2+2]-cycloaddition of two molecules of tert-butyl-phosphaethyne with an alkyne under mild reaction conditions. The final product was formed as an iron complex, from which the free 1,3-diphosphinine ligand was released via oxidation with CCl4 at elevated temperature (Figure 8). Compound XLV[58] represents a phosphonium-substituted 1,3-diphosphinine and could be synthesized by means of dechlorination of the corresponding 1,3-diphosphatetraline derivative, using GaCl3 as the halide-abstracting reagent. A wide range of 1ɉ5,3ɉ5-diphosphinines are also known in the literature. Fluck and co-workers obtained compound XLVI [59] as the final product of the attempted synthesis of 1,1,3,3,-tetrakis(dimethylamino)-1ɉ5,3ɉ5-diphosphete. Here, the diphosphinine was formed in a Diels-Alder reaction of the targeted compound (1,1,3,3,-tetrakis(di-methylamino)-1ɉ5,3ɉ5-diphosphete) with an alkyne derivative. Finally, compound XLVII represents a highly stable version of a 1ɉ5,3ɉ5-diphosphinine reported by Märkl in 1963 that was easily obtained by stepwise deprotonation of 1,1,3,3,-tetraphenyl-1,3-diphosphoniocyclohex-4-ene.[60]
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 Figure 8: Selected examples of 1,3-diphosphinines. In case of 1,4-diphosphinines, L is the only known example, and it possesses four trifluoromethyl substituents (Scheme 12).[61] L was obtained from a two-step synthetic protocol in which the perfluormethylated-1,4-phosphabarrelene XLVIII undergoes a RhIII-catalyzed addition of methanol to form compound XLIX which, finally, eliminates the alkene fragment LI to produce the final compound L under prolonged reflux condition. Due to its extreme air and moisture sensitivity, compound L has never been isolated and fully characterized, and no structural information of a 1,4-diphosphinine is known till date. In the 31P NMR spectrum the resonance signal of L appears in the downfield region at 287 ppm which might be due to the presence of four strongly electron- withdrawing groups.[62] Compound L could be handled as n-hexane solution and used in a few reactions, described in scheme 13. 
 Scheme 12: Synthesis of the solely known 1,4-diphosphinine.[62] Kobayashi and co-workers carried out some reactivity studies of compound L. For example, heating compound L with carbon tetrachloride in a sealed tube at 130°C causes formation of diphos-phanorbornadiene derivative LII[62] by a pathway, possibly analogous to the reaction between PPh3
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and CCl4.[63] Compound L was also used as a diene in several thermal [4+2]-cycloaddition reaction to get access to the diphosphabarrelenes LIII.[62] 
 Scheme 13: Literature reported reactivities of 1,4-diphosphinine L.[62] In the same manner, when heated with an episulfide, compound L produces 2,3,5,6-tetrakis(trifluoromethyl)-7-thia-1,4-diphosphanorbornadiene LV via a formal [4+1]-cycloaddition reaction. Formation of compound LV was further confirmed via desulfurization with PPh3 thus producing the starting material L, again.[64] 
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Chapter 2   As compound XXX showed the structural and chemical potential to act as starting point to access imidazole-2-thione-based tricyclic 1,4-diphosphinines, the main goals and objectives of this PhD thesis were: 
 to investigate the formation of tricyclic 1,4-dihydro-1,4-diphosphinines  
 to develop an alternative reaction protocol for tricyclic 1,4-dihydro-1,4-diphos-phinines 
 to study reactions of tricyclic 1,4-dihydro-1,4-diphosphinines 
 to develop a P-functionality that enables substitution reactions 
 to establish pathways towards 1,4-diphosphinine derivatives and develop their chemistry.
2. Objectives of this PhD thesis 
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Chapter 3     As briefly mentioned beforehand (cf. Scheme 10), compound XXX was initially isolated in low yield from the attempted backbone phosphanylation of 1,3-dimethylimidazole-2-thione while using dimethylamino(dichloro)phosphane as the electrophile, and the pathway remained unclear. Assuming a large synthetic potential of such compounds, especially in further stabilization of the targeted 1,4-diphosphinines by virtue of extended electronic delocalization due to the planar structure of the thione, it was decided to investigate the effect of N- and P-substituents and the stoichiometry on the reaction outcome.  3.1 Effect of N-  and P-substituents  To start this study, the reaction stoichiometry was followed as described in scheme 13 and applied to derivatives with a wide range of P- and N-substituents (R’ and R respectively) (Table 1). The presence of the P-NMe2 group led to 1,4-dihydro-1,4-diphosphinines in low yields (4% for 4a, 16%  
 Scheme 14: Synthesis of bis-(imidazole-2-thione)substituted phosphanes 3a-i and tricyclic 1,4-dihydro-1,4-diphosphinines 4a-c. 
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for 4b), but only for primary alkyl groups (4a,b) at the thione N-centers. Both 4a and 4b were isolated and completely characterized. Interestingly, 4a,b showed two resonance signals in the 31P{1H} NMR spectra, which could be assigned to the pair of stereoisomers originated due to the hindered inversion of the dimethylamino group at the P-center at room temperature (Figure 9). In case of 4a,a’, the trans isomer could be separated using the solubility differences of the isomers by repeated washing of the cis/trans isomeric mixture of 4a,a’ with THF at room temperature. The trans isomer was left in the residue due to its lower solubility. 
 Figure 9: cis and trans isomers of tricyclic 1,4-dihydro-1,4-diphosphinines 4. In contrast, compound 4b,b’, could only be isolated as a mixture of two isomers by means of column chromatography using diethyl ether /petrol ether (40/60) mixtures as eluents, due to the increased solubility of 4b,b’ stemming from longer alkyl chains. This pure cis/trans isomeric mixture was used as such for the full characterization of compound 4b,b’. The 31P NMR spectrum (in CDCl3) of the reaction solution of 4b,b’ showed chemical shifts of 8.7 and 9.2 ppm for the two isomers (ratio 3:1). These values for 4 were in good agreement with literature reported values for 1,4-dihydro-1,4-diphosphinine XXXIV bearing a P-NR2 (R = Me) fragment (15.6 ppm).[46] Furthermore, the 1H NMR spectrum of 4b revealed the absence of any backbone proton resonance, which in turn confirmed the occurrence of cyclization. The yield improved marginally in case of 4b (16%) compared to 4a (only 4%). The main products of these two reaction mixture, i.e., 3a and 3b were also isolated in moderate to good yields (Table 1) and completely characterized. Compound 3b showed exactly similar trends in case of physical and chemical properties as the previously reported N-Me analogue 3a.[35] Single crystals of 4a,b suitable for X-ray crystallographic measurements could be easily grown from its saturated dichloromethane solution at –20 °C, 4a after separation as described beforehand; crystals of 4b were obtained from the isomer mixture. The solid state structures of trans 4a and of 
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Table 1: 31P{1H} NMR spectroscopic data and yields of products 3 and 4 . P-substituents (R’) in R’PCl2 (2a-d) N-substituents (R) in thiones (1a-e) P (from reaction mixture, THF) Isolated yield (%) 3 4 3 4   NMe2 (2a) Me (1a) 14.7[35] (3a) 9.8 , 10.2 (4a,a’) 60 4 Et (1b) 11.9 (3b) 8.7 , 9.2 (4b,b’) 32 16 Ph (1c) 16.7[35] (3c) - 75 - iPr (1d) 15.6[36] (3d) - 81 - NiPr2 (2b) Me (1a) 10.7 (3e) -12.9 , -13.2 (4c,c’) - -  OEt (2c) Me (1a) 68.4 (3f) - -  iPr (1d) 70.2 (3g) - 75 -  Ph (2d) Me (1a) -56.2 (3h) - - - nBu (1e) -59.2 (3i) - 60 -  cis 4b are shown in figure 10. In both isomers the metrical parameters for the middle six-membered ring are invariant, with the exception of the quest for ǲplanarityǳ of the middle ring. In cis 4b, the two P atoms are slightly out of plane by 0.13 Å and the folding angle between P(1)-C(1)-C(2)-P(2) and P(1)-C(4)-C(3)-P(2) planes is 14.1° whereas in trans 4a the 6 atoms are within one plane. 
     Figure 10: Molecular structure of trans 4a and cis 4b; hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°) for trans 4a: P-C(3) 1.8104(4), P-N(3) 1.6631(3), C(3)-C(4) 1.3670(2); C(3)-P-C(4) 94.894(8), C(3)-P-N(3) 103.8. For cis-4b: P(1)-C(1) 1.8143(1), P(1)-N(1) 1.6641(0), C(1)-C(2) 1.3689(0);  C(1)-P(1)-C(4) 95.220(1), N(1)-P(1)-C(1) 107.307(1). On the other hand, when the N-substituent was changed to aryl (Ph, 1c) or secondary alkyl (iPr, 1d) group, the formation of 1,4-dihydro-1,4-diphosphinines was no longer detected, and the acyclic 
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phosphanes 3c-d were obtained as sole products. Compound 3c was reported earlier,[35] and compound 3d was isolated and completely characterized. Both 3b and 3c were isolated in high yields as white powders and the 31P NMR spectra of them revealed same trends in chemical shifts as seen for 3a,b (16.8 ppm for 3c, 15.5 ppm for 3d).  If a sterically more demanding dichlorophosphane was used, having NiPr2 group at the P-center (2b), the formation of two isomers of the tricyclic 1,4-dihydro-1,4-diphosphinine (4c) were observed, along with the acyclic compound (3e). The 31P{1H} NMR spectrum of the reaction mixture showed two resonance signals at -12.9 and -13.2 ppm, respectively, which were tentatively assigned to the two isomers of 4c. While the resonance signal at 10.7 ppm could be assigned to the corresponding acyclic compound 3e. Unfortunately, it was not achieved to get 3e and 4c in pure form. Though the isolation of 4c was not achieved, the NMR spectroscopic investigation of the reaction mixture lend some support to its formation. After the examined the case of aminodichlorophosphanes, we became interested to exploit the scope of this synthetic protocol by employing P-alkoxy derivatives. As a case In point, the dichloro-(ethoxy)phosphane (2c) was employed but no formation of a tricyclic 1,4-dihydro-1,4-diphos-phinine was observed, regardless of the thione used (Table 1). In case of thione 1a, formation of the tris(imidazole-2-thione-4-yl)phosphane was observed in the 31P{1H} NMR spectrum of the reaction mixture (singlet at -78.2 ppm). Apart from that, the reaction mixture was not informative due to an unselective reaction. But in the case of thione 1d, having the iPr group on the N-centers, the reaction was selective and the only product formed in this case was the acyclic compound 3g. Compound 3g could be easily isolated from the reaction mixture in excellent yield as a white powder and was completely characterized by means of all standard analytical methods. The 31P NMR spectrum of compound 3g showed a triplet resonance signal at 70.3 ppm (3JP,H = 10.1 Hz), which proves the bond of the ethoxy group to the P-center. Apart from the analytical confirmation, formation of compound 3g was also established by X-ray crystallographic measurements. Single crystals of compound 3g, were grown carefully from its saturated dichloromethane solution at –20°C. Compound 3g crystallizes in the monoclinic crystal system with the P21/n space group. The sum of bond angles at the P-center is 292.6°, which reflects the non-planar geometry around the P-center. The P-C(1) bond length is 1.8134(1) Å, which falls in accordance with previously reported compounds [cf. PhP(IMSiPr,Me)2 1.817(2), Ph2P-IMSMe,Me 1.8185(18), Ph2P-IMSPh,Ph 1.8190(5) etc.; where IMSR,R = 1,3-dialkylimidazole-2-thione-4-yl].
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 Figure 11: Molecular structure of 3g; hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°): P-C(1) 1.8134(1), P-O 1.6380(1), P-C(10) 1.8010(1); C(1)-P-C(10) 97.162(2), C(1)-P-O 98.913(2). After this unsuccessful attempt, the dichloro(phenyl)phosphane was employed to see the effect of a P-aryl substituent on the reaction outcome, but also here the result was negative as no tricyclic 1,4-dihydro-1,4-diphosphinines could be detected, even for derivatives having primary alkyl groups at the N-centers of the thione such as Me (1a) or nBu (1e) (Table 1). In both cases the acyclic bis(imi-dazole-2-thione-4-yl)phosphanes were the main products. Although compound 3h could not be isolated from the reaction mixture owing to the limited selectivity, compound 3i was isolated as light yellow powder. The 31P NMR spectrum of pure 3i shows a triplet resonance signal at -59.2 ppm (3JP,H = 8.5 Hz). The molecular structure of 3i was confirmed by X-ray crystallographic mea-surements using single crystals grown from saturated diethylether solution at room temperature. Compound 3i crystallizes in the monoclinic crystal system with the C2/c space group. The metrical parameters are in agreement with previously reported analogous phosphorus compounds. 
 Figure 12: Molecular structure of 3i; hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°): P-C(1) 1.8183(1), P-C(23) 1.8291(1), P-C(12) 1.8078(1); C(1)-P-C(12) 99.043(3), C(12)-P-C(23) 98.966(3).
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3.2 Effect of the reaction stoichiometry  After the exploration of N and P-substituents (R and R’) effects on the reaction outcome, the next aspect of interest was the effect of the stoichiometry on the product formation according to scheme 13. To investigate this, the reaction of 1a and 2a was used for this study. Firstly, the amount of nBuLi and 2a were changed, keeping the thione amount constant and when 1 eq. of 1a was treated with 1 eq. of nBuLi and 0.5 eq. of 2a, a minimal yield of only 4% 4a,a’ was formed. If the amount of 2a was doubled keeping the amount of thione and nBuLi constant, there was no change in the yield of 4a. If both the amounts of 2a and nBuLi were doubled then a slight increase of 4a,a’ was observed (from 4% to 10%) (Table 2).  Table 2: Changes in the reaction outcome as effect of a changed reaction stoichiometry. 1a (eq.) nBuLi (eq.) 2a (eq.)  Yield (%) of 4a,a’  1 1 0.5 4 1 1 1 5 1 2 1 10  This study showed the possibility to increase the yield of 3a, but only at the expense of a significantly reduced reaction selectivity. Although some new insight were gained from these results, one basic question remained: how do tricyclic 1,4-dihydro-1,4-diphosphinines form, and/or how do different solubility of tricyclic 1,4-dihydro-1,4-diphosphinines play an important role?  Therefore, the 31P NMR spectra of the reaction mixtures of 1c,d and 2a  (R = Ph, iPr and R’ = NMe2) were again carefully inspected. They showed resonance signals in low intensities at 108.4 ppm (R = iPr; 6%) and 109.2 ppm (R = Ph, 9%) which were tentatively assigned to reactive intermediates, i.e., the mono-substituted compounds, namely the amino(chloro)phosphanyl imidazole-2-thiones 5c,d. Based on this assignment as starting hypothesis, two possible routes I,II (Scheme 15) of cyclization could be imagined: (i) a stepwise deprotonation at the backbone of the acyclic bis(imidazole-2- thione-4-yl)phosphane 3 and a cyclizing phosphanylation, or (ii)  the amino(chloro)phosphanyl imidazole-2-thione 5 is deprotonated first, followed by dimerization via double salt metathesis.
Chapter 3: Investigations on the formation of tricyclic 1,4-dihydro-1,4-diphosphinines 
 35  
 Scheme 15: Hypothetical pathways of cyclization. In both cases the base involved could be the backbone-lithiated 1,3-dialkyl-imidazole-2-thione 6 as the nBuLi solution was added first in the reaction mixture which slowly gets consumed via reaction with either 2 and/or 3 and/or 5. Therefore, the backbone-lithiated 1,3-dimethyl-imidazole-2-thione 6 was synthesized by reacting the corresponding thione with nBuLi at –78 °C (Scheme 16), and could be isolated as white solid via evaporation of all volatiles at room temperature and trituration with n-pentane, hence, obtained only  as crude product.  
 Scheme 16: Synthesis of backbone-lithiated imidazole-2-thione 6. 
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 Figure 13: 1H NMR spectrum of compound 6 in THF-d8. This white solid after trituration with n-pentane gave pure compound 6 as a fine white powder in excellent yield. The 1H NMR spectra (Figure 13) of compound 6 shows loss of symmetry of the N-CH3 protons upon deprotonation along with further shielding of the backbone proton (6.0 ppm) compared 1,3-dimethylimidazole-2-thione (6.7 ppm). Further proof of the formation of 6 was given by the 7Li NMR spectroscopy where it shows a singlet resonance at 0.9 ppm, which was found to be slightly highfield shifted compared to PhLi (1.55 ppm),[65] indicating at higher electron donating ability of the imidazole-2-thione-4-yl substituent in 6. With compound 6 in hand, the viability of the first route was checked in detail using compound 6, nBuLi, tBuLi or MeLi as the base and 2a as the electrophile. Unfortunately, none of these reactions led to the desired tricyclic 1,4-dihydro-1,4-diphosphinines which underlined that the amino(chloro)phosphanyl-imidazole-2-thione (5) seems to be responsible for the cyclization. Therefore synthesis, isolation and characterization of com-pound 5 along with its utilization in the synthesis of tricyclic 1,4-dihydro-1,4-diphosphinines is discussed in the next chapter. 
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Chapter 4       4.1 Synthesis of backbone amino(chloro)phosphanyl-substituted imidazole-2-thiones The synthesis of the backbone amino(chloro)phosphanyl-substituted imidazole-2-thiones 5 started from previously reported (R’2N)2P-substituted imidazole-2-thiones 7, which was chosen due to the facile synthesis of (Et2N)2PCl and the more laborious and costly synthesis of (Me2N)2PCl. To synthesize compounds 5a-f the reaction of 7a-f with PCl3 was examined using a wide range of solvents and conditions (Scheme 17). Independent of the reaction conditions, when dichloromethane was the solvent, a mixture of the amino(chloro)phosphane (ca. 85 % by 31P{1H} NMR spectroscopy) and the diorganoamino(dichloro)phosphane (ca. 15 %) were obtained. But if  
 Scheme 17: Synthesis of the backbone amino(chloro)phosphanyl substituted imidazole-2-thiones 5a-f. 
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 the solvent was changed to diethyl ether and the reactions were carried out at lower temperatures (–20 to –40 °C), the amino(chloro)phosphanes 5a-f were observed as sole products. Compounds 5a-f were isolated as white powders in good to excellent yields via precipitation from n-pentane solutions at –40 °C. The 31P{1H} NMR spectra of 5a-f showed singlet resonance signals around 98.9-108.4 ppm being significantly downfield-shifted compared to  7a-f (Table 3). Apart from full NMR spectroscopic characterization of 5, 5f was also confirmed by X-ray crystallography using single crystals obtained by slow evaporation of its saturated dichloromethane solution at –20°C. Compound 5f crystallizes in the monoclinic crystal system with the space group P21/c. Table 3: 31P{1H} NMR chemical shifts (CDCl3) and yields for compounds 5a-f.  R R’ P Yields (%) 5a Me Et 106.1 87 5b Et Et 106.5 78 5c nBu Et 106.4 83 5d iPr Et 108.4 92 5e Mes Et 102.9 88 5f Me iPr 98.9 85  Interestingly, the molecular structure of 5f (Figure 14) reveals that the dihedral angle between the thione plane and the plane consisting of C1-P-Cl is only 1.7°. In other words, the P-Cl bond is almost coplanar with the imidazole-2-thione ring. Closer inspection of the metrical parameters revealed the  
 Figure 14: Molecular structure of compound 5f; hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°):  P-Cl 2.1274(9), P-C(1) 1.812(3), P-N(3) 1.654(2); Cl-P-N(3) 105.90(8), Cl-P-C(1) 101.69(11).
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 presence of an intramolecular hydrogen bond [dCl-H3 = 2.7557(7) Å] between the backbone H atom and the Cl atom. This H-bonding interaction is accompanied by a P-Cl bond (2.1274(9) Å) that is slightly elongated compared to any ǲnormalǳ covalent P-Cl [cf. 2.061(1) Å in (2,4-(CF3)2C6H4)2PCl][66] but significantly shorter than P-Cl bonds with some ionic character [cf. 2.759(2) Å for the chlorodiazaphospholene [(tBuN-CH=CH-NtBu)P]Cl[67] and 2.3136(7) Å for the chlorodiazaphosphole [(tBuN-CH2CH2-NtBu)P-Cl][67]]  Presumably, this H-bonding interaction causes the co-planarity of the P-Cl bond and the imidazole-2-thione ring plane.  4.2 Optimization of the ring formation reaction 4.2.1 Reaction of amino(chloro) compound 5 with backbone lithiated imidazole-2-thione Having the amino(chloro)phosphanyl-substituted imidazole-2-thiones 5a-f and backbone-lithiated 1,3-dimethylimidazole-2-thione 6 in hand, the reactions were monitored by 31P{1H} NMR spectroscopy under different reaction conditions to check the viability of route II to tricyclic 1,4-dihydro-1,4-diphosphinines. 
 Scheme 18: Reaction of the amino(chloro)compound 5a with the organolithium derivative 6. In all cases, a THF solution of 5a was treated with a THF solution of 6 (Scheme 18), changing only the minimum temperature. When the reaction was started at –78 °C, compound 6 acted only as a nucleophile and gave rise to the bis(imidazole-2-thione-4-yl)phosphane 3j appearing at 10.4 ppm in the 31P{1H} NMR spectra of the reaction mixture (Figure 15).  
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 Figure 15: 31P NMR spectroscopic monitoring of the reaction between 4d and 6. If the reaction was started at a higher temperature, e.g., at –40 °C; then a pair of singlet resonance signals at 3.9 and 4.2 ppm appeared, and if the reaction was performed at room temperature, then a further increase of these two signals were observed. The chemical shifts of these new compounds (Ͷd,d’) were found to be very close to those of 4a,b. Apart from that, further evidence came from the EI-MS data of the reaction mixture which revealed a peak at m/z 458.2. Unfortunately, isolation of 
Ͷd,d’ from this reaction mixture was not achieved, but using a more appropriate base it could be accomplished (shown later in this chapter).  
 Figure 16: Optimized intermediates and final products (H-atoms omitted for clarity) along with the reaction energies of the different steps. 
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 Theoretical insight[68] into this reaction was provided by Frontera on a slightly less bulky model compound 5a* (Me instead of Et) (Figure 16). For the calculations three discrete THF molecules were used to solvate the lithium cation, and THF was used as continuum model to further simulate the experimental conditions. In this theoretical reaction, two possible paths were calculated: the acid-base reaction (i) and the nucleophilic substitution (ii). The formation of 3a (the substitution productȌ was found to be thermodynamically favored ȋΔG1 = –38 kcal/mol) compared to the acid-base reaction, which is also an exergonic process (–9.6 kcal/mol) and produces the intermediate LVI. This intermediate is able to yield directly compound 4a (self-complementary double SN2 reaction) via a highly exergonic process. The possibility of generation of a bicyclic three-membered ring compound LVII, the product of a possible intramolecular substitution reaction, was also studied. But this pathway was highly disfavored from thermodynamic point of view ȋΔG4 = +30.0 kcal/mol). Thus theoretical investigations provided further evidence that the use of a suitable base could lead to the tricyclic 1,4-dihydro-1,4-diphosphinines 4 starting from 5.  4.2.2 Searching for the most suitable base In order to identify the best base and reaction conditions under which the 1,4-dihydro-1,4-diphosphinines can be prepared with an optimized yield,  potassium hexamethyldisilazide (KHMDS) was employed as it is known to act as sterically demanding and weakly nucleophilic  base (Scheme 19). When THF solutions of compounds 5a and 5d were treated with a THF solution of 1 eq. of KHMDS at –78 °C, surprisingly no tricyclic 1,4-dihydro-1,4-diphosphane was observed in the 31P{1H} NMR spectrum of the reaction mixture. 
 Scheme 19: Formation of the substitution products 8a,b via reaction with KMHDS. 
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 Instead, singlet resonance signals were observed at 74.9 (8a) and 74.6 ppm (8b) being very close to the corresponding backbone (R'2N)2-substituted imidazole-2-thiones 7a and 7d. The presence of the resonance signal of the C5-H hydrogen in the 1H NMR spectra of 8a,b also supported the formation of substitution products. This was confirmed by the appearance of a doublet resonance signal with a 2JP,Si coupling constant in the 29Si dept-20 spectra of 8a,b (Table 4). Compounds 8a,b could be easily extracted with toluene from the residue obtained after drying the reaction mixture, and isolated in moderate to good yields. On the other hand, when LDA was employed (Scheme 20) as base under the same reaction conditions the tricyclic 1,4-dihydro-1,4-diphosphinines Ͷd,d’-f,f’ were formed as the sole products in very clean reactions. 
 Scheme 20: Formation of the tricyclic 1,4-dihydro-1,4-diphosphinines 4d-f via reaction with LDA. The 31P{1H} NMR spectra of the reaction mixtures showed a pair of singlet resonance signals as depicted in Table 5.  Table 4: 31P and 1H NMR data for 8a,b.  P 2JSi,P(Hz) H of C5-H  yield (%) 8a 74.9 7.0 6.5 75 8b 74.6 7.2 6.6 81  
Table 5: 31P NMR data for Ͷd,d’-f,f’.  P* Isomeric ratio yield (%) 4d,d’ 3.3 & 3.9 1:1 84 4e,e’ 0.4 & 2.9 1.5:1 62 4f,f’ 0.2 & 3.6 1:1.2 50 *From reaction mixture in THF Compounds Ͷd,d’-f,f’ were easily isolated from the reaction mixture simply by a flash column chromatography using dichloromethane as the eluent followed by washing with an diethyl-ether/n- 
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 pentane mixture. The 31P NMR spectra of Ͷd,d’-f,f’ (as they are mixture of two isomers) showed a similar trend as depicted in Figure 17. Only difference between the alkyl analogues is the ΔP value between the two isomers. As we go from the N-Me derivative 4d to the N-nBu derivative 4f, the ΔP value of two isomers gradually increased (Figure 17). Besides the good yields of these three derivatives, a profoundly improved solubility was observed.  Whereas the Me derivative showed limited solubility in standard laboratory solvents, the Et analogue could be dissolved in solvents like tetrahydrofuran and dichloromethane with great ease, and the nBu derivative could be even dissolved in n-pentane to some extent (up to ~10 g/L). It was also noticed that this reaction protocol led to isomeric ratios of Ͷd,d’-f,f’ that were almost unchanged, thus ruling out any priority for an isomer.  
 Figure 17: Comparison of the 31P NMR spectra (in CDCl3) of Ͷd,d’-f,f’. 4.2.3 X-ray crystal structures and isomer assignment Single crystals for compound 4d could be grown from the mixture of two isomers by slow evaporation of a saturated dichloromethane solution at –20 °C (Figure 18). In this case the cis isomer crystallized preferably. Cis 4d crystallized in the triclinic crystal system with the Pͳ ̅space group. The metrical parameters were in complete alignment with values of cis 4b, but the six-membered ring was not completely planar (atoms P1 and P2 deviate by 0.09 Å from the ring), in 
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 contrast to trans 4a. 
 Figure 18: Molecular structure of compound 4d; hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°):P1-N5 1.685(4), P1–C1 1.819(5), C1-C2 1.367(7), C1-P1-C6 94.9(2), C1-P1-N5 105.9(2). In case of 4f, the high solubility difference between the two isomers enabled separation by repeated washing with n-pentane at –40 °C, thus separate the trans isomer in 98 % purity. This 98:2 isomeric mixture was then subjected to crystallization from n-pentane solution –20 °C, thus providing suitable single crystals for X-ray measurements which confirmed the structure for the trans isomer of 4f (Figure 19). 
 Figure 19: Molecular structure (left) of trans 4f with dispersive interaction (right) between the n-butyl chains shown; hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°):P-N2 1.673(3), P–C1 1.818(3), C1-C11 1.358(4), C1-P-C11 94.59(14), C1-P-N2 105.89(14). The 31P{1H} NMR spectrum of a solution of this crystalline material  showed a resonance signal at 3.6 ppm which clearly revealed that the peak at lower field has to be assigned to the trans isomer. The compound trans 4f crystallized in the tetragonal crystal system with the I41/a space group, and as in the case of trans 4a, the six-membered ring was entirely planar. Closer inspection of the crystal 
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 packing in trans 4f revealed that the n-butyl chains attached to N(3) have two possible orientations (split layers with the ratio of 43:57) (shown with transparent ellipsoids in Figure 19). One of these two orientations of n-butyl groups interact with three more molecules to form a square aggregate of carbon atoms (twelve of them, three from each n-butyl groups), held together by dispersive interactions. 4.2.4 Effect of the P-substitution on the outcome using the optimized protocol  The cyclization reaction was repeated for compounds 5d-f using LDA. Unfortunately, for 5d,e (d: R = iPr, R’ = Et; e: R = Mes, R’ = Et) the selectivity of the reaction mixtures were very low and formation of tricyclic 1,4-dihydro-1,4-diphosphinines was not observed in the 31P{1H} NMR spectra of the reaction mixtures. But in the reaction of 5f (R = Me, R’ = iPr) and LDA at –78 °C, the formation of a P-NiPr2 1,4-dihydro-1,4-diphosphinine derivative was observed in the 31P{1H} NMR spectrum (Figure 20), i.e., the spectrum showed two resonance signals at -12.5 and -13.1 ppm (ratio 1:2), but also those of several other by-products of unknown identity. But these two peaks can be tentatively assigned to the two isomers of the P-NiPr2 derivative although it could not be isolated from the reaction mixture. This study clearly demonstrated, again, the clear need of a sterically less demanding primary alkyl substituent at the thione N-center for the cyclization process to occur in a clean manner. 
 Figure 20: The 31P{1H} NMR spectrum of the reaction solution of 5f and LDA. 
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 4.3 Further reactivity studies on amino(chloro)phosphanyl-substituted imidazole-2-thiones Apart from their usefulness in the synthesis of tricyclic 1,4-dihydro-1,4-diphosphinines, the amino-(chloro)phosphanyl-substituted 5a-f were also tested with respect to their potential as gateway towards phosphaalkenyl-substituted imidazole-2-thiones or NHCs. For this purpose 5d and 5e were selected as they provide more steric protection, compared to 5a-c, which can be anticipated to be very important in the stabilization of a low-coordinate P-center. To start this study of their reac-tivity towards sterically demanding organolithium derivatives, i.e. fluorenyl- and diphenylmethyl-lithium were investigated. In both cases, nucleophilic substitution led to products 9a-c in excellent selectivity (Scheme 21). Importantly, no spectroscopic evidence for a competing backbone deprotonation was obtained. The 31P{1H} NMR spectra of 9a-c revealed singlets at 34.9 (broad), 30.6  
 Scheme 21: Nucleophilic substitution to introduce sterically demanding groups at the P-center in 9. 
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 (sharp) and 28.9 (broad), respectively, which are significantly upfield-shifted compared to 8d,e (108.4 and 102.9 ppm). Firm evidence for the successful formation of 9a-c was provided by the 13C{1H} NMR spectra where doublet resonances were observed that were consistent with the successful formation of the new P-C bond (Table 6). For comparison, the chemical shifts are typical of P–CHPh2 and P–CFluorenyl carbon atoms in related compounds [cf. Ph2PCHPh2: 46.19 ppm (24 Hz)[69]; Mes(nBu)PCHPh2: 51.6 ppm (16 Hz)[70]; FluPtBu(NHtBu): 47.3 ppm (39.2 Hz)[71]]. Compounds 9a-c could be easily isolated in excellent yields from the reaction mixture by flash column chromatography at room temperature using dichloromethane as the eluent. Table 6: 31P and 1H NMR data of 9a-c.  P P of P-C 1JP,C(Hz) H of P-CH  1JP,H(Hz) yield (%) 9a 34.9 51.6 13.0 4.7 3.4 60 9b 30.6 46.5 21.7 4.5 - 60 9c 28.9 47.6 22.7 4.8 - 74  Single crystals of 9a and 9b, suitable for X-ray measurements grown from dichloromethane solution, were examined by X-ray crystallography. The compound 9a (Figure 21) crystallizes in the triclinic crystal system with the space group Pͳ̅. In case of 9b the crystal system was monoclinic and the space group C2/c. The unit cell of compound 9a contains two independent molecules (70:30) which have similar metrical parameters, thus only one molecule is displayed in Figure 21. The molecular structure reveals the effects of a sterically demanding group at the phosphorus center. 
        Figure 21: Molecular structures of compound 9a (left) and 9b (right): hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°): P(1)-C(2) 1.8260(18), P(1)-N(3) 1.6877(18), P(1)-C(10) 1.8905(16); C(2)-P(1)-N(3) 101.995(73), C(10)-P(1)-C(2) 100.198(72). For compound 9b P-C(1) 1.8253(1), P-N(3) 1.6683(1), P-C(22) 1.8813(1); C(1)-P-N(3) 87.991(4), C(22)-P-C(1) 98.362(5). 
Chapter 4: Synthesis and use of amino(chloro)phosphanyl-substituted imidazole-2-thiones in the chemistry of tricyclic 1,4-dihydro-1,4-diphosphinines 
 48  
 Although the P(1)-C(2)  [9a: 1.8260(18) Å ] and analogous P-C(1) [9b: 1.8253(1) Å ] bond length falls in accordance with previously reported analogous P-imidazole-2-thione compounds [cf. PhP(IMSiPr,Me)2 1.817(2)[35], Ph2P-IMSMe,Me 1.8185(18)[10], Ph2P-IMSPh,Ph 1.8190(5)[10] etc.], the P(1)-C(10) [9a:1.8905(16) Å] and analogous P-C(22) bond [9b: 1.8813(1) Å] are significantly elongated compared to P-C bonds in related type of compounds with other substituents on the P-center [cf. Ph2P(O)-(IMSiPr,Me)-PPh2 1.8360(18)[32], Ph2P-IMSMe,Me 1.8368(18),[10] etc.]. Likely, this elongation of the P-C bond reflects the increased steric demand at the P-center caused by the introduction of di-phenylmethyl (9a) and fluorenyl (9b) moiety. To examine whether 9 may serve as a gateway for the broader exploration of phosphorus chemistry, we focused first on the possibility of phosphaalkene formation. To provide protection against dimerization and/or oxidation of the desired P=C bond, the borane adduct 10 was prepared. The reaction of 9c with BH3-SMe2 in dichloromethane was monitored by 31P{1H} NMR spectroscopy to reveal a singlet resonance at 58.1 ppm assigned to 10 that was significantly downfield shifted compared to 9c ( = 28.9) (Scheme 22). Compound 10 was crystallized from a saturated dichlorom- 
 Scheme 22: Synthesis of BH3 complex 5 and imidazolium salt 6. 
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 ethane solution at –20 °C. The borane-adduct 10 crystallized in monoclinic crystal system with the space group P21/c (Figure 22). The molecular structure revealed a slightly shortened P(1)-N(3) bond distance [1.6519(13) Å] compared to a P-N bond in 9a [1.6877(18) Å], upon complexation to borane. The fluorenyl group and the imidazole-2-thione are arranged in an almost perpendicular fashion (dihedral angle 85.24°) which is possibly due to intramolecular steric effects. To check whether compound 9 can act as a precursor for an imidazolium salt and, hence, a precursor to an NHC, compound 9c was reacted with 5.5 eq. of H2O2 in methanol at 0 °C (Scheme 22).  
 Figure 22: Molecular structure of compound 10; hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°): P(1)-B(1) 1.9277(17), P(1)-N(3)  1.6519(13), P(1)-C(10) 1.8568(13), P(1)-C(3) 1.8099(12); N(3)-P(1)-C(10) 109.793(59), C(3)-P(1)-C(10) 101.389(59), B(1)-P(1)-C(10) 109.067(65), B(1)-P(1)-N(3) 114.678(65), B(1)-P(1)-C(3) 117.085(66). Surprisingly, the 31P{1H} NMR spectrum of the reaction mixture revealed only a minor change in the chemical shift of 11 (29.5 ppm) compared to 9c (28.9 ppm). For this reason successful formation of 11 had to be confirmed from the 1H and 13C{1H} NMR spectra of the isolated product. Importantly, the 1H NMR spectrum showed a new resonance at 9.89 ppm assigned to the C2-H of imidazolium derivative 11. Further evidence for the formation of 11 was collected from the 13C{1H} NMR spectrum as the resonance signal for the C=S carbon nucleus was not present (162.4 ppm) and was replaced by a doublet at 142.5 ppm (3JP,C = 5.4 Hz). The latter is characteristic of an imidazolium salt having a C4–bound P-substituent (cf. [Ph(O)P(IMHtBu,Me)2]Cl2: 141.5 ppm; 3JP,C = 5.8 Hz).[19, 34, 72] Conclusive evidence for the assignment of the product as imidazolium 11 was revealed by the ESI-MS spectrum which showed an ion peak at m/z 436.3 corresponding to a cation of C29H36N4OP.
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 To have a broader scope of future investigations on P-substitution reactions, the amino group in 9a,b was exchanged for a P-Cl group using 1 molar eq. of PCl3 in dichloromethane at –20 °C (Scheme 23). The reaction mixture was monitored by 31P{1H} NMR spectroscopy to reveal that the signal for 9a,b (34.9 and 30.6 ppm) had been completely replaced by a new, singlet at 53.4 tentatively assigned to 12a (64.7 ppm for 12b) together with (Et2NPCl2 (163.3 ppm) as the other phosphorus-containing product. Compounds 12a,b were isolated in excellent yields as white powders from the reaction mixture via precipitation from n-pentane at –40 °C. The 1H NMR spectrum of 12a,b confirmed that the signals for the ethyl moieties of the (replaced) NEt2 group were no longer present. 
 Scheme 23: Synthesis of P-Cl derivatives 12 by PCl3 mediated P-N bond cleavage. To examine the reactivity of the P-chloro function in 12 towards a strong donor (and neutral base), reaction of 12a with 1,3,4,5-tetramethylimidazole-2-ylidene[11] in THF at –40 °C was carried out. This showed a clean conversion of compound 12a into the NHC-stabilized phosphenium salt 13 (Scheme 24). Compound 13, due to its ionic character precipitated from the reaction mixture. The crude product was filtered and washed with THF to purify compound 13. This resulted in its isolation in good yields (60 %) and purity. Compound 13 was fully characterized by means of all standard analytical methods. The 31P{1H} NMR spectrum of NHC-phosphenium adduct 13 in CDCl3 showed singlet resonance –47.4 ppm in which is shifted upfield compared to 14 (Figure 23, P = –27.3 ppm).[73] Nevertheless, the value is in good agreement with the related phosphenium cation 15 (P = –68.6 ppm)[36] (Figure 23), reported recently. Further evidence for the assigned structure of 13 was obtained from an ESI-MS experiment which exhibited an ion peak at m/z 505.6, assigned to a cation of C29H36N4PS, which is the m/z value of the cation in 13. 
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  Scheme 24: Reaction of 12a with IME4 to form NHC-stabilized phosphenium salt 13. 
 Figure 23: Chemical shifts of known NHC-stabilized phosphenium derivatives 13-15. The interesting perspective to examine was the viability of P-chloro phosphane 12a as precursor to a novel backbone substituted phosphaalkenyl imidazole-2-thione. Thus, THF solutions of 12a were treated with different bases to achieve the desired dehydrohalogenation. Unfortunately, these efforts were met with limited success as inseparable product mixtures were obtained, irrespective 
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 of the reaction conditions. For example, treatment of a colorless solution of compound 12a with nBuLi (1 eq.) at –78 °C in THF yielded instantly a dark purple solution, which slowly turned yellow over a period of 30 min. The 31P{1H} NMR spectrum of this reaction mixture showed a broad resonance for the major product at –33.9 ppm which was tentatively assigned as 17 (Scheme 25). For comparison, a similar chemical shift was observed for the related lithium-ate complex Li[MesP(nBu)-CPh2] (P = –31.1 ppm).[70] Interestingly, this compound, which was obtained from the reaction of MesP=CPh2 and nBuLi under similar reaction conditions, is also purple in solution. Thus, it was assumed that the target molecule (16) might be formed transiently but reacted with the nucleophile nBuLi to give 17 due to its high reactivity. At this point, it was concluded that an increased steric protection of the P-center might be required. 
 Scheme 25: Attempted dehydrohalogenation of compound 12a using nBuLi. With this result in hand, the reaction was repeated using the sterically more hindered 12b in an effort to stabilize a transiently formed phosphaalkene. Thus 12b was treated first with nBuLi (1 eq.) under same reaction conditions as in the case of 12a. The 31P{1H} NMR spectrum of the reaction mixture showed a resonance signal at –30.6 ppm for the major product along with a signal for a minor product at –60.7 ppm. Interestingly, when 12b was treated with nBuLi (2 eq.) the same species became the major product. Addition of HCl (1 eq. in diethyl ether solution) to this inter-mediate species resulted in complete conversion to the product having the resonance at –30.6 ppm. This final product was isolated and fully characterized as compound 18 (Scheme 26). The 31P NMR spectrum of compound 18 in CDCl3 shows a triplet at –31.3 ppm (3JP,H = 7.9 Hz) indicative of the presence of the P-nBu moiety. Furthermore, the appearance of a doublet at 27.6 ppm (1JP,C = 17.8 Hz) in the 13C{1H} NMR spectrum provides evidence for the P-C bond of the P-nBu moiety in 18. 
Chapter 4: Synthesis and use of amino(chloro)phosphanyl-substituted imidazole-2-thiones in the chemistry of tricyclic 1,4-dihydro-1,4-diphosphinines 
 53  
 Scheme 26: Attempted dehydrohalogenation of compound 12b using nBuLi. This result is remarkable as it suggests that compounds 12a,b, in the presence of nBuLi, have a clear preference for nucleophilic substitution to give 18 over dehydrohalogenation to give the phospha-alkene. In the presence of an excess nBuLi, compound 18 undergoes deprotonation to afford lithium–ate complex 19 which on protonation gives 18. In a final attempt to obtain evidence for a phosphaalkene intermediate, 12b was treated with tBuLi (1 eq.). In stark contrast to reactions involving nBuLi, the 31P NMR spectrum of this reaction mixture showed a doublet at –117.1 ppm (1JP,H = 217.4 Hz) for the major product. The latter data clearly do not correspond to the desired phosphaalkene and the large P-H coupling constant suggests a compound with a direct P–H bond.[36] Unfortunately, attempts to isolate this P-H derivative failed due to decomposition during isolation. In closing, none of the aforementioned reactions of 12 with RLi provided confirmation for the involvement of a phosphaalkene.  
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Chapter 5     As described in chapter 3, the previous route to tricyclic 1,4-dihydro-1,4-diphosphinines, described in Scheme 13, gave access only to P-amino derivatives of compound 4, but other derivatives differing in the nature of the P-substituents failed. Therefore, the synthesis of P-phenyl-substituted derivatives could be promising if the new LDA-based protocol would be employed. 5.1 Synthesis of P-phenyl-substituted 1,4-dihydro-1,4-diphosphinines 5.1.1 Synthesis of the required precursors  The plan to synthesizing P-Ph derivatives of compounds 4 had to start with the diethylamino-(phenyl)phosphanyl-substituted imidazole-2-thiones 20a-c. Here, we initially focused on the synthesis of compounds with only primary alkyl groups on the thione N-centers, as they had allowed to access tricyclic 1,4-dihydro-1,4-diphosphinines when treated with LDA. Compounds 20a-c were easily synthesized via phosphanylation of the corresponding 1,3-dialkyl-imidazole-2-thiones following the literature reported methodology[10, 32, 35, 74] using Et2N(Ph)PCl as the electrophile. These reactions were monitored by 31P NMR spectroscopy, where broad singlet resonance signals were observed at 35.2 ppm (20a), 33.5 ppm (20b), and 32.7 ppm (20c), respectively. Compounds 20a-c were isolated from the reaction mixture in 90-95 % purity in all cases, and were used as such for the next step. The ultimate purification was not done as it was known that this type of reaction is not sensitive towards the presence of slight amount of impurities. Compounds 20a-c reacted with 1molar eq. of PCl3 at r.t. in dichloromethane solution to convert the P-NEt2 into the P-Cl functionality selectively (Scheme 27) which was further confirmed by 1H and 31P NMR spectroscopy. In the 1H NMR spectra of 21a-c the resonance signals for the NEt2 protons 
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 were absent and the 31P NMR spectra showed significantly downfield-shifted triplet resonances when compared to 20a-c (Table 7). Both compounds 21a and 21b were isolated as white powders after trituration of the crude residue obtained after drying the reaction mixture and removal of all volatiles. But in case of 21c, the crude mixture could be purified by washing with n-pentane due to its solubility in n-pentane along with that of the impurities. For this reason the side product, i.e., Et2N PCl2 distilled out (60 °C and 5 × 10-3 mbar) from the crude product mixture. The effect of the replacement of the dialkylamino group with a phenyl group in 21a-c was apparent from the 31P{1H} NMR spectra as a significant upfield-shift, compared to compound 5a-f, was observed  (Table 7). 
 Scheme 27: Synthesis of chloro(phenyl)phosphanyl-substituted imidazole-2-thiones 21. Table 7: 31P{1H} NMR data (CDCl3) and yields for 21a-c.  P P comparision  3JP,H (Hz) Yield (%) 21a 50.5 35.2 (20a) 8.5 85 21b 50.2 33.5 (20b) 8.9 74 21c 49.9 32.7 (20c) 8.9 80  Single crystal of compound 21a suitable for X-ray crystallographic measurements was grown from its saturated dichloromethane solution at –20 °C (Figure 24). It crystallized in the triclinic crystal system with the Pͳ̅ space group. The P-Cl bond in this case is out of the imidazole-2-thione ring plane (dihedral angle between C3-C1-P and Cl-P-C1 planes is 55.204°) unlike in the case of its diisopropylamino analogue where it was almost coplanar with the thione plane. Still the P-Cl bond length is in the same range of previously discussed 5f.  
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 Figure 24: Molecular structure of compound 21a; hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°): P-C(1) 1.7879(1), P-C(6) 1.8270(1), P-Cl 2.1056(1) ;  C(6)-P-C(1) 103.853(3), C(1)-P-Cl 101.480(2).  5.1.2 Application of the new protocol with compounds 21a-c In order to examine the newly developed protocol to form tricyclic 1,4-dihydro-1,4-diphosphinine, the compounds 21a-c were treated with a THF solution of LDA at –78 °C , leading to a clean conversion into two products in each case.  
 Scheme 28: Synthesis of P-Ph tricyclic derivatives 22. According to significantly highfield-shifted singlet resonances in the 31P NMR spectra they were tentatively assigned to the two isomers of 1,4-dihydro-1,4-diphosphinines 22a-c (Scheme 28 and Table 8); 21c and 22c,c’ (two isomers) are shown as examples in figure 25. In case of 21a a white precipitate was formed that could be filtered and characterized as the tricyclic 1,4-dihydro-1,4-diphosphinines 22a,a’. For 21b,c the reactions resulted in clear solutions due to the longer N-bound alkyl chains of the tricyclic 1,4-dihydro-1,4-diphosphinine 22b,b’-c,c’. The latter two were isolated as white powders in moderate to good yields via flash chromatography through a silica bed at room temperature using dichloromethane as the eluent.  
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 Table 8: 31P{1H} NMR chemical shifts, isomer ratio and yields of 22a,a’-c,c’.  P Isomer ratio Yield (%) 22a,a’ -55.9 , -57.1 6:1 80 22b,b’ -54.9 , -56.6 1.2:1 51 22c,c’ -54.9 , -56.2 1:1.9 48  In case of all three tricyclic 1,4-dihydro-1,4-diphosphinine 22a-c two stereoisomers were present in the reaction mixture (Table 8), but with different ratios. For example, for compounds 22a,a’ the ratio of 6:1 was determined by 31P NMR integration revealing the preference for the formation of the cis isomer. 
 Figure 25: Comparison of 31P{1H} NMR spectra of compounds 21c and 22c,c’. Interestingly, the solubility difference between the isomers was pronounced, i.e., the trans isomer was always much less soluble. Furthermore, it was observed that during flash chromatography through a silica bed using dichloromethane as the eluent) the isomeric ratio changed to 17:1 due to a significant loss of the trans isomer on the solid phase of the column.  The mixture mentioned beforehand and being rich in the cis isomer, was used for the crystallization of 22a and single crystal X-ray diffraction measurements confirmed the stereochemistry of cis 22a (see below). The 31P{1H} NMR spectrum of crystals, dissolved in dichloromethane,  showed a signal at -55.9 ppm thus leading to the assignments of the other signal at -57.1 ppm to the trans isomer. 
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 Figure 26: Molecular structure of compound 22a; hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°): P(1)-C(1) 1.8149(8), P(1)-C(7) 1.8084(9), C(1)-C(3) 1.3493(6);  C(1)-P(1)-C(7) 94.580(22). Single crystals of cis 22a suitable for X-ray crystallographic analysis were grown by slow evaporation of a dichloromethane solution at room temperature. 22a crystallized in the monoclinic crystal system with the P21/c space group (Figure 26). Although the phenyl rings were found to be significantly distorted, the structure confirmed the constitution of 22a. Unfortunately, single crystals for 22b could not be grown in good quality, but for 22c crystals were grown from a dichlor-  
    Figure 27: Molecular structure of cis 22c (left) and its solid state arrangement (right); hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°): P(1)-C(1) 1.8149(8), P(1)-C(7) 1.8084(9), C(1)-C(3) 1.3493(6);  C(1)-P(1)-C(7) 94.580(22). omethane solution at –20 °C. X-ray crystallographic measurements revealed that 22c crystallized in the triclinic crystal system with the Pͳ̅ space group (Figure 27).  The six-membered ring was slightly
Chapter 5: Investigations on the synthesis of P-Ph and P-alkyl substituted tricyclic 1,4-dihydro-1,4-diphosphinines 
 59  
 ring was slightly bent showing dihedral angle between the planes C(1)-C(3)-C(12)-C(14) and C(1)-P(1)-C(12) of 10.85°. The packing pattern in compound cis 22c revealed that two neighboring layers juxtaposed on each other in a crisscross fashion with all the n-butyl chains and phenyl ring directed to the inwards direction. This particular orientation is probably due to the presence of dispersion interaction between the alkyl chains of two layers. 5.1.3 Reaction with KHMDS As in the case of 5, compounds 21a-c were subjected to treatment with KHMDS in THF solution at –78 °C (Scheme 29) but the same substitution reaction occurred under this condition to give two products With singlet resonances at 27.1 ppm (23a) and 24.5 ppm (23b) in the 31P{1H} NMR spectrum. Compounds 23a and 23b were isolated by a flash chromatography using a silica bed and toluene as the eluent. Further proof for the substitution was then obtained from the 1H NMR spectra of 23a and 23b showing doublet resonances for the backbone C5-H at 6.5 ppm (for 23a,3JP,H = 1.6 Hz) and 6.3 ppm(for 23b, 3JP,H = 1.5 Hz), respectively.  
 Scheme 29: Reaction of compounds 21a,b with KHMDS.  The substitution product was finally confirmed by X-ray crystallographic measurements of compound 23b using single crystals grown from a saturated solution in diethylether at –20 °C. Compound 23b crystallized in the orthorhombic crystal system with the P212121 space group (Figure 28). 
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 Figure 28: Molecular structure of compound 23b; hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°):P-C(1) 1.8267(1), P(1)-C(8) 1.8327(1), P-N(3) 1.7177(1), N(3)-Si(1) 1.7736(1) ; C(1)-P-C(8) 101.459(3), C(1)-P-N(3) 105.288(3).  5.2 Synthesis of tricyclic 1,4-dihydro-1,4-diphosphinines with P-alkyl substituents 5.2.1 Synthesis of 1,4-dihydro-1,4-dichloro-1,4-diphosphinines In order to enable broader investigations, a study on the synthesis of tricyclic 1,4-dichloro-1,4-dihydro-1,4-diphosphinines, starting from their P-amino analogues, was initiated. Therefore, the with P-diethylamino-substituted 1,4-dihydro-1,4-diphosphines 4d,d’ and Ͷf,f’ were preferentially used to ensure a high solubility of the products. Treatment of colorless solutions of compounds 4d,f in dichloromethane with 2  eq. of PCl3 at room temperature (Scheme 30) resulted in an immediate color change to yellow-orange which, in case of 4d,d’, was accompanied by the formation of a yellow-orange precipitate. 
  Scheme 30: Synthesis of P-Cl functional tricyclic compounds 24a,a’-b,b’. 
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 Figure 29: 31P{1H} NMR spectra of 24a,b in CD2Cl2, room temperature. Surprisingly, the 31P{1H} NMR spectrum of the reaction mixtures did not show any change of the chemical shift values but a broadening of the resonance signals, e.g., the FWHM for 4d was 2.7 Hz compared to 93.5 Hz for 24a (in CD2Cl2).  After separation of the yellow precipitate, the 31P{1H} NMR spectrum of this solid, dissolved in dichloromethane, showed two singlet resonance signals at 5.7 and 10.5 ppm, respectively (ratio 1:1.5) which were different from the starting material 4d; a similar observation was made for 4f and 24b (2.6 and 10.9 ppm respectively for two isomers with a ratio of 1.8:1) (Figure 29). Further analytical studies (EI-MS, EA analysis and HRMS data) confirmed the nature as to be the 1,4-dichloro-1,4-dihydro-1,4-diphosphinines 24a,a’ (two isomers). The P value of 24a appeared to be highfield-shifted compared to the literature reported 1,4-dichloro-1,4-dihydro-1,4-diphosphinine (25.8 ppm), reported by Huryeva et al. in 2010;[46] this is certainly due to their different backbone natures. Both 1,4-dihydro-1,4-dichloro-1,4-diphosphinines 24a,a’-b,b’ were isolated in good yields (90 % for 24a; 82 % for 24b), and a complete analytical data set was obtained for both of them. 5.2.2 Nucleophilic substitution of P-chloro compounds Having the P-chloro derivatives 24a,b in hand, the first reactivity feature was to study substitution reactions, in general, and reactions of carbon-based nucleophiles, in particular. To get access to P-alkyl 1,4-dihydro-1,4-diphosphinines, firstly nBuLi was chosen and the reaction with compounds 24a,a-b,b’  studied at –78 °C in THF (Scheme 31). Due to its limited solubility in THF under the reaction conditions, compound 24a,a’ formed an orange suspension but, upon addition of nBuLi, the
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 Scheme 31: P-substitution reactions on 24a,b using carbon-based nucleophiles. color of the reaction mixture turned dark brown and became a clear solution after some minutes. The 31P{1H} NMR spectrum of an aliquot showed two singlets at –56.5  and –63.5 ppm (ratio 1:2.9), respectively, (Figure 30). As the reaction was very selective, compound 25a,a’ was isolated easily by flash column chromatography; the ratio of the cis and trans isomer was 1:2.3.  In a similar vein, compound 25b,b’ (mixture of two isomers) was easily obtained as a mixture of cis (-66.3 ppm) and trans (-58.5 ppm) isomers (ratio 1:12) (Figure 30) via treatment of 24b,b’ with nBuLi. Compound 25b was fully characterized using crystalline samples of the trans isomer, confirmed by X-ray crystallography, and standard analytical methods.  
 Figure 30: 31P{1H} NMR spectra of 25a,a’-c,c’ in CDCl3, room temperature. 
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 The presence of six hydrophobic n-butyl chains in compound 25b made it highly soluble in solvents like diethyl ether or even in n-pentane to some extent, which is a rare observation in this tricyclic 1,4-dihydro-1,4-diphosphinine chemistry. The molecular structure of trans 25b was confirmed by X-ray diffraction measurements using single crystals grown from a saturated diethylether solution at –20 °C. The compound 25b crystallizes in the monoclinic crystal system with the P21/c space group (Figure 31). The molecular structure reveals planarity of the tricyclic ring and an intermolecular dispersive interaction between the n-butyl chains, thus leading to an alkyl chain pairing that was described previously in compound 4e.  
  Figure 31: Molecular structure of trans 25b (left) and alkyl chain pairing (right) in the solid state; hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°): P-C(1) 1.8108(2), P-C(2) 1.8175(2), P-C(12) 1.8602(2);  C(1)-P-C(2) 95.998(7), P-C(1)-C(2) 131.740(12). To obtain a P-substituent that would allow further functionalization/modification, lithium trimethylsilylacetylide was chosen as the nucleophile, obtained by reacting trimethylsilylacetylene and nBuLi at –78 °C in THF solution, and used in situ in the reaction with 24b,b’ to yield a clean outcome. The 31P NMR spectrum consisted only of two isomers of 25c (Scheme 30) with resonance signals at –79.9 and –88.1 ppm (Figure 30), respectively, (ratio of 1:2). Compound 25c,c’ was isolated as beige powder in moderate yield (45%) via flash column chromatography over a solid phase of silica using toluene as the eluent. 
Chapter 6: Reactivity studies on P- and S-centers of tricyclic 1,4-dihydro-1,4-diphosphinines 
 64  
 
Chapter 6      Though 1,4-dihydro-1,4-diphosphinines are known for over five decades, their reactivity studies lack diversity beyond coordination chemistry which concerns mostly the chemistry of the P-centers. All previously known derivatives, except compound XXXIV, possessed only P-C bonds, thus clearly restricting further functionalization. But even for compound XXXIV, no further reactivity studies were described, except preliminary oxidative studies.[38, 40, 46] Therefore, the exploration of this novel class of tricyclic imidazole-2-thione-based 1,4-dihydro-1,4-diphosphinines 4a-f and 22a-c was a great opportunity. The reactivity studies focused on examples of fundamental reactions of the P-centers such as oxidation/sulfurization and coordination. In addition, reactivity towards hard electrophiles were of interest. 6.1 Oxidation of the P-centers in tricyclic 1,4-dihydro-1,4-diphosphinines For the purpose of oxidizing the P-centers without touching the C=S units, compounds 4d,d’-f,f’, 22a,a’-c,c’ were treated with hydrogen peroxide-urea adduct. From the P-NR2 derivatives of these tricyclic 1,4-dihydro-1,4-diphosphinines compounds 4d-f were chosen for this oxidation studies, mainly because of their superior solubility compared to 4a-b. When dichloromethane solutions of compounds 4d,d’-f,f’ were treated with 2 molar eq. of hydrogen peroxide-urea adduct at ambient temperature, the 31P{1H} NMR spectra of the reaction mixtures revealed complete consumption of the starting materials after 24h for 4d,d’, 36 h for Ͷe,e’ and almost 2 days for Ͷf,f’ (Scheme 32). For example, the 31P{1H} NMR spectrum of the reaction mixture of 26a,a’ (mixture of two isomers) showed two singlets at -4.3 and -5.1 ppm, respectively, (ratio 1.9:1) (Figure 32), and the isomeric
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 Scheme 32: Oxidation of compounds Ͷd,d’-f,f’; ʹʹb,b’-c,c’ using the hydrogen peroxide-urea adduct. ratio did not change during the reaction course. Due to lack of any reported P values for the bis-oxides of 1,4-dihydro-1,4-diphosphinines, a comparison of P values is not possible. Compound 26a was isolated easily in moderate yields by a two-step protocol which includes filtration at the first step to remove the urea and drying over MgSO4 in the next step (Table 9). In all these three cases of 26a,a’-c,c’, the solubility of the products were not largely altered due to oxidation of the P-centers. But for both 26a,a’ and 26b,b’ the melting points went up markedly, compared to their parent compounds 4d,d’-f,f’. For example, upon P-oxidation the 3JP,H coupling constant value between theP-center and the methylene protons of the NEt2 group increased significantly, e.g., from 6.6 Hz in 4d,d’ to 12.5 Hz in 26a,a’, thus also enabling the splitting pattern (quintet) of the resonance signals in the 31P NMR spectrum distinguishable. In the same manner compound 26b,b’ was also isolated easily   
 Figure 32: Comparison of the 31P{1H} NMR spectra (CDCl3) of compounds Ͷd,d’ and 26a,a’. 
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and the chemical shifts (with isomeric ratio) are listed in tabular form in Table 9. For compound 
ʹ͸c,c’ unfortunately the selectivity of the reaction mixture went down significantly which prevented the successful isolation of compound 26c,c’ in proper purity.  Table 9: 31P{1H} NMR chemical shifts, isomer ratio and yields of 26a,a’-e,e’.  R R’ P (CDCl3) Isomer ratio Yield (%) 26a,a’ Me NEt2 -4.3 , -5.1 1.9 : 1 56 26b,b’ Et NEt2 -4.6 , -5.2 1.5 : 1 65 26c,c’* nBu NEt2 -4.8 , -5.4 5.3 : 1 - 26d,d’ Et Ph -5.9 , -7.4 1 : 1.3 68 26e,e’ nBu Ph -6.7 , -8.4 1.3 : 1 75 
* data from the reaction mixture in dichloromethane But closer inspection of the 31P{1H} NMR spectrum of the reaction mixture showed two singlet resonance signals at -4.8 and -5.4 ppm respectively revealing the formation of compound 26c,c’ in the reaction mixture. Single crystals of compound 26a, suitable for X-ray crystallographic measurements could be grown by slow evaporation of its saturated dichloromethane solution at room temperature (Figure 33). The result of this measurement revealed the solid state molecular structure for the trans isomer of compound 26a which crystallized in the triclinic crystal system with the Pͳ̅ space group. The six-membered ring was in plane with the other two five-membered rings.  
 Figure 33: Molecular structure of trans 26a; hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°): P(1)-C(1) 1.7779(1), P(2)-C(2) 1.7784(1), P(1)-O(1) 1.4851(1), P(1)-N(3) 1.6256(1) ;C(1)-P(1)-C(10) 99.446(4), N(3)-P(1)-O(1) 113.239(5). 
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It seemed to be an obvious next step, to compare the reactivity of P-Ph derivatives in this oxidation study using the N-Et (22b,b’) and N-nBu (22c,c’) compounds, but not the N-Me derivative (22a,a’) due to its comparatively lower solubility. The reaction mixtures containing 22b,b’-c,c’ and hydrogen peroxide-urea adduct showed again two singlet resonance signals in their 31P{1H} NMR spectra. The P-dioxides 26d,d’-e,e’ showed a much more pronounced change in the P value from their starting materials 22b,b’-c,c’ (Table 9). This huge change in the P value reflects the drastic change that occurs in the electronic environment of the P-centers upon oxidation (Figure 34). Again the isomeric ratio didn’t change during the process of oxidation but the relative position of the isomers did change. Upon oxidation, the 3JP,H between the P-centers and the two ortho-protons of the phenyl rings increased notably, which changed the signal splitting pattern from 22b,b’ (broad signal) to 26d,d’ (triplet). Compounds 26d,d’-e,e’ could easily be isolated as white powders and the melting point of the P,P’-dioxides 26d,d’-e,e’ were again much more raised than those of compounds 22b,b’-c,c’ like in the cases of compounds P-NR2 derivatives. 
 Figure 34: Comparison of 31P{1H} NMR spectra of compounds 22b,b’ and 26d,d’. Single crystals of compound 26d (Figure 35) could be grown from the cis/trans isomer mixture and were subjected to X-ray crystallographic measurement revealing the solid state structure for the cis-26d; it crystallized in the monoclinic crystal system with the P21/n space group. Although the resulting quality of this crystal structure was not very good, it could be still used to confirm the molecular constitution. The low quality resulted from distorted imidazole-2-thione (C16-N4-Cͳͷ’ fragment) rings which showed unusually short C16-N4 bond and long Cͳͷ’-N4 bond. 
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 Figure 35: Molecular structure of cis 26d; hydrogen atoms are omitted for clarity (50% probability level).  6.2 Oxidation using elemental sulfur The sulfurization of the 1,4-dihydro-1,4-diphosphinines were performed following the same protocol which was reported previously for the sulfurization of backbone phosphanyl-substituted imidazole-2-thiones[32] and bis(imidazole-2-thione-4-yl)phosphanes.[35] In all these reactions 4d,d’-
f,f’ and 22b,b’-c,c’ were employed as starting materials and 2.2 molar eq. of elemental sulfur in each case and heated in toluene solution at 110°C (Scheme 33). All reaction mixtures were monitored with 31P{1H} NMR spectroscopy and consumption was observed after largely varying time spans of 1 day to 1 week. 
  Scheme 33: Synthesis of the P-sulfides 27a,a’-e,e’. 
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The isomeric ratio, revealed from the 31P{1H} NMR spectra of the reaction mixtures, in this case did not change during the course of sulfurization, but the relative position of the isomers did change (Figure 36). After completion, the products 27a,a’-c,c’ were easily isolated by removing the solvent and washing with n-pentane in good yields as white powder. The solubility of these products were not largely altered due to oxidation of the P-centers. Two new singlet resonance signals appeared in the downfield region (around 20 ppm) (Table 10), corresponding to two isomers (cis/trans) of the products. For example, in case of compound 27a,a’ the 31P{1H} NMR spectrum shows two peaks at 19.3 and 20.7 ppm (ratio 1:1.5) respectively for two isomers (Figure 37), which fell in the range of 
P value for the P,P’-disulfides of compound XXXIV (31.9 ppm).[46] The 3JP,H coupling constant for the methylene protons of the NEt2 groups increased, again, significantly (from 6.6 Hz in 4c to 13.6 Hz in 27a, quintet). This incremental increase of the coupling constant seems to be typical for the increased oxidation state of the P-center (III to V). The reaction times, the yields, the ratio of the isomers and the 31P{1H} NMR chemical shifts are listed in Table 10. Table 10: 31P{1H} NMR chemical shifts, isomer ratio and yields of 27a,a’-e,e’.  R R’ P Isomeric ratio Reaction time Yield (%) ʹ͹a,a’ Me NEt2 19.7 , 20.3 1: 1.5 1 day 65 ʹ͹b,b’ Et NEt2 20.1 , 20.5 1:1.2 1 day 72 ʹ͹c,c’ nBu NEt2 19.9 , 20.2 15 : 1 1.5 day 55 ʹ͹d,d’ Et Ph 1.5 , 3.0 1.3 : 1 1 week 80 ʹ͹e,e’ nBu Ph 1.4 , 3.1 10 : 1 1 week 75 
 Figure 36: 31P{1H} NMR spectra of the isomer mixtures of compounds 4d,d’ and 27a,a’. 
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 Figure 37: Molecular structure of trans 27a; hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°):P-C(1) 1.7942(1), P-C(2) 1.7946(1), P-S(2) 1.9376(1), P-N(3) 1.6451(1) ;C(1)-P-C(2) 99.687(5), N(3)-P-S(2) 114.107(4). Single crystals, suitable for X-ray crystallographic measurements, of compound 27a could be grown by slow evaporation of its saturated dichloromethane solution at room temperature (Figure 37). The X-ray crystallographic analysis revealed solid state structure for the trans isomer of compound 27a. It crystallized in the triclinic crystal system with the Pͳ̅ space group. Closer inspection of the metrical parameters revealed that crystal structure of compound 27a showed close similarities with that of literature reported P-disulfide of compound XXXIV.[46] 
 Figure 38: Comparison of 31P{1H} NMR spectra of compounds 22b,b’ and 27d,d’.  
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In case of the P-Ph derivatives 22b,b’-c,c’, the reactions proceeded extremely slow even at this high temperature (110 °C). The 31P{1H} NMR spectra of the reaction mixtures revealed only ~20 % (max.) conversion of the starting materials after a day of heating and completion was achieved after one week at high temperature. The 31P{1H} NMR spectra of the reaction mixtures showed two singlets in the downfield region, again, compared to the starting material. For example, compound 27d,d’ showed two singlets at 1.5 and 3.0 ppm, respectively, (ratio 1.3:1) for its two isomers, shifted almost 50 ppm towards the downfield region. The isomeric ratio in this case was found to be changing slightly from that of the starting material 22b,b’ (1:1.5). This could be due to inversion of the –NR2 at the P-center at higher temperature. Compounds 27d,d’-e,e’ could easily be isolated as white powders from the reaction mixture in excellent yields (Table 10). The increment in the oxidation state of the P-center showed its clear reflection on the P value of the P,P’-disulfide 27d,d’.  (Figure 38). Upon sulfurization, the 3JP,H between the P-centers and the two ortho-protons of the phenyl rings increased notably, which changed the signal splitting pattern from 22b,b’ (broad signal) to 27d,d’ (triplet).  
 Figure 39: Molecular structure of cis isomer of compound 27d; hydrogen atoms are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°): P-C(1) 1.8037(0), P-C(2) 1.7967(1), P-S(2) 1.9731(1), P-C(8) 1.8016(1) ;C(1)-P-C(2) 100.332(2), C(8)-P-S(2) 115.633(1). X-ray crystallographic analysis of compound 27d revealed the solid state structure of the trans isomer, which crystallized in the trigonal crystal system with the P3121 space group. The metrical parameters were found to be similar to the P-NR2 derivative 27a, with the exception of a slightly elongated P-S(2) bond [1.9731(1) Å] compared to 27a [1.9376(1) Å]. 
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6.3 Oxidation using ortho-chloranil Having seen a clear preference for a P-oxidation and P-sulfurization, the 1,4-dihydro-1,4-diphos-phinines 4d,d’-f,f’ and 22b,b’-c,c’ were used to investigate reactions with o-chloranil. Here, the idea was to access first examples of spirocyclic phosphorane derivatives having a tricyclic array. Treatment of 4d,d’-f,f’ and 22b,b’-c,c’ with two eq. of o-chloranil in dichloromethane at ambient temperature, resulted in clean reaction only in case of 4d,d’-f,f’.  In the case of 1,4-dihydro-1,4-diphosphinines 22b,b’-c,c’ the reactions were unfortunately very unselective and nothing could be concluded or isolated from the reaction mixtures.  
 Scheme 34: Oxidation reactions of tricyclic 1,4-dihydro-1,4-diphosphinines Ͷd,d’-f,f’ using o-chloranil. In case of the P-dialkylamino derivatives 4d,d’-f,f’ (Scheme 34), the 31P{1H} NMR spectra revealed a selective formation of 28a,a’-c,c’. The time needed to complete the reaction in these cases was found to have a direct dependence on the N-substituents on the thione fragments of the tricyclic 1,4-dihydro-1,4-diphosphinines 4d,d’-f,f’. The N-Me derivative reacted much faster (6h to reach completion) compared to the bulkier N-nBu analogue (it took 16h, despite the better solubility of the latter). Compound 28a,a’ could be easily isolated from the reaction mixture just by successive washing with dichloromethane (with minimum amount of solvent at 0 °C to minimize compound loss) and diethyl ether in excellent yield (Table 11). In the same manner, compound 28b,b’-c,c’ could also be isolated in great yield as a mixture of two isomers. The 31P{1H} NMR spectrum of 
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 Figure 40: Comparison of 31P{1H} NMR spectra of compounds 4d,d’ and 28a,a’. compound 28a,a’ showed two singlets at -53.2 and -54.9 ppm respectively, for two isomers, with a huge upfield shift of about 50 ppm with respect to the starting material (4d,d’) (Figure 40).  The drastic change in the P value could be attributed to the reshaped geometry and change in the co-ordination number for the P-centers in these spirocyclic phosphorane.[75] One more notable aspects that stands out of the comparison between compound 4d,d’ and 28a,a’ is the dramatic change in the isomeric ratio. This change is due to remarkable difference in the solubility between two isomers. One of the isomers precipitated out of the reaction mixture during the course of the reaction as beige powder, due to its limited solubility; hence causing these visible change in the isomeric ratio in the 31P{1H} NMR spectrum (from 1:1 in Ͷd,d’ to 12:1 in ʹͺa,a’). For 28b,b’-c,c’ also the isomeric ratio remained unaltered. The analytical details for 28a,a’-c,c’ are listed in table 11.   Table 11: 31P{1H} NMR chemical shifts, isomer ratio and yields of 28a,a’-c,c’.  R R’ P* Isomer ratio Reaction time yield (%) ʹͺa,a’ Me NEt2 -53.2 , -54.9 12:1 6h 82 ʹͺb,b’ Et NEt2 -46.7 , -52.2 1:2.5 10h 80 ʹͺc,c’ nBu NEt2 -43.6 , -52.2 1:1 16h 88  
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6.4 Reaction with electrophiles: Competition between the P- and the S-centers Among the most important reactivity aspects of these tricyclic 1,4-dihydro-1,4-diphosphinines was their behavior towards different electrophiles as this may indicate future possible exploitations. Firstly, theoretical calculations were performed by Frontera[68] to allow for a closer inspection of the relative nucleophilicities of the P- and S-centers. Therefore, molecular electrostatic potential (MEP) isosurfaces of compound 4d (P-NEt2) and 22a (P-Ph) were calculated which showed that the MEP value at the S-centers are more negative than that of the P-centers (Figure 41 a,c).  
 Figure 41: (a) MEP isosurface (0.002 a.u.) of compound 4d; selected points of the surface are indicated. (b) HOMO plot of compound 4d. (c) MEP isosurface of compound 22a. (d) HOMO plot of 22a. Furthermore, the orbital coefficients for the HOMO of the molecules were found to be more located at the S- than at the P-centers (Figure 41 b,d). These two data provided strong evidence for a largely pronounced nucleophilicity of the S-centers. 6.4.1 Reaction with methyl trifluoromethanesulfonate To start with the examination of the relative reactivity of the P- and S-centers towards soft and hard carbon-based electrophiles, the methylation reaction was chosen as case study. Firstly, methyl iodide was used as the reagent in dichloromethane, but no reaction was observed for either the P-NR2 derivatives 4d,d’-f,f’ or the P-Ph derivatives 22b,b’-c,c’ at ambient temperature Therefore, methyl trifluoromethanesulfonate (methyl triflate) was chosen as a hard electrophile and stronger methylating reagent and the derivatives 4d,d’-f,f’ and 22b,b’-c,c’ were treated with under the same conditions (Scheme 35). In case of 4d,d’ upon addition of the methylating agent there was no change of color in the reaction mixture, but it slowly turned turbid due to formation of a white 
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 Scheme 35: S-methylation of the tricyclic 1,4-dihydro-1,4-diphosphinines using methyl triflate. precipitate. The reaction was monitored by 31P{1H} NMR spectroscopy. After 2h of stirring at room temperature the starting material was seemed to be completely consumed.  This white precipitate was filtered out and used for further analysis. The 31P{1H} NMR spectrum of the white precipitate in DMSO-d6 didn’t show much of change as per the P value is concerned apart  from slightly increased Δ values between the two isomers compared to the starting material (4d,d’). But the 13C{1H} NMR spectrum of it showed the disappearance of the C=S carbon atom resonance and the appearance of a new singlet at 149.7 ppm, characteristic of a C2-carbon nucleus of an imidazolium salt. This NMR data provided strong evidence for the S-methylation, meaning the formation of 29a,a’ as the final compound. Further support came from the ESI-MS experiment which exhibited an ion peak at m/z 244.1, assigned to the cation C20H38NP2S22+ in 29a,a’. After having had confirmation for S-methylation, the question arose if sterics and electronics (a different P-substituent) might alter the reaction course. But when 4f,f’;22b,b’-c,c’ were employed, compound 29b,b’-d,d’ was formed in the same vein. All of this bis(imidazolium) salts 29b,b’-d,d’ were isolated and fully characterized. The analytical data of these compounds are listed in Table 12. Finally, the S-methylation in 29d,d’ was confirmed by the X-ray crystallographic measurement using single crystals grown from a saturated dichloromethane solution at –20 °C. The result  Table 12: 31P{1H} NMR chemical shifts, isomer ratio and yields of  S-methylated bis(imidazolium salts) 29a,a’-d,d’.  R R' P Isomeric ratio Appearance yield (%) 29a,a’ Me NEt2 3.7 , 5.9 1:11 White solid 45 29b,b’ nBu NEt2 2.2 , 3.2 2.4:1 Orange liquid 89 29c,c’ Et Ph -49.5 , -55.8 1:1.3 White solid 85 29d,d’ nBu Ph -50.1 , -53.7 1.1:1 White solid 89 
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revealed that the trans isomer of compound 29d (Figure 42) crystallized in the triclinic crystal system with the space group Pͳ̅ . Close inspection of the packing pattern revealed that the two S-Me groups are anti-periplanar oriented with respect to each other and the plane of the tricycle. The plane of the Ph groups on the P-centers were found to be almost perpendicular (89.974°) to the planar six-membered ring. The triflate anions are located in between two planes of the cationic fragments in such a manner that it stays in vicinity of the S-Me protons. This could be a consequence of a moderate H-bonding interaction[76] (distance: 2.2698(3) Å) between the O atom of the OTf anion and the H atom of SMe, because the SO3 fragment of the triflate anion sits on the imidazole-2-thione ring of the tricycle. 
 Figure 42: Molecular structure for the cationic part of trans 29d; hydrogen atoms except the borane ones are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°): P-C(1) 1.8173(2), C(1)-C(8) 1.3688(2), P-C(13) 1.8291(2), S-C(7) 1.8114(1);C(1)-P-C(8) 95.223(10), C(1)-P-C(13) 101.210(11). The reaction outcome of S-methylation was according to the prediction using the MEP analysis, i.e., the S-centers were predicted to be more nucleophilic. Nevertheless, further theoretical investigations were performed by Frontera using 22c to calculate the relative energies of the S-methylated (= 22c-SMe) and the P-methylated (= 22c-PMe) product and, surprisingly, the energetic  
 Figure 43: Relative energy difference between the P-methylated (left) and S-methylated (right) product; bond lengths are given in Å. 
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difference between the products is very small (3.6 kcal/mol) (Figure 43). Interestingly, it is the thermodynamically more stable product trans 29d that was observed experimentally (S-methylated), but it might also play a role that this attack should be kinetically favored to a sterically less congested center. 6.4.2 Formation of P-borane adducts via reaction with borane-dimethyl sulfide Equally important for future synthetic exploitations was to gather information on co-ordination properties of these tricyclic 1,4-dihydro-1,4-diphosphinines, and to examine if the results of the MEP calculations could also render useful predictions in this regard. To start this, compounds 4d,d’-
f,f’ and 22b,b’-c,c’ were subjected to reactions with transition-metal complexes e.g. [Cr(CO)5(CH3CN)],  [W(CO)5(CH3CN)] etc., representing examples of soft Lewis acids. But none of the metal complexes showed any reactivity; at least none at the P-centers.  
 Scheme 36: Synthesis of P-borane complexes 30a,a’-c,c’.  To investigate if stronger Lewis acidic reagents might result in a complex formation, we decided to use the borane-dimethyl sulfide adduct. Compounds 4d,d’-f,f’ were treated first with borane-dimethyl sulfide in dichloromethane at room temperature, and the reaction progress monitored by 31P{1H} NMR spectroscopy (Scheme 36). The 31P{1H} NMR spectra of the reaction mixtures showed complete consumption of the starting materials after 2h. Compounds 30a-c could be isolated from the reaction mixture by simply concentrating the reaction mixture and washing the residues with n-pentane to obtain white powders in excellent yield (Table 13).  The 31P{1H} NMR spectrum of 30a,a’ showed a significantly downfield-shifted and broad (FWHM 82.5 Hz) resonance signal at 34.4 ppm (Figure 44).  The appearance of a broad resonance signal could be attributed to the direct connectivity of P-atom to a quadrupolar boron center, thus  
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confirming the occurrence of P- instead of S-borylation. The apparent disappearance of the isomers, depicted in Figure 44, could be due to the close vicinity of the two isomeric signals in the 31P-NMR spectrum leading to superimposed signals, thus only one broad peak is visible in the 31P{1H} NMR spectrum. In case of 30c there were no isomers observed as the pure trans-4f was used as the starting material.  
 Figure 44: Comparison of 31P{1H} NMR spectra (CDCl3) of compounds Ͷd,d’ and 30a. Table 13: 31P{1H} NMR chemical shifts, isomer ratio and yields of the P-borane complexes 30a-c.  R R’ P* Isomer ratio FWHM (Hz) yield (%) 30a,a’ Me NEt2 34.4 -* 82.5 85 30b,b’ Et NEt2 33.7 , 34.3 1.3:1 86.6 82 30c,c’ nBu NEt2 33.3 -* 81.7 60 * the isomeric ratio could not be determined due to broad signals The P-borane adduct formation in case of the P-NR2 derivatives of tricyclic 1,4-dihydro-1,4-diphos-phinines could also be confirmed by means of X-ray crystallographic measurement. Single crystals for compound 30a, obtained by slow evaporation of its saturated dichloromethane solution, were analysed by X-ray crystallography and the results showed the solid state structure for its trans-isomer (Figure 45). It crystallized in the monoclinic crystal system with the P21/c space group. The molecular structure confirmed that the tricyclic array is planar and P-N(3) bond (1.6376(1) Å) is shortened significantly upon borane coordination (compared to compound 4d (1.685(4) Å)). After having studied the P-borane complex formation using P-NR2 derivatives of Ͷd,d’-f,f’, the same reaction conditions were also exerted on the P-Ph derivative of the tricyclic 1,4-dihydro-1,4-diphosphinine 22b,b’. Surprisingly, in case of 22b,b’ the 31P{1H} NMR spectrum of the reaction 
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 Figure 45: Molecular structure of trans 30a; hydrogen atoms except the borane ones are omitted for clarity (50% probability level). Selected bond distances (Å) and angles (°):P-C(1) 1.8083(1), P-C(4) 1.7999(1), P-B 1.9157(1), P-N(3) 1.6376(1), B-H(1) 1.1170(1);C(1)-P-C(4) 98.569(3), B-P-N(3) 117.562(3). mixtures showed a competing S-borylation (Figure 47) as two sets of resonances appeared, i.e., a set of two broad resonance signals at -3.8 ppm and 4.5 ppm, that might be assigned to the isomers of the P-borane adducts. But there were also two pairs of two singlets at -60.5 ppm and -60.6 ppm; assignable to the mono S-borane adduct isomers, whereas the singlets at -55.1 ppm and -55.2 ppm could be attributed to the isomers of the bis(S-borane adduct). The higher Δ value between the isomers of the mono and bis(S-borane adduct) supported this tentative assignment. Unfortunately, this product mixture could not be successfully worked-up to get the products separated.  
 Figure 46: The 31P{1H} NMR spectra for the reaction of 22b,b’ with borane-dimethyl sulfide in dichloromethane. As the MEP analysis did not enable to explain the formation of compounds 30a,a’-c,c’ when BH3 was used as an electrophile, since the S-centers were supposed to be more nucleophilic. In order to shed some light on this issue, the structures were calculated by Frontera for compound 30a (= 30a-P- 
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BH3) and its hypothetical S-borane analogue (= 30a-S-BH3) (Figure 47). The optimized structure of compound 30a was found to be almost identical to the X-ray structure, as exemplified by the P–B distance [1.915 vs exp: 1.9157(1)]. This adduct is 30.2 kcal/mol more stable than the S-borane adduct, in agreement with the experimental result. It should also be mentioned that the S···B distance (2.051) in the S-borane adduct is longer than the sum of the covalent radii of S and B (1.89 Å). This makes the S···B bond in the S-borane adduct only partially covalent, and this weak bond also explains the energetic difference between the P- and S-boranation and, hence, explains the formation of the P-borane product as the preferred final product. In case of the P-Ph derivatives the reduced basicity of the P-centers could attribute to the formation of the S-borane adducts in competing reactions. 
 Figure 47: Optimized structures of 30a (left) and the S-borane adduct (right); distances are given in Å. 6.5 Study on the formation of dianionic tricyclic 1,4-dihydro-1,4-diphosphinines In addition to the electrophilic P-chloro derivatives, interest arose to complement this with anionic and/or dianionic derivatives of tricyclic 1,4-dihydro-1,4-diphosphinines. Having the P-Ph derivatives22 in hand, the alkali metal-mediated P-C bond cleavage of the P-Ph bond was envisaged as key step towards the synthesis of the diphosphanido derivatives 31. Compound 22c was selected for these studies because of its higher solubility compared to 22a,b in common organic solvents. Firstly compound 22c was treated with Lithium metal at r.t. in THF with the goal of a reductive cleavage of the two P-Ph bonds,[77] following the literature reported methodology.[78] Surprisingly, compound22c,c’ didn’t react with lithium metal even under refluxing condition in THF, and also use of sodium metal didn’t led to success. Finally, potassium metal was used successfully in THF (Scheme 37). Upon adding the THF solution of 22c,c’ to the suspension of potassium metal at ambient temperature the color of the solution changed from colorless to light orange, and the color  
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got more intense with an orange precipitate forming with time, indicative of formation of an ionic compound that has limited solubility in THF. The progress of the reaction was monitored by 31P{1H} NMR spectroscopy, which revealed complete consumption of the starting material after 12h. It also 
 Scheme 37: Formation and reaction of intermediate bis-phosphanido derivative 31. showed complete disappearance of the two singlet resonances for the two isomers of compound 22c and a new singlet resonance at –73.9 ppm had appeared; it was presumed to be the dianionic derivative 31 due to a symmetrical structure (Scheme 36). Unfortunately, 31 could not be isolated due to a slow decomposition in solution; the presence of phenyl potassium might also play a role.Therefore to prove the formation (and intermediacy) of 31, it was generated and reacted in situ with n-butyl iodide at –78 °C. Upon addition of n-butyl iodide, the orange turbid reaction mixture immediately turned clear and became light yellow. The 31P NMR spectrum (Figure 49) of this reaction mixture showed two singlet resonance signals at –58.5 and –66.3 ppm (ratio 12:1) , respectively, which was identical with the values of compound 25b,b’. Compound 25b was isolated as white powder in 45 % yield. 
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 Figure 48: Quenching of the dianion 31 by n-butyl iodide to produce 25b. The P value of this intermediate dianion 31, was found to be significantly highfield-shifted compared to literature reported aromatic phospholides LVIII-LIX[79] and LX[80] (Figure 49); but on the other hand it appeared relatively downfield-shifted compared to the acyclic mono anion analogue LXI (P = - 110.2).[36]  
 Figure 49: Selected examples of literature reported phospholides and acyclic phosphanides. 6.6 Oxidative desulfurization of the tricyclic 1,4-dihydro-1,4-diphosphinines As described in the introductory chapter, imidazole-2-thiones can be easily subjected to oxidative desulfurization [34] to get access to imidazolium salts, which in turn can act as a starting material for imidazole-2-ylidenes.[34] Thus, presence of two such imidazole-2-thione moieties in these tricyclic 1,4-dihydro-1,4-diphosphinines makes them plausible precursors corresponding bis-imidazolium salts and, subsequently, bis-imidazole-2-ylidenes. With this objective, the P-NR2 and P-Ph derivativ- 
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es 4d,d’ (N-Me), 22b,b’ (N-Et) were treated with 10 molar eq. of aqueous hydrogen peroxide in dichloromethane at 0 °C. The reactions were monitored by 31P{1H} NMR spectroscopy which revealed  a clean conversion to give products with only slightly highfield-shifted resonance signals (Figure 50). For compound 4d,d’, the31P{1H} NMR spectrum showed a complete  
 Figure 50: Oxidative desulfurization of compound 4d,d’. consumption of the starting material and showed two singlets at -4.8 and -5.6 ppm for two isomers respectively. But unfortunately, during the workup, i.e., evaporation of solvent and washing with ether followed by n-pentane, the compound showed limited stability. The partial decomposition restricted the complete purification and characterization of these targeted bis-imidazolium salts with P-NR2 fragments. The latter is somewhat surprising as related acyclic derivatives have been described formerly.[19, 34] After this partial failure to get hands on the bis-imidazolium salts having the P-NR2 substituents, the P-Ph derivative 22b,b’ (N-Et) was considered for this study. When compound 22b was treated with hydrogen peroxide in dichloromethane solution at 0 °C (Scheme 38), the 31P{1H} NMR spectrum of the reaction mixture showed a clean conversion into the product 32,͵ʹ’. It also revealed a significant downfield shift of the product resonances after oxidative desulfurization but the ΔP value between the two isomers, formed in a 1:1.1 ratio,  (0.3 ppm) was a bit smaller compared to that of  22b,b’ (1.4 ppm).  The product could be isolated as white powder in excellent yield via  
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 Scheme 38: Oxidative desulfurization of 22b,b’ to the bis-imidazolium salt 32,32’. removal of solvent and thereafter washing with diethylether. Characterization of 32,͵ʹ’ (mixture of two isomers) using 1H, 13C{1H} NMR spectroscopy and ESI-MS provide proof for the constitution of the tricyclic bis-imidazolium salt. For example, the 1H NMR spectrum of compound 32 showed a slight downfield shift of the signals for the Ph protons indicating a reduced electron density at the P-centers (supporting the P-oxidation), and it showed a pair of new triplet resonance signals (4JP,H = 2.3 Hz)[72] in the downfield region (9.96 and 9.99 ppm, respectively, ratio 1.2:1) which is characteristic of imidazolium C2-H protons. The 13C{1H} NMR spectra of compound 32 showed absence of typical C=S resonances but a new, broad signal at 146 ppm had appeared which indicates the presence of a imidazolium C2-center.[34, 72] And finally the ESI-MS spectra showed a molecular ion peak at m/z 247.1 assigned to [C26H34N4P2O2]2+ (z = 2) which lends further support to the formation of the bis-imidazolium salt 32. The P values for this bis-imidazolium salt were found to be notably highfield-shifted compared to the acyclic backbone bis(diphenyl)phosphinoyl-substituted imidazolium salt (P = 23.7 ppm)[20] and even the more closely related acyclic analogue ([Ph(O)P(IMHtBu,Me)2]Cl2, where IMHR,R = 1,3-dialkyl-imidazolium-4-yl) (P = 7.4 ppm);[34] thus reflecting the different electronic nature of the imidazolium moiety compared to the phenyl groups.  
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Chapter 7      Compounds 4 and P,P’-dioxides 26, having the tricyclic 1,4-dihydro-1,4-diphosphinine motif, re-present an important extension of the known series of 1,4-dihydro-1,4-diphosphinines because the NHC chemistry seems within reach and, secondly, the six-membered ring might offer access to stable 1,4-diphosphinines. The chemistry of the latter is still largely underdeveloped due to the instability and problematic access of the only known derivative. Ideally, the two C=S fragments present in compound 4 offers an ideal situation to explore the possibility of getting hands on P-containing backbone annulated bis-carbenes LXIII and/or LXIV (containing a 1,4-diphosphinine motif ) which would represent a unique variation of Bielawski-type bis-NHCs LXII.[81, 82] 
 Figure 51: Bielawski-type annulated bis-NHCs LXII and new targeted P-analogues LXIII and LXIV.[82] 7.1 Study on the thermal decomposition of compounds 4 In the EI-MS spectrometric study of compounds 4 it was recognized that in each case the base peak accounted for an m/z value corresponding to the fragment cation [M-2NR2+H]+. For example in case 
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of compound 4e (NR = NEt), the EI-MS spectrum showed a base peak with m/z value 371.0 that can be attributed to a cation with the formal composition of [M-2NEt2+H]+. This indicated that the P-N bonds in compound 4e are labile under the EI-MS conditions and tend to be cleaved. To check the viability of a hypothesis concerning a thermal P-N bond cleavage, the neat white compound 4e was exposed to high temperature (165 °C) in vacuo for prolonged time spans (8 h), and all volatile compounds were trapped. The progress was monitored by 31P{1H} NMR spectroscopy and small portion of the red solid remain were taken, and dissolved in THF. Initially compound 4e had two isomers with a relative ratio of 28:72, but after heating for 3h, the color of the solid had turned bright red and the 31P{1H} NMR spectrum showed a small amount (~ 2 %) of a product appearing at 78.7 ppm (Figure 52). The heating was continued for 5 more hours and up to 18% of this product was formed in the product mixture. More importantly, only one of the two isomers showed this thermal decomposition and the amount of the other isomer remained unaltered during the course of heating. No further conversion, apart from some unknown decomposition, was observed if heating was continued (up to 8 h).   
 Figure 52: 31P{1H} NMR spectrum (THF) of the residue after thermal decomposition of compound 4e. After a total of 8 h at 165 °C, the trapped liquid, colorless compounds, were studied by 1H NMR spectroscopy. The 1H NMR spectrum (C6D6) showed a pair of triplet and quartet resonance signals, and the chemical shifts of which exactly fitted with that of diethylamine.[83] After this study on thermal decomposition of 4e, alternative ways were investigated to get a more facile access to this product, observed in the 31P{1H} NMR spectrum, which might be red in color and relatively robust in  
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 Figure 53: 1H NMR spectrum of the liquid fraction collected in a cooling trap (taken in C6D6). terms of thermal stability. As the most likely precursor the focus was on the 1,4-dihydro-1,4-dichloro-1,-diphosphinines 24a,a’-b,b’. 7.2 Reduction of 1,4-dihydro-1,4-dichloro-1,4-diphosphinines: access to the first tricyclic 1,4-diphosphinines As first step for the planned aromatization of the six-membered ring reduction of the 1,4-dihydro-1,4-dichloro-1,4-diphosphinines 24a,b was chosen to target P-H compounds which might further be aromatized by means of dehydrogenation. Compounds 24a,a’-b,b’ where treated with common reagents such as nBu3SnH or LiAlH4 in THF at –78°C and the color of the reaction mixture turned  
 Scheme 39: Various reactions of compounds 24a,a’-b,b’ leading to red solutions. dark red from orange, which was surprising as a red color for a targeted secondary phosphane-type heterocycle would be very rare (Scheme 39). The 31P NMR spectra of the reaction mixtures not only  
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didn’t show any signal with a 1JP,H coupling constant,  indicative of the formation of a direct P-H bond, but the major products showed resonance signals at low field (76.2 for 24a and 78.1 ppm for 24b) which is also very unlikely for a secondary phosphane-type derivative. A very similar outcome was obtained if Na2[Fe(CO)4] was used, but no compound possessing a P-Fe bond was detected. Importantly, the selectivity of the reaction with Na2[Fe(CO)4] was much better compared to those with nBu3SnH or LiAlH4 which is illustrated by the clean conversion of the two isomers of 24b  yielding one product with a singlet resonance at 78.1 ppm in the 31P{1H} NMR spectrum of the reaction mixture (Figure 54). First of all, the P value of the new product indicated a significant change in the bonding environment of the P-center, and the disappearance of isomers provided a first hint to a low-coordinate P-center in the product. To examine if the reaction course is similar for the reduction of 24a,a’ Na2[Fe(CO)4] was added to a slurry of the starting material in THF at -78 °C. Upon warming up, the reaction mixture gradually changed color from yellow-orange to red, but the product was not well soluble in THF, thus creating a red slurry.  This red precipitate was filtered from the  
 Figure 54: Reduction of compound 24b,b’ using Na2[Fe(CO)4]. 
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reaction mixture and washed several times with THF, to remove any impurities. On the other hand in case of reduction of 24b,b’ the reaction resulted in a clean red solution. The presence of N-butyl groups enabled the isolation of a red solid by means of filtration (through a silica bed) with n-pentane (in ~ 25 % yield, the low yield was due to the problem in separation of the red compound from metal components) which allowed for the full characterization applying all standard analytical methods. In the 1H NMR spectrum (CDCl3) the solution of the red precipitate showed only a singlet resonance signal at 4.0 ppm indicating a highly symmetrical structure, excluding any P-substituent. The EI-MS spectrum showed a base peak at m/z 313.9 which can be attributed to a cation with the composition of C10H12N4P2S2. The HRMS experiment showed an experimental exact mass of 313.9976 (cal. 313.9979) which also does match with the aforementioned chemical composition.  
  Figure 55: Diamond plot of the molecular structure of compound 33a,b. (atomic displacement parameters set at 50% probability level); hydrogen atoms are omitted for clarity. Selected bond distances (Å) and angles (°): for 33a:P-C(1) = 1.755(5), P-C(3) = 1.731(6), C(1)-C(3) = 1.409(7), C(1)-P-C(3) = 97.6(2); for 33b: P-C1 1.741(3), P–C3 1.741(3), C1-C3 1.400(4), C1-P-C3 97.14(15). Combining all these experimental data the red powder was tentatively assigned to the tricyclic 1,4-diphosphinine 33a which was then finally confirmed by the results of an X-ray crystallographic measurement using single crystals grown from a saturated dichloromethane solution at 8 °C. Compound 33a crystallized in the monoclinic crystal system with the P21/c space group (Figure 55). Similarly, single crystal of compound 33b could be grown by slow evaporation of saturated n-pentane solution at 8 °C (Figure 55 right). 33b crystallized in the monoclinic crystal system with the P21/n space group. Investigation of the metrical molecular parameters revealed similar bond lengths and angles for the six-membered ring compared to literature reported phosphinines. For example, the P-C(1) bond distance for compound 33a was found to be 1.755(5) Å, which is close to 
Chapter 7: Entry to imidazole-2-thione-based tricyclic 1,4-diphosphinines 
 90  
that of  2,4,6-triphenylphosphinine[47, 84] (1.758 Å) (Figure 57). The C(1)-C(3) bond distance in compound 33a (1.409 Å) is also in good accordance with that in benzene (1.397 Å).[85] This coherence in the bonding parameters indicated a significant extent of aromaticity in the 1,4-diphosphinine. Further aspects of the solid state structure of 33a is discussed later in this chapter (see Figures 58,59).  
 Figure 56: Literature known 1,4-diphosphinine L and imidazole-2-thione-based new 1,4-diphosphinines 33a,b.  
 Figure 57: Comparison of endocyclic metrical parameters of 33a and 2,4,6-triphenylphosphinine .   A special structural feature of compound 33b was that the n-butyl groups of a given imidazole-2-thione unit are pairwise trans oriented due to dispersive interactions with the next molecules which indicate the presence of effective dispersive interactions between the alkyl chains.[86] The structures of both 1,4-diphosphinines 34a,b showed planar tricyclic arrays with a center of inversion in the mid-point of the central ring. Their packing structures exhibited a laminar arrangement with interplanar distances of 3.56 Å (33a, from centroid of ring-3 of plane-A to centroid of ring-2 of plane-B) and 3.53 Å (33b, same as before) indicating effective  interaction (Figure 58). 
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 Figure 58: Packing diagrams of compounds 33a (left) and 33b (right). Solvent molecules and hydrogen atoms are omitted for clarity. 7.3 Optimization of the synthesis of tricyclic 1,4-diphosphinines 33  The synthetic route to the tricyclic 1,4-diphosphinines via reduction of the corresponding P,P’-dichloro compounds 24a,a’-b,b’ with Na2[Fe(CO)4] furnished access to 33, but only in low yields as the major problem to separate the metal-containing product(s) from 33 could not be solved satisfactorily. This problem was even more prominent in the case of the N-nBu derivative (33b) and resulted in low yield. As the low yield synthesis of compound 33b was a serious hurdle for the development of the 1,4-diphosphinine chemistry, a new, improved synthetic protocol was needed.  An important observation was garnered from the 31P{1H} NMR spectrum of compound 24b,b’ in CDCl3, where it showed two singlet resonance signals at 2.6 and 10.9 ppm respectively for its two stereoisomers and it did not show any color change, at least within the time needed for characterization. But when the compound 24b,b’ was dissolved in THF and a 31P{1H} NMR spectrum measured, it revealed a slow decomposition at room temperature which came together with a change in color of the solution from yellow-orange to red. If the spectrum was recorded immediately after dissolving 24b in THF, there was no visible decomposition and no change of color (Figure 59 A). But keeping the solution at room temperature for 1h caused the color of the solution to turn dark red and the 31P{1H} NMR spectrum showed a new resonance signal at 78.1 ppm (11%) for the tricyclic 1,4-diphosphinine 33b. The amount of 33b in the mixture increased with heating to 65 °C (Figure 59 C and D). This spectroscopically monitored decomposition also revealed that one of 
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the isomers is being preferably converted to the 1,4-diphosphinine 33b. The first conclusion was that the dichloro derivative 24b,b’ is losing two Cl atoms in an unknown pathway and got converted 
 Figure 59: 31P{1H} NMR monitoring of compound 24b,b’ in THF. into the 1,4-diphosphinine. In order to achieve a selective reduction the idea of using an electron-rich trialkyl phosphane was considered, as it is well known that oxidation with elemental halogens  
 Scheme 40: Optimized protocol for the synthesis of tricyclic 1,4-diphosphinines 34a,b. 
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such as chlorine occurs easily and produces the corresponding chlorophosphonium chloride salts. A first attempt of using a THF solution of 24b,b’ and nBu3P at room temperature was only partly successful. Immediately after the addition of the phosphane, the color of the solution turned blood-red but no chlorophosphonium chloride was observed in the 31P{1H} NMR spectrum of the reaction mixture besides the 1,4-diphosphinine 33b  (Figure 59 E). The synthesis of the 1,4-diphosphinines could be optimized, if the reduction with nBu3P was performed in dichloromethane at 0 °C (Scheme 40). The 31P{1H} NMR spectrum not only showed a clean conversion, but also a resonance signal at 104.6 ppm that was assigned to the known chloro-phosphonium chloride [Bu3PCl]Cl[87]. The final product 33b was easily isolated in good yields (58 %) by a simple filtration of the reaction mixture through a silica bed using diethyl ether as solvent. The chlorophosphonium salt stayed on top of the silica column due to its high polarity and limited solubility in diethylether.  Taking advantage of this new protocol, the synthesis of the N-Me derivative 33a was achieved taking a dichloromethane suspension (yellow-orange) of the P,P’-dichloro compound 24a,a’ and adding nBu3P at 0 °C. Here, also the color of the suspension changed to red and got darker with time but due to the limited solubility of the starting material 24a,a’ the progress of the reaction was much slower and the reaction took 12 hours to reach completion. With progress of the reaction a red precipitate of the final product (33a) formed  which was in agreement with since later findings as 33a was found to be almost insoluble in most organic solvents such as  THF, dichloromethane, diethyl ether etc. After filtration, the precipitate was washed a few times with dichloromethane, and compound 33a was isolated in 65 % yield.   7.4 Further insight into the properties of the tricyclic 1,4-diphosphinines After having the tricyclic 1,4-diphosphinines 33a,b isolated in good yield, both compounds were investigated by UV/vis spectroscopy and cyclic voltammetry and, additionally, by theoretical calculations of the aromaticity and the bonding situation including frontier orbitals 7.4.1 Theoretical investigations on the aromaticity of tricyclic 1,4-diphosphinines Detailed theoretical studies on these 1,4-diphosphinines were carried out by Nyulaszi and co-workers using the Gaussian 09 suite of programs.[88] Geometry optimization was carried out at the 
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M06-2X/6-31+G* level of theory,[89] followed by subsequent calculations of the second derivatives at the optimized structures, which turned out to be real minima on the potential energy surface. This level of theory was also used for the GIAO calculations to obtain NICS values, and for calculation of the reference molecules of the isodesmic reactions, and also for cationic and anionic states, which were also geometry optimized. All the theoretical investigations were carried out on the N-Me derivative or compound 33a, simply for the sake of faster calculations. The HOMO of compound 33a was fund to be rather high in energy (-5.80 eV), and as the antibonding combination of the HOMOs of the two imidazole-2-thione fragments (Figure 60). Furthermore, this orbital combination also matched with the HOMO-2 orbital of the parent (unsubstituted) 1,4-diphosphinine. As the imidazole-2-thione HOMO, responsible for the ylidic character of the C=S bond, is of rather high energy, the significant increase of the energy level of the HOMO in 33a was quite reasonable. 
 Figure 60: The Kohn-Sham HOMO (bottom) and LUMO (top) of 33a as combination of the orbitals of imidazole-2-thione and 1,4-diphosphinine.  The LUMO of compound 33a was rather low lying (-2.93 eV) and largely stabilized due to the involvement of the *P=C orbitals.[90] This orbital encompassed with the lowest * orbital of the diphosphinine unit (at -2.54 eV). The LUMO of compound 33a was even more stabilized compared to the LUMO of parent unsubstituted 1,4-diphosphinines, due to the greater delocalization in the former. Altogether, this high lying HOMO and low lying LUMO resulted in small HOMO-LUMO gap which makes the excitation energy to be small that in turn is also in complete agreement with the observed red color of compound 33a. 
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To understand the electronic structure of compound 33a in more detail, M06-2X/6-311+G** calculations considering also dispersion interactions at the bulky substituents were carried out. The theoretically optimized structural parameters were revealed to be similar to those experimentally obtained, where the closed-shell wave function turned out to be stable with a 44.7 kcal/mol singlet-triplet gap. The structurally indicated aromaticity of the six-membered 1,4-diphosphinine ring in 33a was further evidenced by the –9.5 ppm NICS(1)[91] value which was in good agreement with the value of the parent 1,4-diphosphinine (-9.4 ppm). The NICS(1) value in the imidazole-2-thione unit for compound 34a was calculated to be -6.8 ppm, in good agreement with the value of -7.5 ppm  obtained for imidazole-2-thione itself (at the B3LYP/6-311+G* level -6.0 ppm was reported[92]). The 22.2 kcal/mol ISE (isomeric stabilization energy – Scheme 41) of the parent 1,4-diphosphinine was 75% of the benzene value[93] in agreement with previous conclusions based on ASE studies.[94]  
 Scheme 41: M06-2X/6-311+G** Isomeric Stabilization Energy (ISE) for the parent 1,4-diphosphinine.[93, 95]  
  Table 14: M06-2X/6-͵ͳͳ+G** isodesmic reaction energies ΔE ȋkcal/molȌ to investigate the effect of the substituents on parent unsubstituted 1,4-diphosphinine, and NICS(1).[95]   ΔE NICS(1) R,R: -N-C(=S)-N- -2.2 -  8.7 R:    -F 8.1 -  9.4 R:    -CF3 17.8 -10.5 R:    -CH3 2.3 -  9.4 R:    -NH2 -1.2 -  8.6 R:    -SiH3 0.1 -  8.8 
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It is noteworthy that compound 33a appeared to be highly aromatic despite the low HOMO-LUMO gap. Further studies on the effect of the substituents by isodesmic reactions (see Table 14) concluded that the stabilizing effect of the substitution at the ring carbon atoms to be only minor, including the thiourea substitution in 33a, with the noteworthy exception of the CF3 substituted compound L, which is significantly destabilized by comparison. 7.4.2 UV/vis spectroscopy The intense red color of these tricyclic 1,4-diphosphinines 33a,b prompted the necessity of UV/vis spectroscopic investigations to examine the type and strengths of transitions responsible for the color of these compounds; this was then combined with results from TD-DFT studies. The UV/vis spectra for both compounds were taken in dichloromethane solutions at room temperature by taking dilute solutions (concentration ~ 10-5 molar) into air-tight and sealed quartz cells.  
 Figure 61: The UV/vis spectrum of 33a in dichloromethane with the TD-DFT B3LYP/6-311+G**(PCM = dichloromethane)//M06-2X/6-311+G** calculated vertical excitation energies (numbers given in italics) as vertical lines (the length of the vertical lines indicates the calculated oscillatory strength). The UV/vis-spectra of 1,4-diphosphinines 33a,b showed a strong absorption (max = 497 nm for 33a, 498 nm for 33b), which has an excellent numerical agreement with the B3LYP/6-311+G**(PCM:DCM) TD-DFT results for 33a (Figure 61). [19] While the numerical agreement is somewhat worse at the M06-2X/6-311+G** level (accordingly, for the discussion of the orbital energies we use the B3LYP/6-311+G**(PCM:DCM) values), the intense band corresponds at each investigated level to the HOMO()-LUMO(*) excitation. 
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7.4.3 Cyclic voltammetric measurements The redox behavior of the 1,4-diphosphinines 33a,b is of great interest due to their rigid, -electron conjugated tricyclic ring system.[96] To get insight electrochemical studies on these tricyclic 1,4-diphosphinines were carried out in collaboration with Sasamori. Due to the limited solubility of compound 33a in all common solvents we focused on the N-nBu derivative 33b in all electro-chemical studies.  
 Figure 62: Custom-tailored glassware for electrochemical measurements of reactive species.[97] The custom-tailored glassware for the electrochemical measurements for 1,4-diphosphinine 33b was prepared using THF solutions of 33b in a glass bottle equipped with three Pt electrodes, i.e., the working, reference and counter electrodes (Figure 62).[97] The electrochemical experiments used scan rates of 10–500 mVs–1 at r.t. under Ar atmosphere, using ferrocene/ferrocenium hexafluoro-phosphate as internal/external reference to determine the potentials. Sample solutions (THF) were 3 mM in analyte and 0.1 M in [n-Bu4N]PF6 as the supporting electrolyte. The redox behavior of 33b was studied using cyclic and differential potential voltammetry experiments (CV and DPV). In the oxidation region (Figure 64), 33b showed two irreversible oxidation steps at Epa = –0.61, –0.34 V as determined by DPV measurements. This easy oxidation could be attributed to the high energy of the HOMO of 33a. The M06-2X/6-31+G* calculations predicted accordingly a rather low (7.24 eV) first ionization energy for 33a.  
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 Figure 63:  Oxidation region: E1/21 = –0.61 V, E1/22 = –0.34 V (vs. FcH/FcH+) (determined on the basis of DPV measurements). 
 Figure 64: Reduction region: E1/21 = –1.74 V, E1/22 = –2.59 V (vs. FcH/FcH+) (determined on the basis of DPV measurements The formation of the 33a dication needs, however, significantly higher energy (18.50 eV),[98] accordingly the observed second oxidation wave should be attributed to a different process: 33a+. [C10H12N4P2S2]+.  forms an adduct (formed as a dimer due to Ɏ-stacking interaction) with 33a itself (and also with THF). Due to this stabilizing interaction the ionization energy is reduced to 6.92 eV, the 0.3 eV difference matching favorably with the 0.27 V difference between the two oxidation waves. 
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Conversely, 33b showed two-steps of pseudo-reversible redox waves (Figure 63) in the reduction region. The first step of reduction was found to be a 2e-reduction (!) at E1/2 = –1.74 V and a 1e reduction at E1/2 = –2.59 V (vs. FcH/FcH+) in the second step. The M06-2X/6-31+G* calculated relative energies showed the stability of the first radical anionic state having[99] an electron affinity 1.9 eV! This is a consequence of the involvement of the low lying *(P=C) orbitals.[100] Even the calculated Gibbs free energy of the dianion of 5a is only 0.1 eV, showing the exceptional stability of this species, despite the anti-aromaticity of the central dihosphinine ring (NICS(1): + 8.6 ppm), in full accordance with the Hückel rule![101] Clearly, the mono anionic state cannot be accessed, since the dianion is formed preferentially. It is noteworthy that for 2,4,6-tBu-1,3,5-triphosphinine a -1.94 V (in DME),[102] and -3.245 V (in THF)[103]  reduction wave was reported, indicating that 33a has a comparable electron affinity to the former one.  
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 Chapter 8    Although phosphinines[47] and 1,4-diphosphinines[61] were first synthesized within one decade, the development of their chemistry showed significant divergences. While the chemistry of phosphinines[104] are richly developed,[105] only a handful of reactions have been reported for the 1,4-diphosphinine derivative L as mentioned in the introduction (see Scheme 13). The main reason behind this poorly developed chemistry might be the low stability of L and the absence of a facile synthetic protocol.  As reactivity studies are sparse, the newly synthesized tricyclic 1,4-diphosphinines 33a,b were tested in various reactions: [4+2]-cycloaddition, 1,4-addition reactions, oxidative hydrolysis and others.  8.1 [4+2]-cycloaddition reactions: access to tricyclic 1,4-diphosphabarrelenes  The use of (mono-)phosphinines in [4+2]-cycloaddition reactions are well known since 1968, when Märkl and co-workers synthesized the first example of phosphabarrelene by reacting a phos-phinine with alkyne derivatives.[106] They showed that phosphinines, specially the 2,4,6-tri-sub-stituted derivative, are rather weak dienes, and the first example LXV were obtained only with a highly reactive, electron-poor dienophiles such as hexafluoro-2-butyne and DMAD (Figure 65). Later on more examples of such phosphabarrelenes were garnered from [4+2]-cycloaddition of phosphinines and arynes.[107] Since the first discovery of phosphabarrelenes, their chemistry has become highly rich and nowadays it is important as a ligand in Rh-catalyzed hydroformylation[108, 
8. Reactivity studies on tricyclic 
 1,4-diphosphinines 
Chapter 8: Reactivity studies on tricyclic 1,4-diphosphinines 
 101  
109] and hydrogenation[110] of alkenes. Bidentate phosphabarrelenes based P,S ligands[111] were also found to be highly effective in Pd-catalyzed Suzuki-Miyaura cross coupling by Le Floch and co-workers.[112] Recently, a Rh-catalyzed one-pot tandem reaction sequence under hydroformylation conditions was developed using phosphabarrelene as the ligand system by Müller and co-workers.[113] 
 Figure 65: Selected examples of phosphabarrelene LXV, 1,4-diphosphabarrelenes LXVI-LXI and 1,4-diphosphatriptycenes LXVII-LXIX. On the other hand, the first ever example of diphosphabarrelenes was reported back in 1961 by Krespan,[114] where perfluorinated 1,4-diphosphabarrelene LXVI was synthesized by iodine catalysed thermolysis of hexafluoro-2-butyne in the presence of red phosphorus. Synthesis of compound LXVI requires extreme reaction conditions (heating at 200 °C for 8h under autogenous pressure) and yet the yield is quite moderate (43 %).[114] Though the mechanism of formation of compound LXVI was not clear, Märkl suggested the probable intermediacy of tetrakis(trifluoro-methyl)-1,4-diphosphabenzene which would give the final product by [4+2]-cycloaddition with another molecule of hexafluoro-2-butyne. Later on, Kobayashi and co-workers provided firm evidence by synthesizing tetrakis(trifluoromethyl)-1,4-diphosphabenzene L from compound 
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LXVI[61, 115] and reacting it with hexafluoro-2-butyne to get back compound LXVI.[61, 64, 115] They also synthesized a variety of 1,4-diphosphabarrelenes from compound L as shown beforehand (see Scheme 13).  Apart from these, other derivatives such as diphosphatriptycenes are also known in literature. Although all these are 1,4-diphosphabarrelenes, they were prepared via completely different pathways. Compound LXVII was first reported by Weinberg and co-workers in 1971,[116] using  thermolysis of ortho-dichlorobenzene and white phosphorus in the presence of catalytic amount of FeCl3. This synthetic protocol suffers from the drawback of low yield (20 %) and harsh reaction condition (heating at 280 °C for 4 h). Later on, there have been attempts to synthesize other derivatives of this very 1,4-diphosphatriptycenes by Mazaki and co-workers, but again the yield of these reactions were significantly low (only 9 %).[117] Nakayama and co-workers reported the synthesis of the 4,8-diphosphathiophenetriptycene LXVIII,[118] via reaction of tris(thiophene-2-yl)phosphane oxide with trisphenoxyphosphane in the presence of nBuLi as base. The cyclization in this case requires oxidation of the phosphorus and therefore needs to be reduced back to PIII to get access to compound LXVIII. The main downside here also is the yield of the reaction, which is only 11% in the cyclization step and gets further low for the necessity of the extra reduction step. Therefore, an easy access to 1,4-diphosphabarrelenes was desirable and, hence, decided to study the reactivity of compound 33 with a series of dienophiles.   8.1.1 Reaction of tricyclic 1,4-diphosphinine 33b with alkynes  Because of the encouraging background, reactivity studies on compound 33b were started, and the latter chosen due to its high(er) solubility. When compound 33b was heated at 110 °C with a rather electron-rich alkyne like diphenyl acetylene, no reaction could be observed even after one week. The reaction mixture showed no visible color change (from the red color of the starting material) and no new resonance signal was found in the 31P{1H} NMR spectrum of the reaction mixture. But when an electron-deficient alkyne such as dimethyl acetylene dicarboxylate (DMAD) was employed at 35-40 °C in toluene (Scheme 42), an immediate reaction was observed, and the color changed from dark red to dark brown and the 31P{1H} NMR spectrum of the reaction mixture showed a new resonance signal at -87.3 ppm, apart from a complete consumption of 33b.
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A brick red powder could be isolated easily from the reaction mixture in 95 % yield by removing the volatiles under vacuo (8 × 10-3 mbar) and washing with n-pentane (3 × 3 ml). The chemical shift value (-87.3 ppm) fell well into the range of compound LXVIII (-87.1 and -93.4 ppm)[118] indicating the presence of a tricoordinate P-center with three P-C single bonds. Therefore, it was tentatively assigned to the 1,4-diphosphabarrelene derivative 34a. The 1H and 13C{1H} NMR spectra of this compound also supported this assignment with a spectral splitting pattern that corresponds to a molecule with C2v symmetry. The 13C{1H} NMR spectra showed an extra doublet resonance signal (apart from the peaks of compound 33b) at 128.6 ppm (1JP,C = 61.2 Hz) which was assigned to the sp2-carbon atoms of the bridging unit, carrying the –CO2Me groups (166.1 ppm (dd, 2JP,C = 16.8 Hz)) and thus showing further evidence for the 1,4-diphosphabarrelene unit. The structural assignment was further supported by mass spectrometry and EA data, e.g., the HRMS spectrum showed the exact mass value of the molecular ion of 34a (m/z 624.2123).  
 Scheme 42: Reaction of tricyclic 1,4-diphosphinine 33b with DMAD to give 34a.  8.1.2 Reaction of tricyclic 1,4-diphosphinine 33b with C=C and N=N double bond systems After the successful reaction of tricyclic 1,4-diphosphinine 33b with DMAD, it was decided to try reactions with a C=C bond and N=N double bond systems. For this purpose, N-phenylmaleimide (C=C) and 4-phenyl-1,2,4-triazoline-3,5-dione (N=N) were chosen as dienophiles. Monitoring the 
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reaction of compound 33b and N-phenylmaleimide in toluene at ambient temperature (Scheme 43), no reaction was observed in the 31P{1H} NMR spectrum. But at temperatures beyond 60 °C, a new resonance signal at -86.3 ppm grew in, besides that of 33b at 78.1 ppm. For a complete and fast consumption the temperature was raised to 110 °C, and after 3h a clean conversion was observed. In case of 4-phenyl-1,2,4-triazoline-3,5-dione, the reaction was found to be too fast and uncontrolled at room temperature resulting in a poor selectivity. To improve the selectivity, the reaction was carried out at low temperature (-40 °C) in THF as a rather poor solubility of compound 33b had prevented the use of toluene at low temperature. Under these new reaction conditions, the reaction was rather selective, and a singlet resonance signal at -49.4 ppm (90 %) was observed in the 31P{1H} NMR spectrum. 
 Scheme 43: Reaction of tricyclic 1,4-diphosphinine 33b with N-phenylmaleimide and 4-phenyl-1,2,4-triazoline-3,5-dione. In case of N-phenylmaleimide, an orange solid was isolated in 90 % yield after evaporation of the solvent under reduced pressure (8 × 10-3 mbar) and washing with n-pentane (3 × 3 ml). This orange 
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solid showed a resonance at -86.3 ppm (in CDCl3), being very similar to that of compound 34a. The 1H NMR spectrum also showed a triplet resonance signal at 3.72 ppm (3JH,H = 4.9 Hz) for the protons of the bridging P-CH- fragments referring to the formation of bicycle derivative. Finally, further support came from HRMS and EA data of this orange solid as to be the 7,8-dihydro-1,4-diphosphabarrelene derivative 34b. In case of 4-phenyl-1,2,4-triazoline-3,5-dione, the reaction mixture was, again, first evaporated to get a yellow residue which upon washing with diethyl ether (3 × 3 ml) furnished pure 34c in 65 % yield. Compound 34c, the diazo analogue of 34b, showed a resonance value of -49.4 ppm in the 31P{1H} NMR spectrum (CDCl3) which was significantly lowfield-shifted compared to both 34a,b. This (relative) low field resonance of compound 34c is obviously due to the nature of the bridging atoms, thus resulting in an electron-withdrawing effect due to the higher electronegativity of the nitrogen N-atoms. Firm evidence for the formation of these [4+2]-cycloaddition products were obtained from the X-ray crystallographic measurement, for which the single crystals were grown from a saturated dichloromethane solution at -20 °C. The X-ray measurement revealed that compound 34b crystallizes in the monoclinic crystal system with the C2/c space group (Figure 66). 
 Figure 66: Diamond plot of the molecular structure of compound 34b. (atomic displacement para-meters set at 50% probability level); hydrogen atoms are omitted for clarity (except those in the bridging carbons). Selected bond distances (Å) and angles (°): P(1)-C(23) = 1.8973(1), P(1)-C(1) = 1.8263(1), C(1)-C(3) 1.3627(1); C(1)-P(1)-C(23) 94.874(2), P(1)-C(1)-C(3) 123.233(3). The P(1)-C(23) bond length appeared to be significantly longer [1.8973(1) Å] compared to P(1)-C(1) [1.8263(1) Å], which perfectly reflect the different hybridization of C(1) as sp2 and C(23) as sp3. Furthermore the P(1)-C(1) bond length fell well into the range of P-C bonds of the 1,4-diphospha-triptycene derivative LXVII [1.8399(6) Å].[116] The bond angles revealed a strong pyramidalization at the both P-centers [ȋΣ∢ P = 284°) compared to that of PPh3 ȋΣ∢ P = 308°)]. The extent of this pyramidalization was in good agreement with the amount of pyramidalization for 2,4,6-
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triphenyl[7,8]benzo-phospha-bicyclo[2.2.2]octa-2,5,7-triene (283°), reported by Breit and co-workers.[108] This higher extent of pyramidalization should result in higher s-character of the P-lone pairs, which in turn should make 34b a weaker σ-donor compared to a strain-free phosphane,[119] The latter is of interest for the P-donating ability of these new diphosphabarrelenes.  8.1.3 Theoretical insight into [4+2]-cycloaddition reactions Theoretical investigations were carried out by Nyulaszi and Kelemen[120] to get informations on the relative ease of reactions and relative stability of the [4+2]-cycloaddition adducts, following M06-2X/6-311+G** level of theory. Apart from 34a-c, the hypothetical products with acetylene and diphenyl acetylene were investigated. The ΔG values of the corresponding final compounds (Table 15) clearly agrees with experimental results and, accordingly, compound 33b should react with 4-phenyl-1,2,4-triazoline-3,5-dione (-40 °C), leading preferentially to the final product (34c). On the other hand, reaction of 33b with diphenyl acetylene would result in an endergonic reaction.  Table 15: Relative energetics of the [4+2]-cycloaddition reactions.  C2H2 + 33b C2Ph2 + 33b 34a 34b 34c ΔE (kcal/mol) -18.6 -13.9 -24.6 -21.6 -31.6 ΔG(kcal/mol)  -2.5 5.4 -4.9 -2.3 -12.3  8.2 Thermal reaction of tricyclic 1,4-diphosphinine 33b with dichalcogenides As it is known that phosphinines can add oxidatively in a 1,1-fashion, the thermal reactivity of compound 33b towards diaryl dichalcogenides, e.g. Ph2S2, Ph2Se2, Ph2Te2 was examined (Scheme 44). Therefore, the tricyclic 1,4-diphosphinine 33b and 1 molar eq. of Ph2E2 was heated in toluene at 110 °C. The progress of the reaction was monitored by 31P{1H} NMR spectroscopy (taken every 30 min). In case of Ph2S2 and Ph2Se2 the color of the reaction mixture slowly started to change from red to yellow-orange and the 31P{1H} NMR spectra of the reaction mixture showed new singlet resonance signals at -34.1 ppm (Ph2S2) and -44.6 ppm (Ph2Se2), respectively. The reaction mixtures were further heated (2d for Ph2S2 and 6h for Ph2Se2) until complete consumption of the starting material was achieved. 
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 Scheme 44: Thermal 1,4-addition of organic dichalcogenides across the aromatic system of 33b. On the contrary, the reaction with Ph2Te2 showed no sign of progression even after heating a whole week at 110 °C. The latter might be due to either the lower oxidation potential of Ph2Te2 (i) or to the lower stability of the P-Te bond of a transiently formed 1,4-addition product under the given conditions. The major products from the reactions with Ph2S2 and Ph2Se2, were isolated via removal of the solvents in vacuo, and obtained as orange residues. Subsequent washing with diethyl ether and n-pentane resulted in yellow powders in 78 % yield (for Ph2S2) and 75 % (for Ph2Se2) which were used for the full characterization. The 31P{1H} NMR spectra showed highfield-shifted singlet resonance signals, as mentioned beforehand, which clearly speak against a 1,1-addition product having a low-coordinate and one a high-coordinate P-center thus resulting in a AB-type spin system (Figure 67). Furthermore, the 31P NMR spectra of these products showed no P-H couplings which indicated that the Ph groups are not directly bound to the P-atom, i.e., eliminating the possibility of a thermal isomerization of the P-EPh into a P(E)Ph fragment. The latter was also supported by the 1H NMR spectral data supporting the incorporation of two PhE fragment per molecule of 33b. 
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 Figure 67: Comparison of 31P{1H} NMR spectra of compound 33b with the reaction mixtures for 35a,b. 
   Figure 68: Diamond plot of the molecular structure of compound 35a (left), 35b (right); atomic displacement parameters set at 50% probability level and hydrogen atoms are omitted for clarity. Selected bond distances (Å) and angles (°): for 35a: P-C(1) = 1.8034(1), P-C(11) = 1.7994(2), C(1)-C(11) 1.3691(1), P-S(2) 2.1555(2)  ; C(1)-P-C(11) 96.538(7), P-C(1)-C(11) 131.026(9), S(2)-P-C(1) 100.403(7). For 35b: P-C(1) = 1.7991(1), P-C(3) = 1.7978(2), C(1)-C(3) 1.3632(0), P-Se 2.3003(1)  ; C(1)-P-C(3) 96.446(3), P-C(1)-C(3) 132.091(4), Se-P-C(1) 100.993(3). Finally X-ray crystallographic measurements confirmed these yellow powders as the P-thioxy and P-selenoxy substituted 1,4-dihydro,1,4-diphosphinines 35a,b. Single crystals of these compounds could be grown very easily from a saturated solution in dichloromethane at -20 °C. The results of X-ray crystallographic analysis revealed that compound both 35a and 35b crystallize in the monoclinic crystal system with the P21/c space group (Figure 68). The solid state structures of compound 35a and 35b revealed that both compounds prefer to pack in parallel layers. The distance between these layers for 35a was found to be 1.26 Å whereas that for 35b was 1.27 Å. 
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Apart from this parallel packing of the tricyclic heterocyclic part, the phenyl rings and the hydrophobic n-butyl chains were also organized in a paired pattern with respect to each other due to dispersive interaction (Figure 69). 
  Figure 69: Solid state packing of compound 35a and 35b. 
 Scheme 45: Plausible pathway for the formation of trans 35a,b. Another very interesting feature about this reaction was the stereospecificity of the 1,4-addition. In both cases only the trans isomer was formed which can be explained by a plausible two step pathway (Scheme 45), but it still remains to be investigated by theoretical calculations. The first possible step would be the 1,1-addition to one P-center – a formal insertion into the E-E bond – to create a transient 1σ4ɉ5,Ͷσ2ɉ3-diphosphinine LXIX which then undergoes a 1,4-rearrangement of one EPh group to give the final trans products 35a,b in a stereospecific manner.  
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8.3 Sequential reactions of 1,4-diphosphinine 33b with nucleophiles and electrophiles  As described in the introductory chapter, phosphinines have their phosphorus lone pair in a less directional and low lying HOMO, and the LUMO has the largest orbital coefficient on the P-center. Therefore, phosphinines are very weak σ-donor and considerably strong Ɏ-acceptor ligands, and the P-center significantly electrophilic. The first report came from Märkl and co-workers[121] in 1968  
 Figure 70: Examples of sequential nucleophilic/electrophilic reactions in phosphinine chemistry.[121, 122] when 2,4,6-triphenylphosphinine reacted with PhLi to form the 1,2,4,6-tetraphenylphosphinine-ate LXX (Figure 70) which could be quenched with electrophiles to access ͳσ4ɉ5-phosphinines LXXI. If the electrophile used for quenching of an intermediate anionic derivative is the proton, then 1,2-substitution can occur as it was observed for the anionic derivative LXXII that led to product LXIII[122] (Figure 70). 
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 Scheme 46: Reaction of 1,4-diphosphinine 33b with nucleophiles. As the Kobayashi 1,4-diphosphinine had not been studied in this regard, the opportunity to investigate this aspect motivated a first study which will be described hereafter. Focusing on the first step, the addition of a nucleophile, compound 33b was treated with KHMDS or nBuLi (Scheme 46). When a diethyl ether solution of 33b was treated with small portions of a KHMDS solution in diethyl ether at room temperature, a drastic color change from dark red to dark purple was observed which then slowly vanished with further addition of the KHMDS solution, to give a bright orange solution, finally. The 31P{1H} NMR spectrum of the reaction mixture showed two doublets at -12.1 ppm and -76.1 ppm, respectively, with a 3JP,P coupling constant magnitude of 5.7 Hz.
Chapter 8: Reactivity studies on tricyclic 1,4-diphosphinines 
 112  
 
 Figure 71: 31P{1H} NMR spectrum of the reaction mixture of 33b and KHMDS. The splitting pattern in the 31P{1H} NMR spectrum (Figure 71), representing a AB-type spin system, clearly indicated the formation of the anionic adduct 36a formed via nucleophilic attack of  the hexamethyldisilazide anion on the P-center of 33b. As depicted in Figure 71, the conversion of 33b into the adduct 36a was quite selective (up to 90%), but despite this selective reaction, the isolation of 36a could not be achieved due to a rapid decomposition during workup, i.e., removal of the solvent in vacuo,  followed by washing with n-pentane at room temperature. In the same manner, when a diethyl ether solution of compound 33b was treated with 1 molar eq. of nBuLi at room temperature the color of the solution turned from dark red to bright orange. The 31P{1H} NMR spectrum of the reaction mixture showed a pair of doublets at -74.3 ppm and -82.5 ppm, respectively, with a 3JP,P coupling constant magnitude of 4.1 Hz. The reaction mixture selectivity in this case was lesser compared to the KMHDS reaction and hence no isolation of the anionic intermediate could be achieved.  To confirm the nature of the addition products of the anionic derivatives 36a,b quenching with an electrophile was intended. In a modified protocol, the nucleophile was first added to the diethyl ether solution of compound 33b at room temperature and then cooled down to -78 °C, before 1 molar eq. of methyl iodide was added. In doing so in both cases (for KHMDS and nBuLi) the color of the reaction mixture turned from orange to bright yellow. In case of KHMDS, the 31P{1H} NMR spectrum of the reaction mixture showed a product  (37a) with 
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two doublets at -5.1 ppm and -72.4 ppm, respectively, with a 3JP,P coupling constant of 16.7 Hz and, hence,  the formation of new product.  
 Figure 72: Comparison of the 31P{1H} NMR spectra of the reaction mixtures for 37a,b. Strikingly, the 31P{1H} NMR spectrum showed the presence of only one stereoisomer for compound 37a, which might be due to the steric demand of the N(SiMe3)2 group thus directing stereo chemically the incoming electrophile to the opposite side of the plane resulting in the formation of the trans isomer. But when the sterically less demanding nucleophile nBuLi was employed, the presence of both isomers of 37b,b’ was observed in the 31P{1H} NMR spectrum of the reaction mixture (Figure 72). It shows two sets of pairs of doublets for the two isomers being present in a ratio of 1:3.5 (by NMR integration). Both 37a and 37b,b’ were isolated from the reaction mixture in moderate to good yields (80 % for 37a and 35 % for ͵͹b,b’) using flash chromatography through silica and pure toluene as the eluent. Further evidence for the constitution of 37a and 37b,b’ was provided by the 1H, 13C{1H} NMR spectra and mass spectroscopy. For example, the P-Me group in 37a and 37b,b’ appeared each as doublets in the 1H NMR spectra, e.g., 0.77 ppm (2JP,H = 5.2 Hz)  in case of 37a. The pos-ESI-MS data gave further support for the elementary composition, e.g. for 37a the m/z value 658.3142 was obtained, thus showing a reasonably good agreement with the cation C29H57N5P2Si2S2+H (theor. 658.3154).  
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8.4 Oxidative hydrolysis of tricyclic 1,4-diphosphinine 33b Previously, Pfeifer had obtained a structurally characterized bis-phosphinic acid 38a (-7.8 ppm) which was derived from compound 33a (without being aware of the real constitution), and which was structurally characterized.[123] To study this serendipitous finding more precisely, a diethyl ether solution of compound 33b was left stirring under open atmospheric condition for 12 h, which slowly turned colorless. The 31P{1H} NMR spectrum of the reaction solution showed a complete and clean consumption of the starting material and a new resonance signal appeared at -6.9 ppm. Removal of the solvent in vacuo, followed by washing with diethyl ether produced a white powder in excellent yield (92 %). The 13C{1H} NMR spectrum of this white powder showed a doublet of doublet resonance signal at 125.5 ppm (1JP,C = 167.4 Hz, 2JP,C = 21.6 Hz) for the carbons of the six membered ring. The range of coupling constants fell in agreement with the compound 38a (1JP,C = 162.4 Hz, 2JP,C = 20.6 Hz), hence proving the conversion of the P-centers from a low coordinated one to PV-one. The pos-ESI-MS data showed a peak for C22H38N4O4P2S2Na at 517.1721 (m/z, z=1) (calc. 517.1707) which finally confirmed this white powder as the tricyclic bis-phosphinic acid 38b Scheme 46). 
 Scheme 47: Oxidative hydrolysis of compound 33b under atmospheric conditions. Though the exact pathway for the generation of the bisphosphinic acid 38 remains unknown till date, a plausible route can be proposed following a proposal by Dimroth and coworkers (Figure 73),[124] in which phosphinine oxide LXXIV is formed first via reaction with O2, that reacts with 1 eq. of H2O due to its electrophilic nature to form the phosphinic acid LXXV. Although a similar pathway could be imagined also for the tricyclic diphosphinine 33b, but the exact reaction pathway still remains to be established, either experimentally and/or theoretically.  In particular, the origin of the 4th oxygen atom in the reaction product is unclear. 
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 Figure 73: Oxidative hydrolysis of a phosphinine.[124] 
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 Chapter 9   This thesis describes the chemistry of novel tricyclic 1,4-dihydro-1,4-diphosphinines and 1,4-di-phosphinines, whereby an early discovery by Sauerbrey on the formation of a tricyclic 1,4-dihydro-1,4-diphosphinine, detected as byproduct (4 % yield), constituted the starting point. Furthermore, a study on synthesis of precursors for backbone phosphaalkenyl substituted imidazole-2-thiones was carried out.   In chapter 3, detailed investigations are described on how the reaction conditions were tuned to achieve improved yields for tricyclic 1,4-dihydro-1,4-diphosphinines. In particular, a comprehensive study was carried out to examine the effect of N- and P-substituents along with the reaction stoichiometry on the reaction outcome, i.e. the ratio of acyclic and cyclic products using the following reaction scheme; tricyclic 1,4-dihydro-1,4-diphosphinines 4a,a’-b,b’ were isolated as a mixture of cis and trans isomers. The isolated compounds (Table 16) were all fully characterized by modern analytical means. One remarkable aspect stands out: a P-dialkylamino group and primary alkyl groups at the thione N-atoms are needed for a successful ring closure. 
 Scheme 48: Studies of the effects of N,P-substituents and reaction stoichiometry on the formation of tricyclic 1,4-dihydro-1,4-diphosphinines.
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Table 16: Compounds isolated from the old scheme of backbone phosphanylation (scheme 48).  3a 3b 3c 3d 3g 3i 4a,a’ 4b,b’ N-Substituents (R) Me Et Ph iPr iPr nBu Me Et P-substituents ȋR’Ȍ NMe2 NMe2 NMe2 NMe2 OEt Ph NMe2 NMe2 Yields (%) 60 32 75 81 75 60 4 16  Albeit better, this protocol did not improve the yields of 4a,a’-b,b’ to more than 16% and also did not provide evidence for the reaction pathway. Therefore, alternative pathways had to be developed, and there mechanism elucidated.  Chapter 4 describes the synthesis of the backbone amino(chloro)phosphanyl substituted imidazole-2-thiones 5a-f and their use in the synthesis of tricyclic 1,4-dihydro-1,4-diphosphinines Ͷd,d’-f,f’. Compounds 5a-f were obtained from backbone-bis(dialkylamino)phosphanyl substituted phosphanes 7a-f via a PCl3-mediated P-N bond cleavage (Scheme 49). Compounds 5a-c were successfully employed to synthesize the tricyclic 1,4-dihydro-1,4-diphosphinines Ͷd,d’-f,f’ in a selective and high yielding protocol via treatment with LDA as a base. The problem of the limited solubility of these 1,4-dihydro-1,4-diphosphinines, which has been a significant hurdle in the exploration of their chemistry could be also solved by introduction of longer N-alkyl chains. Replacing LDA with KHMDS as the base surprisingly resulted in the formation of P-substituted compounds 8a,b as the major product, in spite of larger steric demand of KHMDS and a very weakly pronounced nucleophilicity. 
 Scheme 49: Reaction of compounds 5 with different amides. 
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Chapter 4 also describes use of these backbone-amino(chloro)phosphanyl substituted imidazole-2-thiones 5a-f in the synthesis of precursors of phosphaalkenyl P-substituted imidazole-2-thiones.  For this purpose compounds 5d,e were treated with sterically demanding anionic nucleophiles bearing an acidic -proton, e.g. Ph2CHLi, FluLi, to get access to compounds 9a-c (Scheme 50).  Compound 9, when treated with borane-dimethyl sulfide was transformed selectively into the P-borane adduct 10, whereas with hydrogen peroxide the imidazolium salt 11 was formed (Scheme 50). Compounds 9 was also converted into the P-Cl compounds 12 via reaction with PCl3. 
 Scheme 50: Reactions of backbone-amino(chloro)phosphanyl substituted imidazole-2-thiones. Compound 12b could be transformed into NHC-stabilized phosphenium salt 13 when treated with 1,3,4,5-tetramethyl imidazole-2-ylidene (Scheme 51), but it was also used as potential starting point 
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for the synthesis of phosphaalkenyl P-substituted imidazole-2-thiones using a base-induced dehydrohalogenation reaction.  Compound 12b reacted with nBuLi to form the P-substituted product 18, thus showing a clear preference over the targeted phosphaalkene derivative. But compound 18 also reacted with a second eq. of nBuLi to generate the carbanion 19 which could be converted back to compound 19 selectively using HCl (Scheme 51). 
 Scheme 51: Reactivity studies of compounds 12. Chapter 5 describes the synthesis of new derivatives of tricyclic 1,4-dihydro-1,4-diphosphinines via synthesis and employment of chloro(phenyl)phosphanyl substituted imidazole-2-thiones 21a-c using the same synthetic protocol. While compounds 21a-c could be successful converted into the P-Ph derivatives of tricyclic 1,4-dihydro-1,4-diphosphinines 22a,a’-c,c’ using LDA as base, they reacted with KHMDS to furnish P-substituted products 23a,b (Scheme 52). In order to have an improved starting point for further functionalization of the P-centers, the 1,4-dichloro-1,4-dihydro-1,4-diphosphinines 24a,a’-b,b’ were synthesized from the P-NEt2 derivatives Ͷd,d’;f,f’ via reaction with PCl3. Compounds 24a,a’-b,b’ opened a new and easy route to access derivatives with different P-substituents using difference 
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nucleophiles, e.g. compounds 25a,a’-c,c’ could be obtained via treatment with two molar eq. of carbon -based nucleophiles (Scheme 52). 
 Scheme 52: Extension of the 1,4-dihydro-1,4-diphosphinines chemistry to other P-substituents. Chapter 6 is focused mainly on redox reaction studies on tricyclic 1,4-dihydro-1,4-diphosphinines. The P-centers of these tricyclic 1,4-dihydro-1,4-diphosphinines could be oxidized (26a,a’-e,e’), sulfurized (27a,a’-e,e’) and complexed to borane (30a,a’-c,c’) upon treatment with hydrogen peroxide, elemental sulfur and borane-dimethyl sulfide complex, respectively (Scheme 53). Furthermore, treatment with 2 eq. of o-chloranil resulted in the formation of the corresponding spirocyclic derivatives 28a,a’-c,c’ in excellent yields (Scheme 53).  The tricyclic 1,4-dihydro-1,4-diphosphinines were also tested for the competing reactivity of the P and S-centers towards electrophiles. While the hard electrophile methyl triflate attacked the S-centers (29a,a’-d,d’), in agreement with favorable molecular electrostatic potential values, the borane adduct formation to give 30a-c occurred at the P-centers due to favorable thermodynamics.  The P-Ph derivative 23c,c’ showed reductive P-CPh bond cleavage, when treated with 4 molar eq. of metallic potassium at room temperature, to produce the dianionic species 31. The latter could not be isolated but used as reactive intermediate in reactions with an electrophile such as nBuI to yield 25b,b’. A first study revealed that compound 22b,b’ could be converted to the corresponding bis-
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imidazolium salt 32,͵ʹ’ via an oxidative desulfurization reaction via treatment with 10 molar eq. of hydrogen peroxide (Scheme 53). 
Scheme 53: Some reactivity studies of the tricyclic 1,4-dihydro-1,4-diphosphinines. 
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Chapter 7 describes first synthesis of the tricyclic 1,4-diphosphinines 33a,b. The dark red colored tricyclic 1,4-diphosphinines were synthesized via a high yielding reduction of the 1,4-dichloro-1,4-dihydro-1,4-diphosphinines 24a,a’-b,b’ using the mild reducing agent nBu3P. The tricyclic 1,4-diphosphinines 33a,b were completely characterized by all analytical methods along with X-ray crystallographic measurements of single crystals. Preliminary studies on their electrochemical behavior were performed using cyclic voltammetry which revealed that compound 33b can undergo two reduction processes (firstly, a 2e-reduction and, secondly, a 1e-reduction) leading to an uptake of 3 electrons. UV/vis spectra were recorded to get first insight into the origin of the red color which was explained as the result of low energy HOMO()-LUMO(*) excitation on the basis of TD-DFT calculations.   Chapter 8 is focused on chemical reactivity studies focusing on addition and cycloaddition reactions of 33. In case of [4+2]-cycloaddition reactions, diphenyl acetylene no reaction was observed, even under harsh reaction conditions. When the electron-deficient dimethyl acetylene dicarboxylate (DMAD) was employed, a clean [4+2]-cycloaddition yielded product 34a. Also electron-deficient C=C or N=N double bond systems such as N-phenylmaleimide or 4-phenyl-1,2,4-triazoline-3,5-dione reacted as dienophiles  to yield 34b,c. The tricyclic 1,4-diphosphinine 33b, when treated with organic dichalcogenides (Ph2E2; E = S, Se) at elevated temperature,  gave rise to a stereospecific trans 1,4-addition of two EPh fragments to furnish the products 35a,b (Scheme 54), which were isolated in high yields. The electrophilic nature of the P-centers in the 1,4-diphosphinines was used in reactions with nBuLi or LDA that led to a nucleophilic attack at the P-center to produce the phosphides 36a,b, which subsequently reacted with methyl iodide to form the asymmetrically substituted tricyclic 1,4-dihydro-1,4-diphosphinines 37a,b. Finally these 1,4-diphosphinines were found to be prone to oxidative hydrolysis, thus producing bis-phosphinic acid derivatives 38a,b, when a solution of 33 was stirred  under atmospheric conditions.  
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 Scheme 54: Examples of [4+2]-cycloaddition, 1,4-addition and other addition reactions of tricyclic 1,4-diphosphinines 33. 
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 Chapter 10    10.1 General Techniques  All reactions were performed under a stream of deoxygenated (using preheated BTS catalyst at 100-130 °C) and dried (using molecular sieve and phosphorus pentoxide) Argon gas, using standard Schlenk techniques. All sensitive chemicals were stored in either Schlenk flasks or handled in the glovebox. All the solvents used in reactions were dried and distilled over sodium wires or calcium hydride (for methylene dichloride) and stored in brown glass bottles having Schlenk connections. All glass wares used were preheated and dried in the oven prior to use. In case air sensitive reactive the Schlenk flasks or tubes were prepared by heating under high vacuo and subsequently refilling with Argon gas. All the glass joints were lubricated with OKS grease type 1112. The high temperature reactions were done with an oil bath whereas the low temperature ones were performed using a liquid nitrogen/ethanol bath. For the purpose of removing salts formed in the reaction mixture common G3 frits having two Schlenk joints were used, along with either silica gel (Merck 60-200) or Celite. For transferring solvents or filtering, stainless steel double needle or filter cannula were used, which were preheated and dried in the oven at 75 °C. Whatman filter papers or glass microfiber filter papers were used for filtration purposes. All the used glass wares were soaked overnight in a KOH-isopropanol bath having some NaOCl (for oxidizing the metal impurities) and then dipped into a HCl-water bath for the sake of neutralization prior to washing with soap water. Then the cleaned glass wares were rinsed with deionized water and acetone simultaneously before drying at 120 °C in the oven overnight. 
10. Experimental Section  
Chapter 10: Experimental Section 
 125  
10.1.1 Melting point determination Melting points were determined using a Büchi 535 Type S melting point apparatus, where the sample were placed inside a both sided closed glass capillary tubes; the values are not corrected.
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10.1.2 Elemental analysis All the elemental analyses were performed with an Elementar Vario Micro elemental analyser by the micro analysis section of the Chemical Institute of the University of Bonn. The mean value of at least three measurements is given. 10.1.3 NMR spectroscopy NMR spectra of all the compounds were recorded on Bruker Avance DMX-300, DPX-300, DPX-400 or DMX-500 spectrometers. Deuterated solvents (CDCl3, THF-d8 or C6D6) were dried using literature procedures and used for the multinuclear NMR characterizations and the chemical resonances are given relative to Tetramethylsilane (1H, 13C, 29Si NMR), 1 M LiCl in D2O (7Li NMR), 15 % BF3·OEt2 in CDCl3 (11B NMR), CFCl3 (19F NMR) or 85% H3PO4 (31P NMR), respectively. The chemical shifts are expressed in parts per million, ppm. Coupling constants are abbreviated as nJX,Y, where X and Y denote the coupling nuclei (ordered by decreasing atomic number, n is the number of bonds that separate X and Y). The following abbreviations were used for expression of the multiplicities of the resonance signals: s = singlet, d = doublet, t = triplet, q = quartet, quin = quintet, sept = septet, m = multiplet and br = broad signal. All the measurements were recorded at 298K unless some specific temperature is given.  HMQC, HMBC and DEPT experiments were used in purpose of assigning the 1H NMR and 13C NMR signals of all compounds. 10.1.4 UV/vis spectroscopy UV/vis spectra were obtained from a Shimadzu UV-1650PC spectrometer (ɉ = 190-900 nm) using dichloromethane as the solvent and quartz glass cells (Hellma) of optical path 1cm at room temperature.  10.1.5 Mass spectrometry Mass spectrometric data were acquired from a Bruker Daltonik micrOTOF-Q using ESI (+/-), a Thermo Finnigan MAT 90 sector instrument equipped with a LIFDI ion source (Linden CMS) or MAT 95 XL Finnigan  using EI (70 eV). Only selected data are given for the detected ions (mass to charge ratio, relative intensity in percent).  10.1.6 Infrared spectroscopy IR-spectra were recorded from the pure solids on a Thermo IR spectrometer with an attenuated total reflection (ATR) attachment or on a Bruker Alpha Diamond ATR FTIR spectrometer at room temperature. The following abbreviations were used for expression of the intensities of the absorption bands: vs = very strong, s = strong, m = medium, w = weak. 
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10.1.7 Cyclic voltammetry The custom-tailored glassware for the electrochemical measurements, equipped with three Pt electrodes (working, reference and counter electrodes), has been prepared (see also figure x on page y).  Electrochemical experiments were carried out on an ALS 1140A potentiostat/galvanostat. Electrochemical samples were recorded with scan rates of 10–500 mVs–1 at r.t. under Ar atmosphere. Ferrocene was used as internal/external reference to determine the potentials. Sample solutions (THF) were 3 mM in analyte and 0.1 M in n-Bu4NPF6 as the supporting electrolyte. 10.1.8 Single crystal X-ray diffraction studies Single crystal were grown by evaporation of saturated solutions of the compounds at -20°C or by diffusion technique. After crystal growing the single crystals were separated from the supernatant solution and were covered with Fomblin for the purpose of protection from further decomposition. A suitable single crystal was selected under the microscope and loaded onto the diffractometer. The crystallographic data was collected on Brucker D8-Venture diffractometer, Bruker X8-KappaApexII, Bruker APEX-II CCD, Nonius KappaCCD or STOE IPDS 2T diffractometer equipped with a low-temperature device at 100.0 K using graphite monochromated Cu-Kradiation (ɉ = 1.54178 Å) or Cu-K radiation (λ = 1.54178). The absorption correction, structure solution and structure refinement was performed by Patterson methods or by full-matrix least squares on F2 using the SHELXL-97 programs. All non-hydrogen atoms were refined anisotropically, the hydrogen atoms were included isotropically using the riding model on the bound carbon atoms. Data analyses and the picture preparation of the molecular structure for all the compounds were done using Diamond 3.0 program. 10.1.9 Chemicals used  All the chemicals used during the experiments are listed below with supplier name in the brackets. All the chlorophosphane, commercially purchased, were subjected to further purification by means of fractional distillation.  Chemicals Supplier Chemicals Supplier 
 Acetonitrile Fisher Scientific  Glyoxal Acros 
 Ammonia solution Grüssing  Hydrogen peroxide Acros 
 Borane   dimethylsulfidecomplex Alfa Aesar  Hydrogen peroxide-urea adduct Acros 
 1-Bromobutane Acros  Imidazole ChemPure 
 1-Bromoethane Acros  Iodomethane Acros 
 n-Butylamine Acros  Isopropanol Biesterfeld 
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 n-Butyllithium Acros  Methanol Aldrich 
 Chloroform Fisher Scientific  Potassium metal Riedel de Haen 
 Chloroform-d Eurisotop  Potassium tert-butoxide Acros 
 Diethylether VWR  Potassium bis(trimethylsilyl)amide Sigma-aldrich 
 Dichloromethane Biesterfeld  n-Pentane Grüssing 
 Diisopropylamine Acros  Petrol ether 40/60 Biesterfeld 
 Dimethylamino Sigma-aldrich  Phenyldichlorophosphane Acros 
 Dichlorophosphane   Phosphorustrichloride Acros 
 Dimethylsulfoxide Acros  Sodium Metal Riedel de Haen 
 Dimethylacetylenedicarboxylate Acros  Sodium Hydride Sigma-aldrich 
 Diphenyldisulfide Sigma-aldrich  Sulfur Acros 
 Diphenyldiselenide Sigma-aldrich  Tetrahydrofuran Fisher Scientific 
 Diphenylmethane Acros  THF-d8 Eurisotop 
 Ethanol Hofmann  Triflicacid methyl ester Sigma-aldrich 
 Formaldehyde Acros  Toluene Fisher Scientific 
 Fluorene Sigma-aldrich  Tributyltin hydride Sigma-aldrich    Tributylphosphane Acros  The following compound were synthesized following published protocols: bis(diethylamino)chlorophosphane[125] 1,3,4,5-tetramethylimidazole-2-ylidene[11] Lithium diisopropylamide[126]   1,3-dimethylimidazole-2-thione[9] 1,3-diethylimidazole-2-thione[9]  1,3-dibutylimidazole-2-thione[9] 10.1.10 Waste disposal The chemical waste disposal was performed on basis of the ǲGefahrstoffverordnungǳ. Organic and inorganic waste were separated from each other and collected in designed container before disposing. Other dry chemical wastes along with column waste were collected together and disposed of. All the dangerous and reactive reagent left overs were destroyed according to the literature reported protocols[127] and taken care of. All the waste were submitted to the department Ͷ.ʹ ǲArbeits und Umweltschutzǳ of the University of Bonn for further caring.   
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10.2 Synthesis of bis(imidazole-2-thione-4-yl)phosphanes 3 To a solution of 1,3-dialkyl-imidazole-2-thione 1 (13.2 mmol) in 30 mL of THF, 8.9 ml of nBuLi (1.6 M in hexane) was added dropwise at –78 ᵒC. Then the reaction mixture was slowly warmed up to –40 ᵒC and stirred for about 3h at this temperature. Then the reaction mixture was again cooled to –78 ᵒC, and 6.6 mmol of dichlorophosphanes 2 were added dropwise into the reaction mixtures. Then the reaction mixtures were allowed to warm up to ambient temperature overnight. For 3a a white precipitate formed, which was filtered off and washed twice with THF (2 × 2 ml) and finally with n-pentane (2 × 5 ml) to get pure trans isomer of 4a as a white powder, finally.  The remaining reaction mixture was dried in vacuo (8×10-3 mbar) to get a brown oily residue which was again taken up in methylene dichloride (60 ml) and filtered through a bed of silica to remove LiCl. The residue after drying this filtrate was subjected to column chromatography over silica gel using a methylene dichloride/diethylether mixture (1:3) as eluent, in order to separate 3a from other impurities.  For 3b the reaction mixture was removed in vacuo (8×10-3 mbar) and then the residue was directly subjected to column chromatography at room temperature using diethylether/petroleum ether  (x/y) mixtures (1:4) as the eluent. Finally, both 3b and 4b were obtained as white powders after evaporation of all volatiles of the corresponding fractions. For 3d,g,i reaction mixtures were concentrated under reduced pressure to get dark yellow to brown residues. These residues were then taken up in methylene dichloride and filtered through a silica bed to remove the LiCl and some of the coloring impurities. The filtrates were dried in vacuo to light yellow solids as the crude products which were in the next step washed with n-pentane (3 × 5 ml) to remove some of the coloring impurities. Finally the remaining solids were dried in vacuo (8×10-3 mbar) to get the products as slightly off white powders. 10.2.1 Bis(1,3-diethylimidazole-2-thione-4-yl)(dimethylamino)phosphane (3b)  Yield: 0.82 g (2.1 mmol, 31.8 %) Appearance: white powder  melting point: 153 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 1.25(t, 6H, 3JH,H = 7.1 Hz, MeCH2N3), 1.31 (t, 6H, 3JH,H = 7.3 Hz MeCH2N1), 2.63 (d, 6H, 3JP,H = 9.9 Hz, P-NMe2), 3.96-4.11 (m, 4H, 3JH,H = 7.3Hz MeCH2N3), 4.16 (q, 2H, 3JHH = 7.1Hz MeCH2N1), 4.19 (q, 2H, 3JH,H = 7.1 Hz MeCH2N1'), 6.55 (br, 2H, C5H). 13C NMR (75.0 MHz, CDCl3Ȍ: δ = 13.8 & 13.9 ( s MeCH2N3), 14.2(s, MeCH2N1), 40.9 (d, 2JP,C = 16.5 Hz, P-NMe2), 41.7 & 41.8 (s, MeCH2N3), 42.9 (s, MeCH2N1), 121.4(s, C5), 125.2 (d, 1JP,C = 8.2 Hz, C4 ), 164.2 (s, C=S). 
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31P NMR (121.5 MHz, CDCl3Ȍ: δ = 12.6 (sept, 3JP,H = 9.9 Hz). IR [cm-1]: ṽ = 3117 (w), 2973 (w), 2941 (w), 1543 (w), 1434 (m), 1410 (s), 1271 (s), 1147 (s), 978 (s).  MS (EI, 70 eV): m/z (%) = 385.2 (100) [M].+, 341.2 (100)  [M-NMe2]+, 156.1 (30) [C7H12N2S].+. HRMS: theor./exp. for [C16H28N5PS2]: 385.1524/385.1520. EA [%]: theor./exp. C 49.85/49.51, H 7.32/7.03, N 18.17/17.99, S 16.63/17.11.   10.2.2 Bis(1,3-diisopropylimidazole-2-thione-4-yl)(dimethylamino)phosphane (3d) Yield: 2.36 g (5.4 mmol, 81.1 %) Appearance: white powder  melting point: 184 °C 
1H NMR (300 MHz, CDCl3): δ = 1.29(d, 6H, 3JH,H = 5.03 Hz, N1CHMe2), 1.32 (d,6H, 3JH,H = 5.03 Hz, N1CHMe2), 1.47 (d,6H, 3JH,H = 6.9 Hz, N3CHMe2), 1.52 (d,6H, 3JH,H = 6.9 Hz, N3CHMe2), 2.65 (d, 6H, 3JH,H = 9.45 Hz, Me2N-P), 5.13 (sept,2H, 3JH,H = 6.9 Hz, N3CHMe2), 5.23 (bs,2H, N1CHMe2), 6.50 (s, 2H, C4H). 13C NMR (75.0 MHz, CDCl3Ȍ: δ = 20.4 & 20.5 (s, N3CHMe2), 20.9 & 21.1 (s, N͵’CHMe2), 21.7 & 21.9 (s, N1CHMe2), 40.8 (d,2JP,C=16.6 Hz, Me2N-P), 48.7 (s, N1CHMe2), 51.9 (s, N3CHMe2), 119.4(s, C5), 126.7 (d, 1JP,C = 17.7 Hz, C4), 163.7 (s,  C=S).  31P NMR (121.5 MHz, CDCl3Ȍ: δ = 15.5 (sept, 3JP,H= 9.5 Hz). IR [cm-1]: ṽ = 2967 (s), 2930 (w), 2874 (w), 1539 (w), 1434 (w), 1412 (s), 1366 (s), 1330 (s), 1288 (s), 1186 (s), 1132 (s), 1062 (s), 982 (vs) MS (EI, 70 eV): m/z (%) = 441.2 (10) [M].+, 397.1(10) [M- NMe2]+, 184.1 (80) [C9H16N2S] .+. HRMS: theor./exp. for [C16H28N5PS2]: 441.2150/441.2150. EA [%]: theor./exp. C 54.39/53.12, H 8.22/7.99, N 15.86/15.49, S 14.52/13.90.   10.2.3 Bis(1,3-diisopropylimidazole-2-thione-4-yl)(ethoxy)phosphane (3g) Yield: 2.11 g (4.8 mmol, 72.0 %) Appearance: white powder  melting point: 146 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 1.26 (t, 3H, 3JH,H= 7.1 Hz, POCH2Me), 1.29 (d, 6H, 3JH,H= 6.5 Hz, N3-CHMe2), 1.32 (d, 6H, 3JH,H = 6.5 Hz, N͵’-CH Me2), 1.40 (d, 6H, 3JH,H= 7.1 Hz, N1-CHMe2), 1.55 (d, 6H, 3JH,H= 
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7 Hz, Nͳ’-CHMe2), 3.85 (dq, 2H, 3JP,H= 10.0 Hz, 3JH,H= 7.1 Hz, POCH2Me), 5.12 (sept, 2H, 3JH,H= 7 Hz, N1-CHMe2), 5.38 (br sept, 2H, 3JH,H = 6.5 Hz, N3-CHMe2), 6.68 (s, 2H, C5-H). 13C NMR (75.0 MHz, CDCl3Ȍ: δ = 17.0 (d,2JP,C = 8.8 Hz, POCH2Me), 21.0 and 21.2 (s, N3-CH Me2), 21.5 and 21.6 (s, N͵’-CH Me2), 21.7 (s, N1-CHMe2), 21.9 (s, Nͳ’-CH Me2), 49.0 (s, N1-CH Me2), 50.8 (s, N3-CH Me2), 66.3 (d,1JP,C = 22.3 Hz, POCH2Me), 120.6 (d, 2JP,C = 5.6 Hz, C5), 127.2 (d, 1JP,C = 22.3 Hz, C4), 164.4 (s, C=S). 
31P NMR (121.5 MHz, CDCl3Ȍ: δ = 70.1 (t, 3JP,H= 10.0 Hz). IR [cm-1]: ṽ = 3114 (w), 2974 (s), 2931 (w), 2874 (w), 1540 (s), 1458 (m), 1411 (vs), 1381 (s), 1295 (vs), 1188 (vs), 1034 (vs), 924 (vs), 750 (s), 712 (s). MS (EI, 70 eV): m/z (%) = 442 (10) [M].+, 184 (75) [C9H16N2S]+, 142 (18) [C6H10N2S]. HRMS: theor./exp. for [C20H35N4OPS2]: 442.1990/442.1992. EA [%]: theor./exp. C 54.27/54.44, H 7.97/7.81, N 12.66/12.57, S 14.49/14.48.   10.2.4 Bis(1,3-di-n-butylimidazole-2-thione-4-yl)(Phenyl)phosphane (3d) Yield: 2.10 g (3.96 mmol, 60.1 %) Appearance: white powder  melting point: 87 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.85(t, 6H, 3JH,H = 7.4 Hz, CH3CH2CH2CH2N3), 0.91(t, 6H, 3JH,H = 7.4 Hz, CH3CH2CH2CH2N1), 1.23-1.38 (m, 8H,  CH3CH2CH2CH2N), 1.55-1.73 (m, 8H,  CH3CH2CH2CH2N), 3.91-4.06 (m, 8H,  CH3CH2CH2CH2N), 6.29 (s, 2H, C5H), 7.34-7.51 (m, 5H, Ph protons). 13C NMR (75.0 MHz, CDCl3Ȍ: δ = 13.61 (s, CH3CH2CH2CH2N3), 13.62 (s, CH3CH2CH2CH2N1), 19.8(s, CH3CH2CH2CH2N3), 19.9 (s, CH3CH2CH2CH2N1), 30.7(d, 3JP,C=2.9Hz, CH3CH2CH2CH2N3), 30.8 (s, CH3CH2CH2CH2N1), 46.8 (d, 3JP,C = 8.3 Hz,  CH3CH2CH2CH2N3), 47.9 (s, CH3CH2CH2CH2N1), 122.4 (d, 1JP,C = 2.9 Hz, C4), 124.0 (s, m-C ph ring), 129.3(d, 2JP,C = 8.3 Hz,  o-C ph ring), 130.1(d, 1JP,C = 2.4 Hz, ipso-C ph ring ), 130.8 (s, p-C ph ring), 133.2 (d, 2JPC = 21.9, Hz, C5), 165.3 (d, 3JP,C = 1.1 Hz, C=S).  31P NMR (121.5 MHz, CDCl3Ȍ: δ = -59.2 (t, 3JP,H= 8.3 Hz). IR [cm-1]: ṽ = 3114 (w), 3062 (w), 2955 (m), 2930 (w), 2870 (w), 1549 (w), 1440 (m), 1410 (s), 1328 (m), 1220 (m), 1104 (m), 753(m). MS (EI, 70 eV): m/z (%) = 530.2 (90) [M].+, 453.2 (10) [M- Ph]+, 319.1 (100)  [M- Thione]+, 211.1 (20) [Thione] .+ 
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HRMS: theor./exp. for [C28H43N4PS2]: 530.2667/530.2671. EA [%]: theor./exp. C 63.36/63.31, H 8.17/7.98, N 10.56/10.43, S 12.08/12.00.  10.3 Synthesis of 1,4-dihydro-1,4-diphosphinines 4a,b Compounds 4a,b were isolated from the reaction mixtures for the synthesis of compounds 3a,b. For 3a,4a there was a white precipitate formed, which was filtered off and washed twice with THF (2 × 2 ml) and finally with n-pentane (2 × 5 ml) to get pure trans isomer of 4a as a white powder, finally. For 3b,4b the reaction mixture was removed in vacuo (8×10-3 mbar) and then the residue was directly subjected to column chromatography using diethylether/petroleum ether mixtures (1:4) as the eluent. Finally, both 3b and 4b were obtained as white powders after evaporation of all volatiles (8×10-3 mbar) of the corresponding fractions. 10.3.1  4,8-Bis(dimethylamino)-1,3,5,7-tetramethyl-4,8-dihydro[1,4]diphosphi-nine[2,3-d:5,6-d']bisimidazole-2,6-dithione (4a)  Yield: 0.11 g (0.3 mmol, 4.5 %) Appearance: white powder  melting point: 358 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 2.52 (br, 12H, P-NMe2), 3.76 (s, 12H, N-Me).  13C NMR (75.0 MHz, CDCl3Ȍ: δ = 34.5 (t, 3JP,C = 4.8 Hz, N-Me), 40.0 (br, P-NMe2), 129.3 (s, C4,5), 167.9 (s, C=S).  
31P NMR (121.5 MHz, CDCl3Ȍ: δ = 9.4 (hept. 3JP,H = 3.6 Hz).  IR [cm-1]: ṽ = 3376 (m), 2889 (w), 2800 (w), 1639 (w), 1427 (m), 1366 (s), 1334 (m), 1277 (m), 1161 (s), 1066 (w), 979 (s), 851 (s). MS (EI, 70 eV): m/z (%) = 402.0 (70) [M].+, 358.0 (15) [M-NMe2]+, 315.0 (100) [M-NMe2-C2H5N]+. HRMS: theor./exp. for [C14H24N6P2S2]: 402.0974/402.0978. EA [%]: theor./exp. C 41.78/41.28 , H 6.01/6.08, N 20.88/19.29, S 15.93/14.46.  10.3.2 4,8-Bis(dimethylamino)-1,3,5,7-tetraethyl-4,8-dihydro[1,4]diphosphinine[2,3 -d:5,6-d']bisimidazole-2,6-dithione (4b) Yield: 0.23 g (0.5 mmol, 15.9 %)      Appearance: white powder    melting point: decom. at 165 °C 
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1H NMR (300 MHz, CDCl3Ȍ: δ = 1.41 & 1.42(t, 12H, 3JH,H = 7.1 Hz, MeCH2N) ratio 1:3, 2.52 (br, 6H, P- NMe2), 2.70 (d, 6H, 3JP,H = 8.1 Hz, P- NMe2 2nd isomer), 4.10-4.22 (m, 4H, MeCH2N), 4.32-4.49 (m, 4H, MeCH2N 2nd isomer). 13C NMR (75.0 MHz, CDCl3Ȍ: δ = 12.4 (s, MeCH2N), 38.6 (br, P- NMe2), 41.6 (two d merged as t, MeCH2N), 127.3 (s, C4,5), 165.2 (s, C=S). 31P NMR (121.5 MHz, CDCl3Ȍ: δ = 8.61 & 8.71 (br ,3:1) two isomers. IR [cm-1]: ṽ = 2976 (w), 2752 (s), 2485 (s), 1732 (w), 1637 (w), 1443 (w), 1410 (m), 1191 (s), 1041 (s), 797 (s). MS (EI, 70 eV): m/z (%) = 458.2 (50) [M].+, 341.2 (100)  [M- 2NMe2 +H]+, 156.1 (10) [C7H12N2S].+. HRMS: theor./exp. for [C18H32N 6P2S2]: 458.1605/458.1607. EA [%]: theor./exp. C 47.15/46.65, H 7.02/6.87, N 18.33/17.76, S 13.98/14.28. 10.4 Synthesis of the backbone amino(chloro)substituted imidazole-2-thiones 5a-f A solution of 7a-f (5.6 mmol) in 35 ml diethyl ether was treated with PCl3 (6.1 mmol, 1.1 equiv) at –40 °C. The reaction mixture was then allowed to warm up slowly till ambient temperature (2h) (for 7d it was stirred at r.t. for overnight, and for 7e it was slightly warmed for 1h), after which the solvent was removed under reduced pressure (8 × 10-3 mbar) to get a yellow oily residue. Then 20 ml of n-pentane was added to the residue and stirred for few minutes, which results in removal of all the by-products and resulted in the formation of a fine white powder. The powder was then separated by cannula filtration and dried in vacuo (8 × 10-3 mbar) to get the pure compounds. 10.4.1 1,3-Dimethyl-4-diethylaminochlorophosphanyl-imidazole-2-thione (5a) Yield: 1.29 g (4.9 mmol, 87.5 %)  Appearance: white powder   melting point: 51 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 1.07 (t, 6H, 3JH,H = 7.2 Hz, CH3CH2N), 3.08 (q, 2H, 3JH,H = 7.2 Hz, CH3CH2N), 3.12 (q, 2H, 3JH,H = 7.3 Hz, CH3CH2N), 3.56 (s, 3H, N1-CH3), 3.61 (s, 3H, N3- CH3), 7.09 (d, 1H, 3JP,H = 2.4Hz, C5H). 13C NMR (75.0 MHz, CDCl3Ȍ: δ = 13.9 (d, 3JP,C = 6.8 Hz, CH3CH2N-P), 33.5 (d, 3JP,C = 6.6 Hz, N3-CH3), 35.4 (s,  N1- CH3), 43.5(d, 2JPC = 14.2 Hz, CH3 CH3N ), 125.2(d, 2JP,C = 8.1 Hz, C5), 126.2 (d, 1JP,C = 29.1 Hz, C4 ), 166.3 (s, C=S). 
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31P NMR (121.5 MHz, CDCl3Ȍ: δ = 106.06 (quint, 3JP,H = 12.2 Hz). IR [cm-1]: ṽ = 3152 (w), 2964 (s), 2822 (m), 2481 (m), 1561 (w),  1375 (s), 1152 (s), 1021 (s), 939 (s), 793 (s). MS (EI, 70 eV): m/z (%) = 265.0 (30) [M].+, 230.0 (10) [M- Cl]+, 192.9 (15)  [M- NEt2]+, 128.0 (100) [C5H8N2S] + HRMS: theor./exp. for [C9H17N3PClS]: 265.0569/265.0568. EA [%]: theor./exp. C 40.65/40.68, H 6.47/6.45, N 15.71/15.81, S 12.11/12.07.  10.4.2 1,3-Diethyl-4-diethylaminochlorophosphanyl-imidazole-2-thione (5b) Yield: 1.30 g (4.4 mmol, 78.5 %)  Appearance: white powder   melting point: 59 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 1.10 (t, 6H, 3JH,H = 7.1 Hz, CH3CH2N-P), 1.32 (t, 3H, 3JH,H = 7.1 Hz, CH3CH2N1), 1.39 (t, 3H, 3JH,H = 7.1 Hz, CH3CH2N3), 3.14 (dq, 4H, 3JP,H = 13.1 Hz, 3JH,H = 7.1 Hz, CH3CH2N-P), 3.93-4.24 (m, 3H, CH3CH2N), 4.27-4.41 (m, 1H, CH3CH2N), 7.15 (d, 1H, 3JP,H = 2.0Hz, C5H). 13C NMR (75.0 MHz, CDCl3Ȍ: δ = 13.8 (s, CH3CH2N1), 13.9 (s, CH3CH2N3), 14.2 (s, CH3CH2N-P), 41.3(d, 3JP,C = 6.1 Hz, CH3CH2N3), 42.9(s, CH3CH2N1), 43.5(d, 2JP,C = 14.4 Hz, CH3CH2N-P), 123.8(d, 2JP,C = 6.9 Hz, C5), 125.8 (d, 1JP,C = 30.8 Hz, C4), 164.8 (s, C=S). 31P NMR (121.5 MHz, CDCl3Ȍ: δ = 106.5 (quint, 3JP,H = 11.9 Hz). IR [cm-1]: ṽ = 3130 (w), 3173 (w), 2969 (m), 2869 (w), 1549 (w), 1414 (s), 1374 (m), 1271 (s),1150 (s), 1022 (s), 941 (s), 791 (s), 667 (s). MS (EI, 70 eV): m/z (%) = 293.1 (20) [M].+, 221.0 (40)  [M- NEt2]+, 156.0 (100) [C7H12N2S]+. HRMS: theor./exp. for [C11H21N3PClS]: 293.0882/293.0881. EA [%]: theor./exp. C 44.78/44.79, H 7.29/7.20, N 14.21/14.30, S 10.09/10.91.  10.4.3 1,3-Di-n-butyl-4-diethylaminochlorophosphanyl-imidazole-2-thione (5c) Yield: 1.63 g (4.6 mmol, 82.1 %)  Appearance: white powder  melting point: liquid at r.t. 
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1H NMR (300 MHz, CDCl3Ȍ: δ = 0.81 and 0.83 (t, 6H, 3JH,H = 7.5 Hz, CH3CH2CH2CH2N), 0.98 (t, 3H, 3JH,H = 7.2 Hz, CH3CH2N-P), 1.19-1.31 (m, 4H,  CH3CH2CH2CH2N), 1.56-1.71 (m, 4H,  CH3CH2CH2CH2N), 2.95-3.06 (m, 4H, CH3CH2N-P), 3.69-4.23 (m, 4H, CH3CH2CH2CH2N), 7.04 (d, 1H, 3JP,H = 2.0 Hz, C5H). 13C NMR (75.0 MHz, CDCl3Ȍ: δ = 13.60 and 13.64 (s, CH3CH2CH2CH2N), 13.76 and 13.85 (s, CH3CH2N-P), 19.70 (s, CH3CH2CH2CH2N1), 19.92 (d, 5JP,C = 0.9 Hz, CH3CH2CH2CH2N3), 30.45 (d, 4JP,C = 4.5 Hz, CH3CH2CH2CH2N3), 30.78 (s, CH3CH2CH2CH2N1), 43.46 (d, 2JP,C = 14.2 Hz, CH3CH2N-P), 46.04 (d, 2JP,C = 14.2 Hz, CH3CH2CH2CH2N3), 47.73 (s, CH3CH2CH2CH2N1), 124.4(d, 2JP,C = 6.8 Hz, C5), 125.7 (d, 1JP,C = 31.5 Hz, C4), 165.2 (s, C=S). 31P NMR (121.5 MHz, CDCl3Ȍ: δ = 106.4 (quint, 3JP,H = 12.4 Hz). IR [cm-1]: ṽ = 2958 (m), 2930 (m), 2871 (w), 1551 (w), 1439 (m), 1411 (s), 1378 (m), 1219 (m), 1199 (m), 1167 (m), 1021 (s), 939 (s), 782 (s). MS (EI, 70 eV): m/z (%) = 349.1 (40) [M].+, 277.0 (100)  [M- NEt2]+. HRMS: theor./exp. for [C15H29N3PClS]: 349.1508/349.1508. EA [%]: theor./exp. C 51.49/51.30, H 8.35/8.61, N 12.01/11.53, S 9.16/8.92.  10.4.4 1,3-Diisopropyl-4-diethylaminochlorophosphanyl-imidazole-2-thione (5d) Yield: 1.67 g (5.2 mmol, 92.8 %)  Appearance: white powder   melting point: 68 °C. 
1H NMR (300 MHz, CDCl3Ȍ: δ = 1.08 (t, 6H, 3JH,H = 7.2 Hz, CH3CH2N-P), 1.37 (d, 3H, 3JH,H = 6.0 Hz N-CHCH3CH3), 1.39 (d, 3H, 3JH,H = 6.0 Hz N-CHCH3CH3), 1.51 (d, 3H, 3JH,H = 6.8 Hz, N-CHCH3CH3), 1.61 (d, 3H, 3JHH = 6.8 Hz N-CHCH3CH3), 3.15-2.95 (m, 4H, 3JH,H = 7.2Hz, 3JP,H = 2.8 Hz, CH3CH2N-P), 5.17 (sept, 1H, 3JH,H = 6.8 Hz, N-CHCH3CH3), 5.27 (bs, 1H, N-CHCH3CH3), 7.29 (d, 1H, 3JP,H = 1.4 Hz, C5-H).  13C NMR (75.0 MHz, CDCl3Ȍ: δ = 12.78 (d, 3JP,C = 7.0 Hz, CH3CH2N-P), 19.7 (s, N3CHCH3CH3), 20.0 (s, N3CHCH3CH3), 20.8 (s, N1CHCH3CH3), 20.9 (s, N1CHCH3CH3), 42.4 (d, 2JP,C = 14.8 Hz, CH3CH2N-P), 47.9 (s, N1CHCH3CH3), 50.3 (s, N3CHCH3CH3), 120.8 (d, 2JP,C = 5.1 Hz, C5), 125.5 (d, 1JP,C = 39.3 Hz, C4 ), 163.0 (s, C=S). 
31P NMR (121.5 MHz, CDCl3Ȍ: δ = 108.4 (br, s). IR [cm-1]: ṽ = 3129 (w), 2972 (m), 2871 (w), 2823 (w), 2481 (w), 1541 (m), 1413 (s), 1361 (s), 1336 (s), 1286 (s), 1187 (s), 1168 (s), 1019 (s). 
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MS (EI, 70 eV): m/z (%) = 321.1 (40) [M].+, 286.1 (10) [M-Cl]+, 249.0 (55)  [M-NEt2]+, 184.1 (75) [Thione]+. HRMS: theor./exp. for [C13H25N3PClS]: 321.1195/321.1200. EA [%]: theor./exp. C 48.51/47.47, H 7.84/7.56, N 13.06/12.43, S 9.96/9.89.  10.4.5 1,3-Dimesityl-4-diethylaminochlorophosphanyl-imidazole-2-thione (5e) Yield: 2.32 g (4.9 mmol, 87.5 %)  Appearance: white powder   melting point: 153 °C. 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.96 (t, 6H, 3JH,H = 7.1 Hz, Me2CHN-P), 2.12 & 2.13 (s, 3H each, o-CH3 of N3-Mes), 2.17 (s, 6H, p-CH3 of Mes), 2.32 & 2.34 (s, 3H, o-CH3 of N1-Mes), 2.91-3.24 (m, 4H, Me2CHN-P), 6.97 & 6.99 (s, 1H each, m-CH3 of N3-Mes), 7.01 (s, 2H, m-CH3 of N1-Mes), 7.28 (d, 1H, 3JP,H = 1.7 Hz, C5H). 13C NMR (75.0 MHz, CDCl3Ȍ: δ = 13.8  ( d, 3JP,C = 7.8 Hz, P-NCHMe2), 18.07 (s, p-CH3 of Mes), 17.95 & 18.00 (s, o-CH3 of N3-Mes), 18.23 & 18.35 (s, o-CH3 of N3-Mes),  21.20 & 21.24 (s, o-CH3 of N1-Mes),  43.4 (d, 2JP,C = 15.9 Hz, P-NCHMe2),  125.4(d, 2JP,C = 3.4 Hz, C5), 128.4 (d, 1JP,C = 30.4 Hz, C4),  129.27, 129.29, 129.44 & 129.46 (s, m-CH of Mes), 131.7 (d, 4JP,C = 1.3 Hz, o-C of Mes), 133.4 (s, o-C of Mes), 135.2 & 135.7 (ipso-C of Mes),135.8 (d, 4JP,C = 1.6 Hz, o-C of Mes), 136.9 (s, o-C of Mes), 139.4 & 139.6 (s, p-C of Mes), 166.2 (s, C=S).   
31P NMR (121.5 MHz, CDCl3Ȍ: δ = 102.9 (quint, 3JP,H = 10.8 Hz). IR [cm-1]: ṽ = 3159 (w), 2973 (m), 2916 (w), 1553 (m), 1481 (m), 1370 (m), 1344 (s), 1296 (w), 1026 (s), 946 (s). MS (EI, 70 eV): m/z (%) = 473.1 (60) [M].+, 438.1 (25) [M-Cl]+, 401.1 (100)  [M-NEt2]+. HRMS: theor./exp. for [C25H33N3PClS]: 473.1821/473.1824.  EA [%]: theor./exp. C 63.34/62.90, H 7.02/7.22, N 8.86/8.74, S 6.76/6.78.  10.4.6 1,3-Dimethyl-4-diisopropylaminochlorophosphanyl-imidazole-2-thione (5f) Yield: 1.38 g (4.7 mmol, 83.9 %)  Appearance: white powder   melting point: 144 °C. 
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1H NMR (300 MHz, CDCl3Ȍ: δ = 1.13 (bs, 6H, Me2CHN-P), 1.29 (bs, 6H, Me2CHN-P), 3.57 (s, 3H, N1-CH3), 3.63 (s, 3H, N3-CH3), 7.13 (d, 1H, 3JP,H = 2.6 Hz, C5H). 13C NMR (75.0 MHz, CDCl3Ȍ: δ = 23.1 (bs,  Me2CHN-P), 33.4 (d, 3JP,C = 7.2 Hz,  N3-CH3), 35.4 (s,  N1-CH3), 47.5(s,  Me2CHN-P ), 125.4(d, 1JP,C = 26.9 Hz, C4), 126.1 (d, 2JP,C = 8.1 Hz, C5 ), 166.3 (s, C=S).   31P NMR (121.5 MHz, CDCl3Ȍ: δ = 98.93 (t, 3JP,H = 10.5 Hz). IR [cm-1]: ṽ = 3134 (w), 3084 (w), 2966 (m), 2927 (w), 2720 (w), 2488 (w), 1556 (m), 1458 (m), 1378 (s), 1150 (s), 1015 (m), 971 (s), 796 (s). MS (EI, 70 eV): m/z (%) = 321.1 (40) [M].+, 286.1 (10) [M-Cl]+, 249.0 (55)  [M-NEt2]+, 128.1 (100) [C5H8N2S]+. HRMS: theor./exp. for [C11H21N3PClS]: 293.0882/293.0884.  EA [%]: theor./exp. C 44.97/45.02, H 7.20/7.43, N 14.30/14.15, S 10.91/10.50. 10.5 Reaction of compound 5 with KHMDS To a solution of 5 (4.1 mmol) in 25 mL of THF, a solution of KHMDS (0.826 g, 4.1 mmol, 1equiv) in THF (30 mL) was added at –78 ᵒC. Then the reaction mixture was slowly warmed to room temperature (2h). Afterwards the solvent was removed in vacuo (8 × 10-3 mbar) to get a yellow oil, which was again dissolved in 30 ml of toluene. This solution was filtered through a small celite® bed to remove KCl. Then the filtrate was concentrated in vacuo (8 × 10-3 mbar) until a yellow oil was obtained as crude product. This was then triturated with 10 ml of n-pentane at room temperature to get a white powder, which was dried in vacuo (8 × 10-3 mbar) after removal of the n-pentane. 10.5.1 1,3-Dimethyl-4-{bis(trimethylsilyl)amino}diethylaminophosphanyl-imida-zole-2-thione (8a) Yield: 1.1g (2.8 mmol, 68.9 %)  Appearance: white powder   melting point: 108 °C. 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.166 & 0.169 (s, 18H, SiMe3), 1.05(t, 6H, 3JH,H = 7.2 Hz, CH3CH2N-P), 3.05-3.19 (m, 4H, CH3CH2N-P ), 3.54 (s, N3-CH3), 3.57 (s, N1-CH3), 6.45 (d, 1H, 3JP,H = 2.8 Hz, C5H). 13C NMR (75.0 MHz, CDCl3Ȍ: δ = 4.29 (d, 2JSi,P= 7.4 Hz, N-SiMe3), 14.5 (d, 3JP,C = 2.9 Hz, CH3CH2N-P ), 33.6 (d, 2JP,C = 7.1 Hz, N3-CH3 ), 35.1 (s, N1-CH3 ), 42.3 ( d, 2JP,C = 19.9 Hz, CH3CH2N-P), 120.8 (d, 2JP,C = 7.4 Hz, C5), 133.0 (d, 1JP,C = 29.5 Hz, C4 ), 164.3 (s, C=S). 31P NMR (121.5 MHz, CDCl3Ȍ: δ = 74.92 (bs). 
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29Si NMR (59.5 MHz, CDCl3, 25 °C): δ =  7.62 (d, 2JSi,P = 7.0 Hz). IR [cm-1]: ṽ = 3139 (w), 2966 (m), 1552 (w), 1381 (m), 1251 (m), 1178 (m), 1016 (m), 917 (s). MS (EI, 70 eV): m/z (%) = 390.1 (20) [M].+, 318.1 (100)  [M-NEt2]+, 317.1 (20) [M-TMS]+, 128.0 (100) [C5H8N2S]+. HRMS: theor./exp. for [C15H35N4PSSi2]: 390.1859/390.1858. EA [%]: theor./exp. C 46.12/45.84, H 9.03/8.66; N 14.34/14.41, S 8.21/8.16.  10.5.1 1,3-Diisopropyl-4-{bis(trimethylsilyl)amino}diethylaminophosphanyl-imida-zole-2-thione (8b) Yield: 1.47 g (3.3 mmol, 80.5 %)  Appearance: white powder   melting point: 55 °C. 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.18 (s, 18H, SiMe3), 1.04 (t, 6H, 3JH,H = 7.2 Hz, MeCH2N-P), 1.27 (d, 3H, 3JH,H = 6.8 Hz N3-CHMeMe), 1.30 (d, 3H, 3JH,H = 6.8 Hz N3-CHMeMe), 1.69 (d, 3H, 3JH,H = 6.8 Hz N1-CHMeMe), 1.78 (d, 3H, 3JH,H = 6.8 Hz N1-CHMeMe), 3.11 (br quintet, 4H, 3JH,H = 7.2Hz, MeCH2N-P), 4.61 (br, 1H, N3-CHMeMe), 5.17 (sept, 1H, 3JHH = 6.8 Hz, N1-CHMeMe), 6.59 (d, 1H, 3JP,H = 2.0 Hz, C5H).  13C NMR (75.0 MHz, CDCl3Ȍ: δ = 4.2 & 4.3 (s, N-SiMe3), 14.3 (d, 4JP,C = 2.8 Hz, MeCH2N-P), 19.8(s, N3-CHMeMe), 19.9(s, N3 CHMeMe), 21.6(s, N1 CHMeMe), 22.3(s, N1 CHMeMe), 42.3 (d, 2JP,C =19.9 Hz, MeCH2N-P), 47.2(s, N1 CHMeMe), 51.3(d, 4JPC = 10.9 Hz, N3CHMeMe), 117.2(d, 2JP,C = 5.9 Hz, C5), 133.6 (d, 1JP,C = 36.1 Hz, C4), 160.9 (s, C=S). 31P NMR (121.5 MHz, CDCl3Ȍ: δ = 74.9 (br). 29Si NMR (59.5 MHz, CDCl3, 25 °C): δ =  6.90 (d, 2JSi,P = 7.2 Hz). IR [cm-1]: ṽ = 3142 (w), 2972 (s), 1550 (w), 1432 (m), 1313 (m), 1190 (m), 1020 (m), 927 (s). MS (EI, 70 eV): m/z (%) = 446.3 (80) [M].+, 374.2 (25)  [M- NEt2]+, 373.2 (20) [M-TMS]+,263.2 (100) [C10H28N2PSi2]+. HRMS: theor./exp. for [C19H43N4PSSi2]: 446.2485/446.2484. EA [%]: theor./exp. C 51.08/50.43, H 9.70/9.50; N 12.54/12.26, S 7.18/7.26. 
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10.6 Synthesis of 1,4-dihydro-1,4-diphosphinines 4d-f A solution of LDA (50.58 mmol) in 50 ml of THF was added dropwise to a solution of 5a-c (45.16 mmol) in 120 mL of THF with continuous stirring through a double-ended needle over 30 minutes at -ͺͲ ˚C. The reaction mixture was then allowed to warm up to ambient temperature overnight. The solvent was then removed to get a dark brown residue which was taken up in 120 ml of methylene dichloride and filtered through a celite® bed to remove LiCl formed during the course of the reaction. The filtrate was concentrated under reduced pressure (8 × 10-3 mbar) to obtain a light brown solid which was then washed again with n-pentane (3×10 ml) to get a white powder and, finally, dried under reduced pressure (8 × 10-3 mbar) for 2 h to get the pure compounds as cis/trans mixtures (ratio 1:1.7 for 4d, 1:1.4 for 4e, 1:9 for 4f). 10.6.1 4,8-Bis(diethylamino)-1,3,5,7-tetramethyl-4,8-dihydro[1,4]diphosphinine[2,3 -d:5,6-d']bisimidazole-2,6-dithione (4d) Yield: 8.7g (18.9 mmol, 84.4 %)  Appearance: white powder   melting point: 160 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.88 (br s, 12H,  P-NCH2Me), 0.97 (t, 12H, 3JH,H = 7.0 Hz, P-NCH2Me) (2nd isomer), 2.86 (bs, 8H, P-NCH2Me), 3.06 (quint, 8H, 3JH,H = 7.0 Hz, P-NCH2Me) (2nd isomer), 3.73 (s, 12H, N-CH3), 3.78 (s, 12H, N-CH3)(2nd isomer). 13C NMR (75.0 MHz, CDCl3Ȍ: δ = 14.0 (bs, CH3CH2N-P), 14.1 (d, 3JP,C =4.6 Hz , CH3CH2N-P) (2nd isomer), 32.9 (d, 2JP,C =9.8 Hz,  N-CH3 ), 34.6 (t, 2JP,C = 5.0 Hz , N-CH3 ) (2nd isomer), 43.3 (bs, P-NCH2Me), 44.1 (d, 2JP,C = 16.9 Hz, P-NCH2Me ) (2nd isomer), 125.5 (t, 1JP,C = 3.5Hz, P-C of middle ring), 129.9 (t, 1JP,C = 0.99 Hz, P-C of middle ring) (2nd isomer), 167.6 (t, 3JP,C = 1.5 Hz,  C=S), 167.7 (t, 3JP,C = 1.4 Hz, C=S) (2nd isomer).  
31P NMR (121.5 MHz, CDCl3Ȍ: δ = 3.30 (quint, 3JP,H = 7.1 Hz ), 3.79 (m) two isomers (ratio 1:1.7). IR [cm-1]: ṽ = 2970 (m), 2363 (w), 1732 (w), 1460 (m), 1426 (m), 1377 (s), 1161 (s), 1018 (s), 931 (s), 852 (s). MS (EI, 70 eV): m/z (%) = 458.2 (90) [M].+, 386.1 (10) [M-NEt2]+, 315.0 (100)  [M-2NEt2+H]+, 128.0 (50) [C5H8N2S]+, 72.1 (100) [NEt2]+. HRMS: theor./exp. for [C18H32N6P2S2]: 458.1605/ 458.1605. EA [%]:theor./exp. C 47.15/46.86, H 7.03/7.14; N 18.33/17.74, S 13.98/13.56. 
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10.6.2 4,8-Bis(diethylamino)-1,3,5,7-tetraethyl-4,8-dihydro[1,4]diphosphinine[2,3 -d:5,6-d']bisimidazole-2,6-dithione (4e) Yield: 7.21 g (14.1 mmol, 61.9 %)  Appearance: white powder melting point: decom. at  165°C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.84 (br, 12H,  P-NCH2Me), 0.99 (t, 12H, 3JH,H = 6.7 Hz, P-NCH2Me) (2nd isomer), 1.39(t, 12H, 3JH,H = 5.9 Hz, NCH2Me), 1.42 (t, 12H, 3JH,H = 6.8 Hz, NCH2Me) (2nd isomer), 2.83 (br, 8H, P-NCH2Me), 3.09 (quintet, 8H, 3JH,H = 7.0 Hz, P-NCH2Me) (2nd isomer), 4.05 (m, 4H, NCH2Me), 4.40-4.66 (m, 4H, NCH2Me). 13C NMR (75.0 MHz, CDCl3Ȍ: δ = 13.6 (br, NCH2Me), 13.8 (br, NCH2Me) (2nd isomer), 14.0 (br, P-NCH2Me), 14.1 (d, 2JP,C = 5.1 Hz , P-NCH2Me) (2nd isomer), 40.9 (m,  NCH2Me), 42.1 (t, 2JP,C= 4.1 Hz, NCH2Me) (2nd isomer), 43.3 (br, P- NCH2Me), 43.5 (br, P- NCH2Me)  (2nd isomer), 125.3 (t, 1JP,C = 2.4 Hz, P-C), 129.2 (t, 1JP,C = 2.0 Hz, P-C) (2nd isomer), 166.1 (br, C=S). 31P NMR (121.5 MHz, CDCl3Ȍ: δ = 0.4 & 2.9 (br, two isomers, ratio 1:1.4). IR [cm-1]: ṽ = 2969 (m), 2932 (m), 2829 (w), 1437 (m), 1400 (s), 1267 (s), 1150 (s), 1016 (s), 977 (s), 926 (s), 791 (s). MS (EI, 70 eV): m/z (%) = 514.1 (50) [M].+, 371.0 (100)  [M-2NEt2+H]+, 72.0 (40) [NEt2]+. HRMS: theor./exp. for [C22H40N6P2S2]: 514.2231/514.2231. EA [%]: theor./exp. C 51.34/51.27, H 7.83/7.69; N 16.33/16.16, S 12.46/12.42.  10.6.3 4,8-Bis(diethylamino)-1,3,5,7-tetra-n-butyl-4,8-dihydro[1,4]diphosphinine [2,3 -d:5,6-d']bisimidazole-2,6-dithione (4f) Yield: 7.7 g (11.3 mmol, 50.3 %)  Appearance: white powder    melting point: 155 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.89 (bs, 12H,  P-NCH2Me), 0.99 (t, 12H, 3JH,H = 7.4 Hz, NCH2CH2CH2Me), 1.38-1.50 (m, 8H, NCH2CH2CH2Me ), 1.76-2.00 (m, 8H, NCH2CH2CH2Me ), 2.85 (bs, 8H, P-NCH2Me ), 3.89-4.02 (m, 4H, NCH2CH2CH2Me ), 4.49-4.60 (m, 4H, NCH2CH2CH2Me ) (2nd isomer). 
13C NMR (75.0 MHz, CDCl3Ȍ: δ = 13.8 (s, NCH2CH2CH2Me), 14.0 (bs, P-NCH2CH3), 20.1 (s, NCH2CH2CH2Me), 20.2 (s, NCH2CH2CH2Me) (2nd isomer), 30.2 (bs, NCH2CH2CH2Me ), 30.4 (t, 3JP,C = 1.4 Hz,  NCH2CH2CH2Me ) (2nd isomer), 44.3 (d, 2JP,C = 17.9 Hz, P-NCH2CH3), 45.8 (bs, NCH2CH2CH2Me ), 
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46.9 (t, 2JP,C = 3.4 Hz, NCH2CH2CH2Me )  (2nd isomer), 125.7 (bs, P-C of the middle ring), 129.3 (t, 1JP,C = 2.3 Hz, P-C of the middle ring) (2nd isomer), 166.5 (t, 3JP,C = 1.5 Hz, C=S). 31P NMR (121.5 MHz, CDCl3Ȍ: δ = 0.19 (bs) and 3.62 (bs) two isomers. ratio 1:9. IR [cm-1]: ṽ = 2956 (m), 2930 (m), 2870 (w), 1464 (w), 1434 (w), 1398 (s), 1217 (m), 1176 (m), 1146 (m), 1016 (S), 926 (s). MS (EI, 70 eV): m/z (%) = 626.3 (40) [M].+, 483.1 (100)  [M-2NEt2+H]+. HRMS: theor./exp. for [C30H56N6P2S2]: 626.3483/626.3483. EA [%]:theor./exp.  C 57.48/57.53, H 9.00/9.05; N 13.41/13.31, S 10.23/10.15. 10.7 Substitution reaction at the P-center of amino(chloro)compounds/ synthesis of 9a-c In a Schlenk flask, diphenylmethane (12.4 mmol, for 9a) or fluorene (12.4 mmol, for 9b,c) was dissolved in 80 ml of THF and 7.94 ml of nBuLi (1.6 M in hexane) was added dropwise at -78 °C. The reaction mixture was stirred at this temperature for 1h to complete the lithiation. In the meantime, in a separate Schlenk flask 4g of 5 was dissolved in 60 ml of THF and cooled down to -78 °C. Then the solution of lithiated salt was transferred into the solution of 5, through a double-ended needle over 15 minutes. After that the reaction mixture was warmed up to ambient temperature and the solvent was removed under reduced pressure to get a yellow solid residue, which was then taken up in 60 ml of methylene dichloride. The solution of the residue was filtered through a layer of Celite® using a G3 frit, to remove the LiCl. The filtrate was concentrated in vacuo to get the crude product as a yellow solid, which was then washed with minimum amounts of toluene (~5 mL) followed by washing with n-pentane (2 × 15 ml) to remove the coloring impurities. Finally the compound was dried under reduced pressure (8 × 10-3 mbar) to get 9a-c as white powder. 10.7.1 1,3-Diisopropyl-4-diethylamino(diphenylmethyl)phosphanyl-imidazole-2-thione (9a) Yield: 2.8 g (7.5 mmol, 60.4 %),  Appearance: white powder    melting point: 185 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.56 (t, 6H, 3JH,H = 7.0 Hz, P-NCH2CH3), 1.11 (d, 3H, 3JH,H = 6.8 Hz, N1CHCH3CH3), 1.34 (d, 3H,  3JH,H  = 6.8 Hz, N1CHCH3CH3), 1.61 (d, 3H, 3JH,H = 6.9 Hz, N3CHCH3CH3), 1.66 (d, 3H, 3JH,H = 6.9 Hz, N3CHCH3CH3), 2.78-3.03 (m, 4H, P-NCH2CH3), 4.67 (d, 1H, 3JH,H = 3.4 Hz,  P-CH), 
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5.08 (sept, 1H, 3JH,H = 6.8 Hz,  N1CHCH3CH3 ), 5.47 (bs, 1H, N3CHCH3CH3), 6.76 (s, 1H, C5H), 7.10 – 7.49  (m, 10H, Ph ring protons). 
13C NMR (75.0 MHz, CDCl3Ȍ: δ = 13.6 (bs, CH3CH2N-P), 21.4 (s, N1CHMe2), 22.2 (s, N3CHMe2), 43.3 (d, 2JP,C = 15.7 Hz, CH3CH2N-P), 48.4  (s, N1CHMe2), 50.5 (s, N3CHMe2), 51.52 (d, 2JP,C = 11 Hz, P-CH) 126.6 (d, 2JP,C = 8.1 Hz, C5), 128.2 (d, 1JP,C = 34.5 Hz, C4), 128.3 (d, 1JP,C = 34.4 Hz, P-CH), 128.7 (s, o-C of  Ph), 128.8 (s, m-C of  Ph), 128.9 (s, p-C of  Ph), 141.3 (d, 2JP,C = 14.6 Hz, quart-C Ph ring ), 141.8 (d, 2JP,C = 14.6 Hz, quart-C Ph ring ), 161.3 (s,  C=S). 
31P NMR (121.5 MHz, CDCl3Ȍ: δ = 34.9 (br. s). MS (EI, 70 eV): m/z (%) = 453 (50) [M].+, 286 (100) [M-Ph2CH]+, 184.1 (10) [C9H16N2S]+, 167 (30)  [Ph2CH]+ HRMS: theor./exp. for [C26H36N3PS]: 453.2365/453.2366. EA [%]:theor./exp.  C 68.84/67.94, H 8.00/8.15; N 9.26/8.95, S 7.07/6.85. 10.7.2 1,3-Dimesityl-4-diethylamino(fluorenyl)phosphanyl-imidazole-2-thione  (9b) Yield: 4.47 g, (7.4 mmol, 59.6 %)  Appearance: white powder    melting point: 207 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.82 (t, 6H, 3JHH = 7.2 Hz, P-NCH2CH3), 1.62 & 2.12 (s, 3H each, o-CH3 of N3-Mes), 2.18 & 2.19 (s, 3H each, p-CH3 of Mes), 2.33 & 2.41 (s, 3H, o-CH3 of N1-Mes), 2.78-2.92 (m, 4H, Me2CHN-P), 4.46 (s, C9-H of Flu), 6.71 & 6.86 (s, 1H each, m-CH of N3-Mes), 6.76 (d, 1H, 3JP,H = 0.5 Hz, C5H), 7.01-7.67 (m, 10H, Flu ring protons and m-CH of N1-Mes). 
13C NMR (75.0 MHz, CDCl3Ȍ: δ = 14.8 (d, 3JPC = 3.9 Hz, CH3CH2N-P), 18.3 (s, p-CH3 of Mes), 18.5 (d, 4JPC = 0.6 Hz, o-CH3 of N3-Mes), 18.7 (d, 4JPC = 4.4 Hz, o-CH3 of N3-Mes), 21.1 & 21.3 (s, o-CH3 of N1-Mes), 45.2 (d, 2JP,C = 15.7 Hz, P-NCHMe2), 46.5 (d, 1JP,C = 21.7 Hz, P-CH of Flu), 122.2 (d, 2JP,C = 4.4 Hz,  C5),120.1 & 120.2 (s, CH of Flu), 126.1 (d, JP,C = 2.2  Hz, CH of Flu), 126.2 (d, JP,C = 5.2 Hz, CH of Flu), 126.3 (d, JP,C = 3.5 Hz, CH of Flu), 126.6 (d, JP,C = 4.0 Hz, CH of Flu), 127.2 (d, JP,C = 3.9 Hz, CH of Flu), 127.3 (d, JP,C = 3.4 Hz, CH of Flu), 128.9, 129.2, 129.5 & 129.6 (s, m-CH of Mes), 131.5 (d, 1JP,C = 25.7 Hz, C4 ), 132.5 (d, 4JP,C = 1.5 Hz, o-C of Mes), 133.7 (s, o-C of Mes), 135.74 (s, o-C of Mes),  135.5 & 135.7 (ipso-C of Mes),  136.1 (d, 4JP,C = 1.3 Hz, o-C of Mes), 139.1 & 139.6 (s, p-C of Mes), 141.1 (d, JP,C = 8.8 Hz, quart-C Flu), 141.2 (d, JP,C = 1.5 Hz, quart-C Flu), 141.8 (d, JP,C = 3.1 Hz, quart-C Flu), 143.1 (d, JP,C = 7.8 Hz, quart-C Flu), 165.1 (s,  C=S). 31P NMR (121.5 MHz, CDCl3Ȍ: δ = 30.6 (quint, 3JP,H = 8.6 Hz). 
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MS (EI, 70 eV): m/z (%) = 603.3 (30) [M].+, 531.2 (70) [M-NEt2]+, 438.2 (100) [M-Flu]+.  HRMS: theor./exp. for [C38H42N3PS]: 603.2833/603.2833. EA [%]:theor./exp.  C 75.59/75.23, H 7.01/7.05; N 6.96/6.90, S 5.31/5.54.  10.7.3 1,3-Diisopropyl-4-diethylamino(fluorenyl)phosphanyl-imidazole-2-thione (9c) Yield: 4.15 g, (9.2 mmol, 74.2 %)  Appearance: white powder    melting point: 182 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.89 (t, 6H, 3JHH, = 7.1 Hz, P-NCH2CH3), 1.36 (bs, 3H, N3CHCH3CH3), 1.42(d, 3H, 3JH,H = 6.8 Hz, N1CHCH3CH3 ), 1.47 (d, 3H, 3JH,H = 6.8 Hz, N1CHCH3CH3), 1.51 (d, 3H, 3JH,H = 6.9 Hz, N3CHCH3CH3), 3.02-3.29 (m, 4H, P-N-CH2CH3), 4.81 (s, C9-H of fluorene), 5.32 (sept, 1H, 3JH,H = 6.8 Hz,  N1CHCH3CH3), 5.57 (bs, 1H, N3CHCH3CH3), 6.86 & 7.11 (t, 3JH,H = 7.3 Hz; & d, 3JH,H = 7.7 Hz,  C1 & C8-H of fluorene), 7.20 (s, 1H, C5H), 7.33 (m, 2H, C2 & C7-H of fluorene), 7.40 (m, 2H, C3 & C6-H of fluorene), 7.82 & 7.84 (d, 1H, 3JH,H = 3.9 Hz; & d, 1H, 3JHH = 4.9 Hz, C4 & C5-H of fluorene). 13C NMR (75.0 MHz, CDCl3Ȍ: δ = 14.2 (bs, CH3CH2N-P), 22.0 (s, N1CHMe2), 22.2 (s, N3CHMe2), 45.1 (d,2JP,C = 16.5 Hz, CH3CH2N-P), 48.3 (d, 1JP,C = 85.2 Hz, P-CH), 50.5 (s, N1CHMe2), 50.6 (s, N3CHMe2), 120.2 (d, 2JP,C = 14.3 Hz,  C5), 125.2 & 126.3 (d, 3JPC = 4.1 Hz; & d, 3JPC = 4.4 Hz, C1 & C8 of fluorene), 126.5 & 127.3 (d, 5JP,C = 1.8 Hz; & d, 5JP,C = 1.9 Hz, C3 & C6 fluorene), 126.6 & 127.2 (d, 4JP,C = 2.3 Hz; & d, 4JP,C = 2.3 Hz, C2 & C7  fluorene), 129.5 (d, 1JP,C = 34.1 Hz, C4 ), 141.1 (d, 3JP,C = 2.5 Hz, quart-C fluorene), 141.7 (d, 2JP,C = 12.7 Hz, quart-C fluorene), 141.8 (d, 3JP,C = 3.1 Hz, quart-C fluorene), 142.8 (d, 2JP,C = 8.1 Hz, quart-C fluorene), 162.4 (s,  C=S). 31P NMR (121.5 MHz, CDCl3Ȍ: δ = 28.9 (br. s).  IR (Diamond ATR): ʋ (cm-1) = 3395 (s), 3114 (w), 2971 (w), 1543 (w), 1431 (s), 1410 (s), 1372 (s), 1330 (s), 1176 (s), 1019 (s), 730 (s). MS (EI, 70 eV): m/z (%) = 451.1 (20) [M].+, 286.1 (10) [M-Flu]+, 184.1 (10) [C9H16N2S]+, 165.0 (70)  [Fluorene]+, 152.0 (40) [C12H8]+. HRMS: theor./exp. for [C26H34N3PS]: 451.2211/451.2210. EA [%]:theor./exp.  C 69.15/67.97, H 7.59/7.20; N 9.30/8.80, S 7.10/6.75. 
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10.8 Synthesis of borane complex of the substitution product/ synthesis for 10 In a Schlenk flask, a solution of 1.42g of 9c (3.2 mmol) in 15 mL of THF, was treated with 0.4 ml of borane-dimethyl sulfide adduct (3.9 mmol, 1.2 equiv) at r.t. The reaction mixture it was stirred at r.t. for about 2h and then the solvent was removed under vacuum to get a light yellow solid, which upon washing with n-pentane (2 × 5 ml) gave a white solid. Finally the com-pound was dried in vacuo (8 × 10-3 mbar) to obtain pure 10 as a white powder. 10.8.1 1,3-Diisopropyl-4-diethylamino(fluorenyl)borophosphinoyl-imidazole-2-thione (10) Yield: 1.3 g (2.8 mmol, 87.5 %)  Appearance: white powder melting point: decom. at 220°C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.67 (br, BH3), 0.79 (t, 6H, 3JH,H = 7.2 Hz, CH3CH2N-P), 1.38 (d, 3H, 3JH,H = 6.7 Hz, N1CHCH3CH3), 1.40 (d, 3H, 3JH,H = 6.7 Hz, N1CHCH3CH3), 1.85 (d, 3H, 3JH,H = 11 Hz  N3CHCH3CH3), 1.89 (d, 3H, 3JH,H = 11 Hz  N3CHCH3CH3), 2.79-3.10 (m,8H, CH3CH2N-P), 4.79 (d, 1H, 3JP,H = 11.5 Hz, P-CH of Flu), 5.06 (sept, 1H, 3JH,H = 6.5 Hz, N1CHCH3CH3), 5.31 (sept, 1H, 3JH,H = 6.8 Hz, N3CHCH3CH3), 7.01 (d, 1H, 3JP,H = 1.5 Hz, C5H), 7.08-7.88 (m, 8H, Flu protons). 13C NMR (75.0 MHz, CDCl3Ȍ: δ = 14.5 (s, CH3CH2N-P), 18.9 & 19.1 ( two s, N1CHMe2), 21.9  & 22.1 (two s, N3CHMe2), 42.8 (d, 2JP,C = 3.2 Hz, CH3CH2N-P), 47.9 (s, N1CHCH3CH3), 48.2 (d, 3JP,C = 32.5 Hz, N3CHCH3CH3), 20.3 (d, 2JP,C = 18.8 Hz, C5), 121.1 (d, 2JP,C = 9.8 Hz, quart-C Flu), 122.5 (d, 1JP,C = 68.6 Hz, C4 ),  125.4 & 126.6 (d, 3JP,C = 2.7 Hz, C1 & C8 of Flu), 126.9 & 128.3 (s , C3 & C6 of Flu), 127.2 & 128.2 (d, 4JP,C = 2.4 Hz, & d, 4JP,C = 2.4 Hz, C2 & C7 of Flu, 139.0 (s, C4 & C5 of Flu), 139.2 & 142.0 (d, 2JP,C = 4.9 Hz, quart-C Flu), 142.0 (d, 2JP,C = 4.7 Hz, quart-C Flu, 142.4 (d, 3JP,C = 3.4 Hz, quart-C Flu), 163.6 (s, C=S). 
31P NMR (121.5 MHz, CDCl3Ȍ: δ = 58.9 (br). 11B NMR (96.25 MHz, CDCl3Ȍ: δ = - 37.6 (br. s). MS (EI, 70 eV): m/z (%) = 465.2 (20) [M].+, 451.2 (90) [M-BH3]+. HRMS: theor./exp. for [C26H37N3PSB]: 451.2211/451.2211. EA [%]:theor./exp.  C 67.09/66.66, H 8.01/8.12; N 9.03/8.92, S 6.89/6.80. 
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10.9 Oxidative desulfurization of compound 9c To a suspension of 9c (0.18 g, 0.4 mmol) in 10 ml of methanol, 0.2 ml of H2O2 (30% in water) (2.4 mmol, 5.5 equiv) was added at 0 °C. As the reaction mixture was stirred, it turned into a clear solution within 30 minutes. It was then stirred at r.t. for 15 more min, and the solvent removed under reduced pressure (8×10-3 mbar) to get a yellow oil. This was then dissolved in 20 ml of methylene dichloride and dried over MgSO4 for 15 minutes, and filtered. The filtrate was concentrated in vacuo (8×10-3 mbar) to get a yellow gel, to which was added 20 ml of n-pentane and triturated to a fine powder. Finally the solvent was removed by cannula filtration and the light yellow powder was finally dried under vacuum (8 × 10-3 mbar) to remove traces of solvent. 10.9.1 1,3-Diisopropyl-4-diethylamino(fluorenyl)phosphinoyl-imidazolium hydrogensulfate (11) Yield: 0.19 g (0.3 mmol, 80.1 %) Appearance: yellow powder (extremely hygroscopic) Melting point: 81 °C.  1H NMR (300 MHz, CDCl3Ȍ: δ = 1.05 (d, 3H, 3JH,H = 6.6 Hz, N1CHCH3CH3), 1.11 (d, 3H, 3JH,H = 6.6 Hz, N1CHCH3CH3), 1.21 (d, 3H, 3JH,H = 6.6 Hz, N3CHCH3CH3), 1.26  (t, 6H, 3JH,H = 7.1 Hz, CH3CH2N-P), 1.42 (d, 3H, 3JH,H = 6.6 Hz,  N3CHCH3CH3), 3.27-3.41 (m, 8H, CH3CH2N-P), 4.86 (sept, 1H, 3JH,H = 6.6 Hz, N1CHCH3CH3), 5.05 (sept, 1H, 3JH,H = 6.6 Hz, N3CHCH3CH3), 5.90 (s, 1H, P-CH of Flu),  7.31 – 7.97 (m, 9H, C5H & Flu ring protons), 9.89 (s, C2-H).  13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 13.6 (d, 3JP,C = 4.4 Hz, CH3CH2N-P), 22.2 (s, N1CHCH3CH3), 22.5 (s, N1CHCH3CH3), 23.1 (s, N3CHCH3CH3), 24.3 (s, N3CHCH3CH3), 40.04 (br, s, CH3CH2N-P), 48.6 (d, 1JP,C = 91.1 Hz, P-CH), 52.7 (s, N1CHMe2), 53.4 (s, N3CHMe2), 120.1 & 120.6 (d, 4JP,C = 1.1 Hz, & d, 4JP,C = 1.2 Hz; C4 & C5 of Flu), 124.2 (d, 2JP,C = 14.7 Hz, C5), 125.6 & 127.7 (d, 4JP,C = 2.9 Hz, & d, 4JP,C = 2.6 Hz; C2 & C7 of Flu), 127.5 (two d merged, C3 & C6 of Flu), 128.7 & 128.8 (d, 3JP,C = 2.3 Hz, & d, 3JP,C = 2.3 Hz; C1 & C8 of Flu), 137.7 & 138.3 (d, 3JP,C = 3.9 Hz, & d, 3JP,C = 5.0 Hz; quart-C of Flu), 138.5 (d, 2JP,C = 6.4 Hz, quart-C of Flu), 140.8 (d, 1JP,C = 5.5 Hz, C4),  142.5 (d, 3JP,C = 5.4 Hz, C2).  31P NMR (121.5 MHz, CDCl3Ȍ: δ = 29.5 (nonet, 3JP,H = 12.4 Hz).  Pos. ESI-MS: for C29H36N4OP+ theor. 436.25, exp. 436.30.  EA[%]: not measured due to an extreme hygroscopicity. 
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10.10 PCl3 induced P-N bond cleavage in compound 9 To a solution of 9a,b (2.3 mmol) in 15 ml of dichloromethane, 0.2 mL of PCl3 (2.4 mmol, 1.1 equiv) was added at –20 °C and slowly warmed till room temperature within 2 hours. Afterwards the solvent was removed in vacuo (8 × 10-3 mbar) to get a yellow oil, to which 10 ml of n-pentane was added and stirred for a few minutes, which resulted in the formation of a white solid. The solid was separated by cannula filtration and was dried in vacuo (8 × 10-3 mbar) to get pure 12a,b. 10.10.1 1,3-Diisopropyl-4-chloro(diphenylmethyl)phosphanyl-imidazole-2-thione (12a) Yield: 0.71 g (1.7 mmol, 73.9 %)  Appearance: white powder  Melting Point: 169 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 1.26 (d, 3H, 3JH,H = 6.6 Hz N1-CHCH3CH3), 1.34 (d, 3H, 3JH,H = 6.6 Hz N1-CHCH3CH3), 1.42 (bs, 3H, N3-CHCH3CH3), 1.58 (d, 3H, 3JH,H = 6.6 Hz, N3-CHCH3CH3), 4.84 (s, 1H, P-CH), 5.11 (sept, 1H, 3JH,H = 6.6 Hz N1-CHCH3CH3), 5.44 (bs, 1H, N3-CHCH3CH3), 7.13 (bs, 1H, C5H), 7.08-7.58 (m, 10H, Ph ring protons). 
13C{ͳH} NMR ȋ͹ͷ.Ͳ MHz, CDCl͵Ȍ: δ = 21.4 (bs, N3CHMe2), 21.9 (s, N1CHMe2), 49.2 (s, N1CHMe2), 51.0 (s, N3CHMe2), 58.1 (d, 1JP,C = 26.4 Hz, P-CH), 122.7 (d, 2JP,C = 3.6 Hz,  C5), 125.7 (d, 1JP,C = 51.7 Hz, C4), 127.6 (s, Ph ring CH), 128.5 (d, 3JPC = 9.9 Hz, Ph ring CH), 128.9 (d, 3JPC = 9.6 Hz, Ph ring CH), 128.9 (s, Ph ring CH), 129.2 (s, Ph ring CH), 138.5 (d, 2JPC = 5.7 Hz, quart-C Ph ring), 138.7 (d, 2JPC = 5.2 Hz, quart-C Ph ring), 162.9 (s,  C=S). 
31P NMR (121.5 MHz, CDCl3Ȍ: δ = 53.4 (br). MS (EI, 70 eV): m/z  (%) = 416 (40) [M].+. HRMS: theor./exp. for [C22H26N2PClS]: 416.1239/416.1239. EA[%]:theor./exp.  C 63.37/61.97, H 6.29/6.53; N 6.72/6.65, S 7.69/6.69.  10.10.2 1,3-Dimesityl-4-chloro(diphenylmethyl)phosphanyl-imidazole-2-thione (12b) Yield: 1.03 g (1.8 mmol, 78.3 %)  Appearance: white powder  Melting Point: 197 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 1.39 & 1.84 (s, 3H each, o-CH3 of N3-Mes), 2.04 & 2.14 (s, 3H, o-CH3 of N1-Mes), 2.33 & 2.36 (s, 3H each, p-CH3 of Mes), 4.67 (d, 2JP,H = 7.8 Hz, C9-H of Flu),5.86 (s, C5-H), 6.88 & 7.02 (s, 1H each, m-CH of N3-Mes), 6.95 (s, m-CH of N1-Mes), 7.30-7.94 (m, 8H, Flu ring protons).
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13C{ͳH} NMR ȋ͹ͷ.Ͳ MHz, CDCl͵Ȍ: δ = 17.4 & 17.8 (s, o-CH3 of N1-Mes), 17.5 (d, 4JPC = 0.9 Hz, o-CH3 of N3-Mes), 18.1 (d, 4JPC = 3.5 Hz, o-CH3 of N3-Mes), 21.2 & 21.3 (s, p-CH3 of Mes), 50.2 (d, 1JP,C = 34.9 Hz, P-CH of Flu), 120.3 & 120.4 (s, CH of Flu), 125.5 (d, 1JP,C = 46.3 Hz, C4), 125.51 (d, 2JP,C = 7.3 Hz,  C5), 125.6 (s, CH of  Flu),  125.7 (d, JP,C = 3.2  Hz, CH of Flu), 127.1 (s, CH of  Flu), 127.4 (d, JP,C = 1.8 Hz, CH of Flu), 128.4 (s, CH of  Flu), 128.5 (d, JP,C = 2.7 Hz, CH of Flu), 129.1, 129.2, 129.3 & 129.4 (s, m-CH of Mes), 125.5 (d, 1JP,C = 46.3 Hz, C4), 131.6 (d, 4JP,C = 2.1 Hz, o-C of Mes), 133.1 (s, o-C of Mes), 134.9 & 135.4 (s, ipso-C of Mes),   136.1 (d, 4JP,C = 2.3 Hz, o-C of Mes), 136.6 (d, 4JP,C = 1.5 Hz, o-C of Mes), 139.3 & 139.7 (s, p-C of Mes), 139.5 (s, quart-C Flu), 141.2 (d, JP,C = 3.5 Hz, quart-C Flu), 141.6 (s, quart-C Flu), 141.8 (d, JP,C = 2.1 Hz, quart-C Flu), 165.0 (s,  C=S). 31P NMR (121.5 MHz, CDCl3Ȍ: δ = 64.7 (d, 2JP,H = 7.5 Hz). MS (EI, 70 eV): m/z (%) = 566.2 (10) [M].+, 532.2 (20) [M-Cl+H].+, 401.1 (100) [M-Flu].+. HRMS: theor./exp. for [C34H32N2PClS]: 566.1708/566.1708. EA[%]:theor./exp.  C 72.01/71.20, H 5.69/5.86; N 4.94/4.94, S 5.65/5.36. 10.11 Synthesis of imidazole-2-ylidene stabilized phosphenium salt 13 To a solution of 12a (0.77 g, 1.9 mmol) in 8 ml of THF, the 1,3,4,5-tetramethylimidazol-2-ylidene (0.23 g, 1.8 mmol) in THF (3 mL) was added slowly at –40 °C. The reaction mixture was stirred for overnight upon which a white precipitate was observed which was isolated via cannulation and washed multiple times with tetrahydrofuran, followed by washing with n-pentane and then dried in vacuum (8×10-3 mbar) to obtain a white powder. 10.11.1 1,3,4,5-Tetramethyl-2-((1,3-diisopropyl-imidazole-2-thione)-4-yldiphenyl-methylphosphino)-imidazolium chloride Yield: 0.6 g (1.2 mmol, 60.6 %)  Appearance:  white powder.   Melting Point: 163 °C  
1H NMR (300 MHz, CDCl3Ȍ: δ = 1.09 (d, 3H, 3JH,H = 7.1Hz, N1-CHCH3CH3), 1.20 (d, 3H, 3JH,H = 7.1Hz, N1-CHCH3CH3), 1.50 (m, 6H, N3-CHMe2), 2.17 (s, 6H, C-CH3), 3.78 (s, 6H, N-CH3), 4.93 (sept, 1H, 3JH,H = 7.1Hz, N1-CHMe2), 5.42 (bs, 1H, N3-CHMe2), 6.92 (d, 1H, 3JH,H = 8.2 Hz, C5-H), 6.99-8.01 (10H, Ph protons), 8.79 (s, P-CH). 
13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 9.5 (s, C-(CH3)2), 20.9 (d, 4JP,C = 8.7 Hz, N3-CHCH3CH3), 21.3 (s, N1-CHCH3CH3), 22.2 (d, 4JP,C = 8.2 Hz, N3-CHCH3CH3 ), 22.4 (s, N1-CHCH3CH3), 34.5 (d, 3JP,C = 10 Hz, N-CH3), 50.1 (s, N1-CHMe2), 50.3 (s N3-CHMe2), 68.1 (s, P-CH), 111.2 (d, 1JP,C = 8.4 Hz, C4), 127.7 (s, C5), 
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128.6 (d, 3JP,C= 6.5 Hz, Ph ring C), 128.9 (s, Ph ring CH), 129.1(s, Ph ring CH), 130.3 (s, p-CH of  Ph), 130.9 (s, C=C), 138.2 (d, 2JP,C = 16.6 Hz, quart-C of Ph ring), 139.0 (d,2JP,C = 11.8 Hz, quart-C of Ph ring), 140.6 (d, 1JP,C = 58.6 Hz, N-C-N), 164.0 (s, C=S). 31P NMR (121.5 MHz, CDCl3Ȍ: δ = - 47.4 (br). Pos. ESI-MS: for C29H36N4PS+ theor. 505.25, exp.  505.30.  10.12 Synthesis of compound 18 To a solution of 12b (0.15 g, 0.3 mmol) in THF, 0.55 mmol of nBuLi (2.1 equiv) was added at –78 °C. The color of the solution changed from colorless to bright yellow. Under these conditions the reaction mixture was stirred for 30 min and then cooled to –78 °C. Then 0.3 mmol of HCl (1M solution in diethyl ether) was added to the reaction mixture, upon which the bright yellow color disappeared and the solution became colorless. The solvent was removed in the next step to get a light yellow residue, which was taken up in toluene (30 ml) and filtered through a silica bed to separate from the lithium chloride formed in the reaction mixture. The filtrate was concentrated under reduced pressure (8 × 10-3 mbar) to get a light yellow solid, which was washed with pentane (2 × 2 ml) and then dried in vacuo (8 × 10-3 mbar) to get the pure compound. 10.12.1 1,3-Dimesityl-4-butyl(fluorenyl)phosphanyl-imidazole-2-thione (18) Yield: 0.09 g (0.2 mmol, 66.7 %)  Appearance: white powder.  Melting Point: 188 °C. 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.62 (t, 3H, 3JHH, = 6.9 Hz, PCH2CH2CH2CH3), 0.87- 1.35 (m, 6H, PCH2CH2CH2CH3), 2.14 (s, 3H, p-CH3 of N3-Mes), 2.18 & 2.24 (s, 3H each, o-CH3 of N3-Mes), 2.33 (s, 3H, p-CH3 of N1-Mes), 2.37 & 2.41 (s, 3H each, o-CH3 of N1-Mes),  4.03 (s, C9-H of Flu), 6.49 (s, 1H, C5H), 7.01 & 7.03 (s, 1H each, m-CH of N3-Mes), 7.08 & 7.14 (m-CH of N1-Mes), 7.23-7.82 (m, 10H, Flu ring protons). 
13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 13.4 (s, PCH2CH2CH2CH3), 17.9 & 18.1 (s, p-CH3 of Mes), 18.3 (s, o-CH3 of N1-Mes), 18.6 (d, 4JPC = 8.1 Hz, o-CH3 of N3-Mes), 18.8 (d, 3JPC = 11.7 Hz, PCH2CH2CH2CH3), 21.2 & 21.3 (s, o-CH3 of N1-Mes)  23.9 (d, 2JPC = 13.4 Hz, PCH2CH2CH2CH3), 27.6 (d, 1JPC = 17.8 Hz, PCH2CH2CH2CH3) 44.7 (d, 1JP,C = 25.1 Hz, P-C9H of Flu), 119.9 & 120.3 (s, CH of Flu), 122.6 (d, 2JP,C = 3.1 Hz, C5), 124.4 (d, JP,C = 2.6 Hz, CH of Flu), 124.9 (d, JP,C = 9.4 Hz, CH of Flu), 126.3 (s, CH of Flu), 126.9 (d, JP,C = 0.9 Hz, CH of Flu), 127.1 (s, CH of Flu), 127.2 (d, JP,C = 2.1 Hz, CH of Flu), 129.3, 129.4, 129.5 & 129.6 (s, m-CH of Mes), 132.5 (d, 4JP,C = 0.6 Hz, o-C of Mes), 133.6 (s, o-C of Mes), 135.3 & 135.7 (ipso-C of Mes), 136.1 (d, 4JP,C = 1.3 Hz, o-C of Mes), 136.2 (s, o-C of Mes), 139.4 & 139.5 (s, p-C 
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of Mes), 140.1 (d, JP,C = 3.6 Hz, quart-C Flu), 141.1 (s, quart-C Flu), 142.5 (d, JP,C = 2.9 Hz, quart-C Flu), 143.1 (d, JP,C = 10.4 Hz, quart-C Flu, 165.6 (s,  C=S). 31P NMR (121.5 MHz, CDCl3Ȍ: δ = -31.3 (t, 3JP,H = 7.9 Hz).  MS (EI, 70 eV): m/z (%) = 588.3 (10) [M].+, 423.2 (30) [M-Flu]+,180.0 (100) [C14H12]+,  Pos. ESI-MS: for [C38H41N2PS + H]+ calc. 589.2801 found 589.2823.  EA: theor./exp.  C 77.52/76.95, H 7.02/6.96; N 4.76/4.56, S 5.45/5.32. 10.13 Synthesis of backbone phenyl(chloro)phosphanyl substituted imidazole-2-thiones 21a-c A solution of 20a-c (5.6 mmol) in 35 mL of diethyl ether was treated with PCl3 (6.1 mmol, 1.1 equiv) at –40°C. The reaction mixture was then allowed to warm up slowly till ambient temperature (2h), after which the solvent was removed under reduced pressure (8 × 10-3 mbar) to get a yellow oily residue. Then 20 ml of n-pentane was added to the residue and stirred for few minutes. The solvent was removed by cannula filtration and the white solid was isolated. This resulted in removal of all the by-products and formation of a fine white powder. The powder was then separated by cannula filtration and dried in vacuo (8 × 10-3 mbar) to get the pure compounds 21a-c. 10.13.1 1,3-Dimethyl-4-phenyl(chloro)phosphanyl-imidazole-2-thione (21a) Yield: 1.29 g (4.7 mmol, 83.9 %)  Appearance: white powder  Melting point: 110 °C.  
1H NMR (300 MHz, CDCl3Ȍ: δ = 3.52 (s, 3H, N3-Me), 3.57 (s, 3H, N1-Me), 6.67 (s, 1H, C5H), 7.45- 7.65 (m, 5H, Ph ring protons).  
13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 33.8 (d, 3JP,C = 5.6 Hz, N3-Me), 35.4 (s,  N1-Me), 126.0 (d, 1JP,C = 48.0 Hz, C4), 127.4 (d, 2JP,C = 31.2 Hz, C5), 129.0 & 129.1 (s, Ph ring C), 130.7 (s, Ph ring C), 130.9 & 131.1 (s, Ph ring C), 133.6 (d, 1JP,C = 25.2 Hz, ipso-C of Ph ), 167.4 (s, C=S).  31P NMR (121.5 MHz, CDCl3Ȍ: δ = 50.5 (t, 3JP,H = 8.5 Hz).  IR [cm-1]: ṽ = 3128 (w), 3051 (w), 2931 (w), 1543 (m), 1468 (m), 1392 (m), 1373 (m), 1341 (m), 1161 (m), 794 (s).   MS (EI, 70 eV): m/z (%) = 270.0 (25) [M].+, 252.0 (100) [M-Cl+ OH]+, 236.0 (40)  [M-Cl+H]+. HRMS m/z: theor./exp. for [C11H12N2PClS]: 423.0147/270.0143.  
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EA [%]: theor./exp. C 48.80/48.41, H 4.47/4.68; N 10.35/10.22, S 11.84/11.90.  10.13.2 1,3-Diethyl-4-phenyl(chloro)phosphanyl-imidazole-2-thione (21b) Yield: 1.24 g (4.1 mmol, 73.2 %)  Appearance: white powder   Melting Point: 68 °C  
1H NMR (300 MHz, CDCl3Ȍ: δ = 1.26 (s, 3H, 3JP,H = 7.1 Hz, N3-CH2Me), 1.29 (s, 3H, 3JP,H = 7.1 Hz, N1-CH2Me),  4.01 (q, 2H, 3JP,H = 7.1 Hz, N3-CH2Me), 4.17 (br, 2H,  N1-CH2Me),  6.50 (s, 1H, C5H), 7.46- 7.72 (m, 5H, Ph ring protons).  
13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 13.3 (d, 4JP,C = 1.9 Hz, N3- CH2Me), 14.1 (s, N1- CH2Me),  41.9 (d, 3JP,C = 6.2 Hz, N3-CH2Me), 42.9 (d, 3JP,C = 6.2 Hz, N1-CH2Me),  125.2 (d, 2JP,C = 20.9 Hz, C5), 126.7 (d, 1JP,C = 45.7 Hz, C4), 128.9 & 129.1 (s, Ph ring C) 131.2 & 131.3 (s, Ph ring C) 131.4 (s, Ph ring C), 133.6 (d, 1JP,C = 24.9 Hz, ipso-C of Ph ), 165.6 (s, C=S).  31P NMR (121.5 MHz, CDCl3Ȍ: δ = 50.2 (t, 3JP,H = 8.9 Hz).  IR [cm-1]: ṽ = 3112 (w), 2977 (w), 1538 (m), 1414 (vs), 1320 (s), 1296 (vs), 1180 (s), 1153 (vs), 1090 (s).  MS (EI, 70 eV): m/z (%) 298.0 (40) [M].+, 282.0 (100) [M-Cl+OH]+, 264.0 (50)  [M-Cl+H]+. HRMS m/z: theor./exp. for [C13H16N2PClS]: 298.0460/298.0462.  EA [%]: theor./exp. C 52.26/51.56, H 5.40/5.78; N 9.38/9.28, S 10.73/10.96.  10.13.3 1,3-Di-n-butyl-4-phenyl(chloro)phosphanyl-imidazole-2-thione (21c) Yield: 1.59 g (4.5 mmol, 80.4 %)   Appearance: orange oil    Melting Point: liq. at r.t. 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.91 (s, 3H, 3JH,H = 7.4 Hz, N3-CH2CH2CH2Me), 0.93 (s, 3H, 3JH,H = 7.4 Hz, N1-CH2CH2CH2Me), 1.27-1.39 (m, 4H, N-CH2CH2CH2Me), 1.65-1.75 (m, 4H, N-CH2CH2CH2Me), 3.97 (t, 2H, 3JH,H = 7.4 Hz, N1-CH2CH2CH2Me), 4.09 (br, 2H, 3JH,H = 7.4 Hz, N3-CH2CH2CH2Me),  6.50 (s, 1H, C5H), 7.49- 7.75 (m, 5H, Ph ring protons).  
13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 13.61 & 13.62 (s, N-CH2CH2CH2Me), 19.8 & 20.1 (s, N-CH2CH2CH2Me), 30.1 (d, 4JP,C = 2.0 Hz,  N3-CH2CH2CH2Me), 30.8 (s, N1-CH2CH2CH2Me),  46.8 (d, 3JP,C = 6.0 Hz,  N3-CH2CH2CH2Me), 47.8 (s,N1CH2CH2CH2Me), 125.7 (d, 2JP,C = 19.9 Hz, C5), 126.8 (d, 1JP,C = 45.6 
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Hz, C4), 128.9 & 129.0 (s, Ph ring C) 131.2 & 131.3 (s, Ph ring C), 133.8 (d, 1JP,C = 25.1 Hz, ipso-C of Ph), 165.9 (s, C=S).  
31P NMR (121.5 MHz, CDCl3Ȍ: δ = 49.9 (t, 3JP,H = 8.9 Hz).  IR [cm-1]: ṽ = 3112 (w), 3054 (w), 2956 (m), 2930 (m), 2871 (m), 1536 (m), 1414 (s), 1218 (m), 1156 (s), 1103 (s), 749 (s).   MS (EI, 70 eV): m/z (%) 354.1 (40) [M].+, 336.1 (60) [M-Cl+OH]+.  HRMS m/z: theor./exp. for [C17H24N2PClS]: 354.1086/354.1085.  EA [%]: theor./exp. C 57.54/57.66, H 6.82/6.87; N 7.89/7.89, S 9.03/9.37. 10.14 Synthesis of 1,4-dihydro-1,4-diphosphinines 22a-c The synthetic protocol for 22a-c is the same as that for 4c-e, and the reactions were also done in the same scale. Only difference in these cases is that the product obtained after the filtration over the silica gel is not completely pure. Compound 22a,b were washed with diethyl ether (3×10 ml) to remove these impurities and finally after drying in vacuo (8 × 10-3 mbar) pure 9a,b were obtained as white powders. In case of 22c, due to its high solubility it could not be washed with ether. That’s why this crude product was again subjected to a flash chromatography over silica gel using toluene as the eluting solvent. And finally after concentrating the filtrate the residue was washed with n-pentane (2×10ml) to get pure 22c as a white powder. 10.14.1 4,8-Diphenyl-1,3,5,7-tetramethyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d'] bisimidazole-2,6-dithione (22a) Yield: 8.58 g (18.3 mmol, 80.2 %)    Appearance: white powder. Melting Point: decom. at 350 °C. 
1H NMR (300 MHz, CD2Cl2Ȍ: δ = 3.51 & 3.57 (s, 12H, N-Me), 7.44-7.68 (m, 10H, Ph ring protons).  13C{1H} NMR (75.0 MHz, CD2Cl2Ȍ: δ = 33.4 (t, 3JP,C = 5.3 Hz, N-Me), 124.0 (dd, 1JP,C = 5.1 Hz, 2JP,C = 3.9 Hz  C4,5), 129.6 (t, JP,C = 4.2 Hz, Ph ring C), 131.1 (d, 1JP,C = 13.7 Hz, ipso-C of Ph ), 131.4 (s, Ph ring C), 133.9 (t, JP,C = 6.5 Hz, Ph ring C), 134.2 (t, (t, JP,C = 6.8 Hz, Ph ring C) 168.1 (t, 3JP,C = 1.3 Hz,  C=S).  31P NMR (121.5 MHz, CD2Cl2Ȍ: δ = -55.6 & -57.4 (s, two isomers). IR [cm-1]: ṽ = 2931 (w), 1975 (w), 1458 (w), 1432 (s), 1369 (s), 1330 (m), 1159 (s), 854 (s), 744 (s).   MS (EI, 70 eV): m/z (%) = 468.1 (40) [M+H2O].+, 372.9 (100) C15H11N4P2S2.  
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HRMS m/z: theor./exp. for [C11H12N2PClS]: 468.0761/468.0762.  EA [%]: theor./exp. C 56.40/56.35, H 4.73/5.04; N 11.96/11.80, S 13.69/13.79.  10.14.2 4,8-Diphenyl-1,3,5,7-tetraethyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d'] bisimidazole-2,6-dithione (22b) Yield: 6.13 g (11.7 mmol, 51.3 %)  Appearance: white powder.  Melting Point: decom.  at 330 °C.  
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.95 (t, 12H, 3JH,H = 6.9 Hz, N-CH2Me), 1.11 (m, 12H, 3JH,H = 6.9 Hz N-CH2Me) 2nd isomer, 3.81-4.35  (m, 8H, N-CH2Me), 7.33-7.64 (m, 10H, Ph ring protons).  13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 12.7 (s, N-CH2Me), 13.1 (s, N-CH2Me) 2nd isomer, 42.0 (t, 3JP,C = 4.8 Hz,  N-CH2Me), 42.7 (t, 3JP,C = 4.8 Hz, N-CH2Me) 2nd isomer, 124.0 (dd, 1JP,C = 4.5 Hz, 2JP,C = 3.2 Hz C4,5), 125.1 (br, C4,5) 2nd isomer,   129.6 (d, Ph ring C), 131.7 (d, Ph ring C), 132.2 (m, ipso-C) 134.2 (m, Ph ring C) 166.2 (s, C=S), 166.4 (s, C=S) 2nd isomer.  
31P NMR (121.5 MHz, CDCl3Ȍ: δ = -55.4 & -56.8 (s, two isomers, ratio 1.2:1).  IR [cm-1]: ṽ = 2979 (w), 2933 (w), 1437 (s), 1401 (vs), 1336 (m), 1155 (s), 1024 (w), 998 (s).   MS (EI, 70 eV): m/z (%) = 524.1(100) [M]+, 447.0 (30) [C20H25N4P2S2]+, 156.1 (5) [C7H12N2S]2+.  HRMS m/z: theor./exp. for [C26H30N4P2S2]: 524.1387/524.1387.  EA [%]: theor./exp. C 59.53/58.87, H 5.76/6.01; N 10.68/10.25, S 12.22/11.43.  10.14.3 4,8-Diphenyl-1,3,5,7-tetra-n-butyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d'] bisimidazole-2,6-dithione (22c) Yield: 7.01 g (10.9 mmol, 48.7 %)   Appearance: white powder     Melting Point: decom. at 250 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.83 & 0.85 (t, 12H, 3JH,H = 7.2 Hz, N-CH2CH2CH2Me), 1.09-1.36 (m, 8H, N-CH2CH2CH2Me), 1.83 (br, 8H, N-CH2CH2CH2Me), 3.78-4.21 (m, 8H, N-CH2CH2CH2Me), 7.39-7.64 (m, 10H, Ph ring protons).  
13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 13.5 & 13.6 (s, N-CH2CH2CH2Me), 19.9 (s, N-CH2CH2CH2Me), 29.4 & 29.8 (br N-CH2CH2CH2Me), 46.2 (t, 3JP,C = 4.4 Hz, N-CH2CH2CH2Me), 47.7 (t, 3JP,C = 4.4 Hz, N-CH2CH2CH2Me) 2nd isomer, 125.1 (dd, 1JP,C = 4.5 Hz, 2JP,C = 3.1 Hz, C4,5), 125.3 (br,  C4,5) 2nd isomer, 
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129.5-129.7 (m, Ph ring C),  131.5 & 131.7 (s, Ph ring C), 133.9-134.5 (m, Ph ring C) 132.3-132.4 (m, ipso-C of Ph), 166.6 (t, 3JP,C = 1.4 Hz,  C=S), 166.7 (t, 3JP,C = 1.4 Hz, C=S) 2nd isomer.  31P NMR (121.5 MHz, CDCl3Ȍ: δ = -55.3 & -57.2 (s, two isomers, ratio 1:1.3).  IR [cm-1]: ṽ = 3049 (w), 2956 (m), 2929 (w), 2867 (w), 1435 (m), 1404 (s), 1288 (w), 1216 (m).   MS (EI, 70 eV): m/z (%) = 636.2(50) [M]+, 559.2 (10) [M-Ph]+., 319.1 (60) [M+2H]2+.  HRMS m/z: theor./exp. for [C34H46N4P2S2]: 636.2639/636.2641.  EA [%]: theor./exp. C 64.13/63.97, H 7.28/7.30; N 8.80/8.65, S 10.07/10.15. 10.15 Reaction of compound 21 with KHMDS To a solution of 21a,b (4.1 mmol) in 25 mL THF, a solution of KHMDS (0.826 g, 4.1 mmol, 1eq) in THF (30 mL) was added at –78°C. Then the reaction mixture was slowly warmed to room temperature (2 hours). Afterwards the solvent was removed in vacuo (8 × 10-3 mbar) to get a yellow oil, which was again dissolved in 30 ml of toluene. This solution was filtered through a small celite® bed to remove KCl. Then the filtrate was concentrated in vacuo (8 × 10-3 mbar) till yellow oil was obtained as crude product. This was then triturated with 10 ml of n-pentane at room temperature to get a white powder, which was dried in vacuo (8 × 10-3 mbar) after removal of the n-Pentane. 10.15.1 1,3-Dimethyl-4-{bis(trimethylsilyl)amino}phenylphosphanyl-imidazole-2-thione  (23a)  Yield: (1.38 g, 3.5 mmol, 85.4 %)  Appearance: White solid   Melting point: 157 °C  
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 0.18 (s, 18H, SiMe3), 3.61 (S, N3-Me), 3.70 (s, N1-Me), 6.49 (d, 1H, 3JP,H = 1.7 Hz, C5H), 7.32-7.41 (m, 5H, Ph protons).  13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 4.2 & 4.3 (s, N-SiMe3), 33.8 (d, 3JP,C = 11.1 Hz, N3-Me), 35.3 (s, N1-Me), 122.6 (br, C5), 128.2 & 128.3 (s, Ph ring C), 128.4 (d, JP,C = 1.1 Hz, Ph ring C), 129.9 (d, 1JP,C = 26.8 Hz, C4), 130.1 & 130.4 (s, Ph ring C), 138.5 (d, 1JP,C = 17.2 Hz, ipso C of Ph), 164.9 (s, C=S).  31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = 27.1 (br).  IR [cm-1]: ṽ = 3162 (w), 2949 (w), 1520 (w), 1432 (w), 1378 (m), 1247 (s), 1152 (m), 1089 (w).  MS (EI, 70 eV): m/z (%) = 395.1 (100) [M].+, 380.1 (20)  [M- Me]+, 323.1 (20) [M-TMS]+.  HRMS m/z: theor./exp. for [C17H30N3PSSi2]: 395.1436/395.1437.  
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EA [%]: theor./exp. C 51.61/51.23, H 7.64/7.18; N 10.62/9.81, S 8.10/8.05.  10.15.2 1,3-Diethyl-4-{bis(trimethylsilyl)amino}phenylphosphanyl-imidazole-2-thione  (23b)  Yield: (1.18 g, 2.8 mmol, 68.3 %)  Appearance: White solid       Melting Point: 105 °C 
1H NMR (300.1 MHz, Toluene-d8, ʹͷ °CȌ: δ = 0.17 (s, 9H, SiMe3), 0.18 (s, 9H, SiMe3), 0.96  (t, 3H, 3JH,H = 7.19 Hz,  N3-CH2Me), 1.51 (t, 1H, 3JH,H = 7.07, N1- CH2Me), 3.42-3.55 (m, 1H,  N-CH2Me), 3.87-3.99 (m, 1H, N-CH2CH3), 4.18-4.29 (m, 1H,  N-CH2Me), 4.49-4.61 (m, 1H,  N-CH2Me), 6.27 (d, 1H, 3JP,H = 1.3 Hz, C5-H), 7.05-7.45 (m, 5H, Ph protons).  
13C{1H} NMR (75.5 MHz, Toluene-d8, ʹͷ °CȌ: δ = 3.8 & 3.9 (s, N-SiMe3), 13.7 (d, 4JP,C = 3.9 Hz, N3-CH2Me), 13.9 (s, N1- CH2Me), 41.4 (d, 3JP,C = 8.4 Hz, N3-CH2Me), 42.1 (s, N1-CH2Me),  121.4 (br, C5), 127.9 & 128.0 (s, Ph ring C), 127.5 (d, 1JP,C = 25.6 Hz, C4), 129.9 & 130.2 (s, Ph ring C), 137.1 (s, Ph ring C) 139.5 (d, 1JP,C = 17.5 Hz, ipso C of Ph), 165.8 (s, C=S).  31P NMR (121.5 MHz, Toluene-d8, ʹͷ °CȌ: δ = 24.5 (br).  IR [cm-1]: ṽ = 2973 (w), 1540 (w), 1440 (vs), 1348 (m), 1252 (vs), 1148 (s), 1091 (m), 1024 (w). MS (EI, 70 eV): m/z (%) = 423.1 (100) [M]+, 254.1 (35) [C11H21NPSi2]+.  HRMS m/z: theor. /exp. for [C19H34N3PSSi2]: 423.1750/423.1750.  EA [%]: theor./exp. C 53.86/53.86, H 8.09/7.94; N 9.92/9.90, S 7.31/7.80. 10.16 Synthesis of 1,4-dihydro-1,4-dichloro-1,4-diphosphinines 24a,b PCl3 (0.35 mL, 4 mmol) was added to a solution of 4d,f (0.92 g of 4d, 1.25 g of 4f, 2 mmol each) in 30 mL of methylene dichloride at room temperature, and the color of the solution turned orange in both cases, though 24a started to precipitate from the reaction mixture. The reaction for 24a was completed within 3h, but for 24b it took around 24h to complete conversion. Thereafter, the solvent was removed under reduced pressure (8 × 10-3 mbar) and the residue was washed with n-pentane (3 × 5 ml). After washing, the yellow products were dried under reduced pressure (8 × 10-3 mbar) for 1h to remove any volatiles left, thus affording compounds 24a and 24b as light yellow-orange solids. 
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10.16.1 4,8-Dichloro-1,3,5,7-tetramethyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d'] bisimidazole-2,6-dithione (24a) Yield: (0.69 g, 1.8 mmol, 90.0 %).    Appearance: Orange solid.  Melting Point: decomp.  at 160 °C 
1H NMR (300.1 MHz, CD2Cl2, ʹͷ °CȌ: δ = 3.89 & 4.01 (s, N-CH3).  13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 34.1(t, 3JP,C = 4.5Hz, NCH3), 170.1 (s, C=S).  31P NMR (121.5 MHz, CD2Cl2, ʹͷ °CȌ: δ = 9.2  (br).  IR [cm-1]:  ṽ = 2933 (w), 1428 (s), 1367 (s), 1329 (s), 1299 (m), 1165 (s), 1061 (w), 858 (s).  MS(EI, 70 eV): m/z (%) = 383.9 (10) [M].+, 313.9  (100)  [M-2Cl]+ .  HRMS: theor./exp. for [C10H12N4Cl2P2S2]: 383.9355/ 383.9357.  EA [%]: theor./exp. C 31.18/31.54 , H 3.18/2.99 ; N 14.55/14.61 , S 16.65/17.55.  10.16.2 4,8-Dichloro-1,3,5,7-tetra-n-butyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d'] bisimidazole-2,6-dithione (24b) Yield: (0.91 g, 1.6 mmol, 82.1 %)   Appearance: Orange solid        Melting Point: decomp. at 150 °C 
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 1.02 (t, 12H, 3JH,H = 7.3 Hz, NCH2CH2CH2Me), 1.43-1.56 (m, 8H, NCH2CH2CH2Me ), 1.93 (bs, 8H, NCH2CH2CH2Me), 4.23 (bs, 4H, NCH2CH2CH2Me), 4.41 (bs, 4H, NCH2CH2CH2Me) (2nd isomer).  13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 13.6 (s, NCH2CH2CH2Me), 20.1 (s, NCH2CH2CH2Me), 30.4 (bs, NCH2CH2CH2Me), 47.2 (bs, NCH2CH2CH2Me), 127.0 (bs, P-C of the middle ring), 168.5 (bs, C=S).  31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = 2.58 (br) & 10.88 (br) ratio of two isomers 1.85:1. IR [cm-1]: ṽ = 2956 (m), 2930 (w), 2870 (w), 1398 (s), 1337 (m), 1217 (s), 1176 (s), 1146 (s), 1016 (s), 926 (s).  MS (EI, 70 eV): m/z (%) = 552.1 (40) [M].+, 482.1  (100)  [M-2Cl]+.  HRMS (m/z): theor./exp. for [C22H36N4Cl2P2S2]: 552.1233/552.1234.  EA [%]: theor./exp. C 47.74/47.31 , H 6.56/6.71, N 10.12/9.92, S 11.58/10.97. 
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10.17 Substitution reaction on the P-centers of 24a,b A solution of 24a,b (2.2 mmol) in 30 ml of THF was treated with 4.4 mmol of nBuLi (for 25a,b) or 4.4 mmol of lithiumtrimethylsilyl acetylide (for 25c) at –78 °C. The reaction mixture was then slowly warmed up to r.t. over a span of 3 h. Afterwards the reaction mixture was concentrated to a  dark yellow residue in vacuo (8×10-3 mbar). This residue was then taken up in toluene (30 ml) and filtered through a silica bed to remove salts and coloring impurities. The filtrate was then concentrated in vacuo (8 × 10-3 mbar) to get a solid which was then triturated with n-pentane (2×2 ml) to get yellow to beige powders that were then dried in vacuo (8×10-3 mbar) for prolonged time. 10.17.1 4,8-Di-n-butyl-1,3,5,7-tetramethyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d']bisimidazole-2,6-dithione (25a) Yield: 0.36 g (0.85 mmol, 38.6 %)  Appearance: beige powder.  Melting Point: m.p. 185 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.77 (t, 12H, 3JH,H = 7.3 Hz, P-CH2CH2CH2Me), 0.88 (t, 6H, 3JH,H = 6.9 Hz, P-CH2CH2CH2Me), 1.13-1.79 (m, 12H, methylene protons of P-CH2CH2CH2Me)  3.73 & 3.75 (s, 12H, N-Me) two isomers.  
13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 13.5 (s, P-CH2CH2CH2Me), 23.6 & 24.1 (m, P-CH2CH2CH2Me, two isomers), 27.3 & 28.3 (m, P-CH2CH2CH2Me, two isomers), 31.9 (t, 1JP,C = 7.5 Hz, P-CH2CH2CH2Me), 32.1 (t, 1JP,C = 7.5 Hz, P-CH2CH2CH2Me) 2nd isomer,   33.8 (m, N-Me), 34.8 (m, N-Me) 2nd isomer, 125.2 (t, JP,C = 1.6 Hz, C4,5), 127.1 (d, JP,C = 2.4 Hz, C4,5) 2nd isomer, 167.3 & 167.9 (s, C=S for two isomers).  31P NMR (121.5 MHz, CDCl3Ȍ: δ = -56.5& -63.5 (br, two isomers, ratio 1:2.3).  IR [cm-1]: ṽ = 3371 (s), 2925 (m), 2855 (w), 1430 (s), 1332 (m), 1160 (s), 1042 (w), 853 (s).   MS (EI, 70 eV): m/z (%) = 428.1(30) [M]+, 371.0(50) [M-C4H9]+, 313.9 (100) [M-C8H18]+.  HRMS m/z: theor./exp. for [C18H30N4P2S2]: 428.1387/428.1388.  EA [%]: theor./exp. C 50.45/49.85, H 7.06/6.95; N 13.07/12.91, S 14.96/14.88.  10.17.2 4,8-Di-n-butyl-1,3,5,7-tetra-n-butyl-4,8-tetrahydro[1,4]diphosphinine[2,3-d:5,6-d']bisimidazole-2,6-dithione (25b) Yield: 1.12 g (1.9 mmol, 86.4 %)  Appearance: white powder  Melting Point: 108 °C. 
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1H NMR (300 MHz, CDCl3Ȍ: δ = 0.74 (t, 6H, 3JH,H = 7.3 Hz, P-CH2CH2CH2Me), 0.99 (t, 12H, 3JH,H = 7.3 Hz, N-CH2CH2CH2Me), 1.08-1.21 (m, 4H, P-CH2CH2CH2Me), 1.38-1.51 (m, 12H, P-CH2CH2CH2Me & P-CH2CH2CH2Me), 1.61 (q, 4H, 3JH,H = 8.6 Hz,  P-CH2CH2CH2Me), 1.67-1.81 (m, 4H, N-CH2CH2CH2Me),  1.96-2.10 (m, 4H, N-CH2CH2CH2Me), 3.81-3.91 (m, 4H, N-CH2CH2CH2Me), 4.42-4.52 (m, 4H, N-CH2CH2CH2Me). 13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 13.6 (s, P-CH2CH2CH2Me), 13.7 (s, N-CH2CH2CH2Me), 19.9 (s, N-CH2CH2CH2Me), 23.4 (t, 3JP,C = 2.7 Hz, P-CH2CH2CH2Me), 25.7 (br, P-CH2CH2CH2Me) 28.4 (d, 1JP,C = 5.5 Hz, P-CH2CH2CH2Me), 28.7 (d, 1JP,C = 5.5 Hz, P-CH2CH2CH2Me), 30.3 (s, N-CH2CH2CH2Me), 47.5 (t, 3JP,C = 7.5 Hz, N-CH2CH2CH2Me),124.7 (t, JP,C = 2.7 Hz, C4,5), 166.8(s, C=S).  31P NMR (121.5 MHz, CDCl3Ȍ: δ = -58.5 & -66.3 (s, two isomers, ratio 12:1).  IR [cm-1]: ṽ = 2956(m), 2929 (m), 2871 (w), 1435 (m), 1400 (s), 1217 (m), 1150 (m), 859 (m).  MS (EI, 70 eV): m/z (%) = 596.4(40) [M]+, 539.3 (100) [M-C4H9]+.  HRMS m/z: theor./exp. for [C30H54N4P2S2]: 596.3265/596.3259.  EA [%]: theor./exp. C 60.37/60.10, H 9.12/8.76; N 9.39/9.29, S 10.74/10.44.  10.17.3 4,8-Bis(trimethylsilylethinyl)-1,3,5,7-tetra-n-butyl-4,8-tetrahydro[1,4]di phosphinine[2,3-d:5,6-d']bisimidazole-2,6-dithione (25c) Yield: 0.61 g (0.9 mmol, 40.9 %)  Appearance: beige powder.  Melting Point: 158 °C.  
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.18 & 0.19 (s, 18H,  SiMe3 for two isomers), 1.02 (t, 6H, 3JH,H = 7.4 Hz, N-CH2CH2CH2Me), 1.04 (t, 6H, 3JH,H = 7.4 Hz, N-CH2CH2CH2Me) 2nd isomer, 1.44-1.56 (m, 8H, N-CH2CH2CH2Me), 1.82-2.08 (m, 8H, N-CH2CH2CH2Me), 4.11-4.44 (m, 8H, N-CH2CH2CH2Me). 13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = -0.7 & -0.6 (s, SiMe3),  13.6 & 13.7 (s, N-CH2CH2CH2Me), 20.0 & 20.1 (s, N-CH2CH2CH2Me), 29.9 & 30.5 (s, N-CH2CH2CH2Me), 47.1 (t, 3JP,C = 4.7 Hz, N-CH2CH2CH2Me), 47.9 (t, 3JP,C = 3.5 Hz, N-CH2CH2CH2Me) 2nd isomer,   117.1 (t, 2JP,C = 1.9 Hz, P-C-C-TMS), 117.3 (t, 2JP,C = 2.1 Hz, P-C-C-TMS) 2nd isomer, 120.7 (t, 2JP,C = 3.9 Hz, P-C-C-TMS), 121.6 (t, 1JP,C = 15.7 Hz, C4,5), 166.8 (t, 3JP,C = 1.9 Hz, C=S), 167.6 (t, 3JP,C = 1.6 Hz, C=S) 2nd isomer.  31P NMR (121.5 MHz, CDCl3): δ = -79.9 & -88.1 (br, two isomers, ratio 1:2).  IR [cm-1]: ṽ = 2958 (m), 2931 (m), 2871 (w), 1437 (m), 1401 (s), 1216 (m), 1159 (m), 840 (s).
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MS (EI, 70 eV): m/z (%) = 676.1(100) [M]+.  HRMS m/z: theor./exp. for [C32H54N4P2S2Si2]: 676.2804/676.2806.  EA [%]: theor./exp. C 56.77/56.57, H 8.04/7.93; N 8.28/8.21, S 9.47/9.52. 10.18 Oxidation of the tricyclic 1,4-dihydro-1,4-diphosphinines / Synthesis of the P-dioxides 26a-e A solution of 4d-f;22b,c (5.5 mmol) in methylene dichloride (50 ml) at r.t. was treated with 27.5 mmol (5 equiv) of hydrogen peroxide-urea adduct. The reaction mixture was then stirred at for 2days to complete the oxidation. Afterwards the reaction mixture was filtered through a filter paper to remove the urea. MgSO4 was then added to the filtrate in order to remove traces of water. In the next step the solution was again filtered to remove the MgSO4. This filtrate was then concentrated in vacuo (8 × 10-3 mbar) to get a yellow solid which was then triturated with 20 ml of n-pentane. After filtering of the n-pentane, a white solid was left which was finally dried under reduced pressure (8 × 10-3 mbar). 10.18.1 4,8-bis(diethylamino)-1,3,5,7-tetramethyl-4,8-dihydro[1,4]diphosphi-nine[2,3 -d:5,6-d']bisimidazole-2,6-dithione-4,8-dioxide (26a) Yield: (1.51 g, 3.1 mmol, 56.4 %)  Appearance: White powder   Melting Point: 280 °C.  
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 1.00(t, 12H, 3JH,H = 7.2 Hz, P-NCH2Me), 1.05(t, 12H, 3JH,H = 7.2 Hz, P-NCH2Me) (2nd isomer), 3.11- 3.24 (m, 8H, P-NCH2Me), 3.77 (s, 12H, N-Me). 13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 13.2 & 13.3 (s, P-NCH2Me), 34.5 ( br, N-Me), 37.8 (d, 2JP,C = 5.8 Hz, P-NCH2Me), 126.7(dd, 1JP,C = 155.1 Hz, , 2JP,C = 19.6 Hz C5), 126.9(dd, 1JP,C = 155.1 Hz, , 2JP,C = 19.6 Hz, C5) (2nd isomer), 169.8 (t, 3JP,C = 6.9 Hz, C=S).   31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = -4.3 (quin, 3JP,H = 12.2 Hz ), -5.1(quin, 3JP,H = 12.2 Hz ) 2nd isomer, ratio = 1.9 :1.  IR [cm-1]: ṽ = 2971 (s), 1699 (w), 1436 (m), 1333 (m), 1230 (s), 1169 (s), 1018 (s), 951 (s), 853 (s), 735 (s).  MS (EI, 70 eV): m/z (%) = 490.2 (100) [M].+, 72 (60) [NEt2]+.  HRMS m/z: theor./exp. for [C18H32N6P2S2O2]: 490.1503/490.1508.  EA [%]: theor./exp. C 44.07/43.55, H 6.57/6.53; N 17.13/16.89, S 13.07/12.58. 
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10.18.2 4,8-Bis(diethylamino)-1,3,5,7-tetraethyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d']bisimidazole-2,6-dithione-4,8-dioxide (26b) Yield: (1.95 g, 3.6 mmol, 65.5 %)  Appearance: White powder   Melting Point: 268 °C.  
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 1.02 (t, 12H, 3JH,H = 7.1 Hz, NCH2Me), 1.10 (t, 12H, 3JH,H = 7.1 Hz, NCH2Me) (2nd isomer), 1.44-1.49 (m, 12H, P-NCH2Me), 3.14-3.31 (m, 8H, P-NCH2Me), 4.01-4.15 (m, 4H, NCH2Me), 4.48-4.63 (m, 4H, NCH2Me).   13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 13.1 (d, 3JP,C = 2.2 Hz, P-NCH2Me), 13.3 (d, 3JP,C = 1.9 Hz, P-NCH2Me) 2nd isomer, 13.4 & 13.7 (s, NCH2Me, two isomers), 37.9 (d, 2JP,C = 4.8 Hz, P-NCH2Me), 38.0 (d, 2JP,C = 5.4 Hz, P-NCH2Me) 2nd isomer,43.2 & 43.3 (s, NCH2Me), 126.6(dd, 1JP,C = 154.9 Hz, 2JP,C = 19.7 Hz C5), 126.8(dd, 1JP,C = 155.1 Hz, 2JP,C = 19.9 Hz, C5) (2nd isomer), 168.2 (t, 3JP,C = 7.1 Hz, C=S), 168.3 (t, 3JP,C = 7.1 Hz, C=S) 2nd isomer.   31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = -4.6 (quin, 3JP,H = 11.8 Hz ), -5.2 (quin, 3JP,H = 12.2 Hz ) 2nd isomer, ratio = 1.5 :1.  IR [cm-1]: ṽ = 2974 (m), 2938 (w), 1673 (w), 1440 (m), 1410 (s), 1315 (m), 1266 (s), 1163 (s), 1066 (s), 945 (s), 794 (s), 712 (s).  Pos-ESI-MS: for C22H40N6P2S2O2Na theor./exp. 569.2027/ 569.2029.  EA [%]: theor./exp. C 48.34/47.99, H 7.38/7.28; N 15.37/15.56, S 11.73/12.66.  10.18.3 4,8-Diphenyl-1,3,5,7-tetraethyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d']bisimidazole-2,6-dithione-4,8-dioxide (26d) Yield: 2.08 g (3.7 mmol, 67.3 %)  Appearance: white powder   Melting Point: 245 °C. 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.96 (t, 12H, 3JH,H = 7.1 Hz, N-CH2Me), 1.07 (m, 12H, 3JH,H = 7.1 Hz N-CH2Me) 2nd isomer, 3.92-4.08  (m, 8H, N-CH2Me),  4.26-4.39 (m, 8H, N-CH2Me) 2nd isomer,  7.62-7.96 (m, 10H, Ph ring protons).  
13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 12.6 (s, N-CH2Me), 12.8 (s, N-CH2Me) 2nd isomer, 43.5 (br,  N-CH2Me), 125.5 (dd, 1JP,C = 132.4 Hz, 2JP,C = 16.6 Hz, C5), 125.9 (dd, 1JP,C = 131.9 Hz, 2JP,C = 16.1 Hz, C5) 2nd isomer, 126.6 (d,  1JP,C = 54.1 Hz, ipso-C), 128.2 (d,  1JP,C = 54.6 Hz, ipso-C) 2nd isomer, 130.12, 130.13, 130.32 & 130.33 (s, o-C of Ph ring), 131.6, 131.8, 131.9 & 132.1 (s, m-C of Ph ring), 134.3, 
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134.4, 134.5 & 134.6 (s, p-C of Ph ring), 168.8 (t, 3JP,C = 6.1 Hz, C=S), 168.9 (t, 3JP,C = 6.1 Hz, C=S) 2nd isomer.  
31P NMR (121.5 MHz, CDCl3Ȍ: δ = -5.9 (t, 3JP,H = 14.4 Hz) & -7.4 (t, 3JP,H = 13.5 Hz) ratio 1:1.3. IR [cm-1]: ṽ = 2988 (w), 1723 (w), 1439 (m), 1216 (s), 1151 (s), 1059 (s), 997 (s).  MS (EI, 70 eV): m/z (%) = 556.1(100) [M]+.  HRMS m/z: theor./exp. for [C26H30N4O2P2S2]: 556.1285/556.1281.  EA [%]: theor./exp. C 56.10/56.19, H 5.43/5.53; N 10.07/10.18, S 11.52/10.58.  10.18.4 4,8-Diphenyl-1,3,5,7-tetra-n-butyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d']bisimidazole-2,6-dithione-4,8-dioxide (26e) Yield: 2.76 g (4.1 mmol, 74.5 %)  Appearance: white powder   Melting Point: 182 °C  
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.56-0.91 (m, 4H, N-CH2CH2CH2Me), 0.76 & 0.78 (t, 12H, 3JH,H = 6.6 Hz, N-CH2CH2CH2Me), 1.05-1.32 (m, 8H, N-CH2CH2CH2Me), 1.74-1.90 (br, 4H, N-CH2CH2CH2Me), 3.82-4.23 (m, 8H, N-CH2CH2CH2Me), 7.61-7.97 (m, 10H, Ph ring protons). 13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 13.4 (s, N-CH2CH2CH2Me), 19.8 & 19.9 (s, N-CH2CH2CH2Me), 29.3 & 29.4 (s, N-CH2CH2CH2Me), 48.1 & 48.3 (s, N-CH2CH2CH2Me), 125.5 (dd, 1JP,C = 132.4 Hz, 2JP,C = 16.4 Hz, C4,5), 125.9 (dd, 1JP,C = 131.9 Hz, 2JP,C = 16.3 Hz, C4,5) 2nd isomer,  126.8 (d,  1JP,C = 50.6 Hz, ipso-C), 128.4 (d,  1JP,C = 51.2 Hz, ipso-C) 2nd isomer, 129.9, 130.1, 130.2 & 130.3 (s, o-C of Ph ring),  131.7, 131.8, 131.9 & 132.0 (s, m-C of Ph ring), 134.2, 134.3, 134.3 & 134.4 (s, p-C of Ph ring), 169.1 (t, 3JP,C = 6.6 Hz,  C=S), 169.2 (t, 3JP,C = 6.9 Hz, C=S) 2nd isomer.  31P NMR (121.5 MHz, CDCl3Ȍ: δ = -6.7 (t, 3JP,H = 16.5 Hz) & -8.4 (t, 3JP,H = 14.0 Hz) ratio 1.3:1. IR [cm-1]: ṽ = 2957 (m), 2872 (w), 1435 (m), 1412 (s), 1212 (s), 1108 (w), 856 (s), 724 (s), 694(s).   Pos-ESI-MS: for C22H40N6P2S2O2Na theor./exp. 691.2435/ 691.2433.  EA [%]: theor./exp. C 61.06/60.18, H 6.93/7.05; N 8.38/8.65, S 9.59/9.06. 
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10.19 Oxidation of the tricyclic 1,4-dihydro-1,4-diphosphinines with elemental sulfur / synthesis of the P-dioxides 27a-e To a solution of 4d-f; 22b,c (5.5 mmol) in toluene (50 ml), 12.1 mmol (2.2 equiv) of elemental sulfur was added. This mixture was then heated at 105°C for a week to complete the reactions. After the completion of the reaction the solvent was removed under reduced pressure (8 × 10-3 mbar) and the residue was washed with n-pentane (3 × 5 ml) to get a light yellow solid as the pure compound. 10.19.1 4,8-Bis(diethylamino)-1,3,5,7-tetramethyl-4,8-dihydro[1,4]diphosphi-nine[2,3-d:5,6-d']bisimidazole-2,6-dithione-4,8-disulfide (27a) Yield: (1.87 g, 3.6 mmol, 65.4 %).  Appearance: light yellow solid  Melting Point: 275 °C 
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 1.07 (t, 12H, 3JH,H = 6.7 Hz, P-NCH2Me), 1.09 (t, 12H, 3JH,H = 6.7 Hz, P-NCH2Me) (2nd isomer), 3.27- 3.42 (m, 8H,  P-NCH2Me), 3.89 & 3.91 (s, 12H, N-Me).  13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 13.2 (d, 3JP,C = 2.3 Hz, P-NCH2Me), 13.3 (d, 3JP,C = 2.7 Hz, P-NCH2Me) 2nd isomer,  34.2 ( br, N-Me), 39.1 (d, 2JP,C = 5.2 Hz, P-NCH2Me), 39.2 (d, 2JP,C = 5.8 Hz, P-NCH2Me) 2nd isomer,   125.1 (dd, 1JP,C = 134.7 Hz, , 2JP,C = 16.5 Hz C5), 125.2 (dd, 1JP,C = 133.1 Hz, , 2JP,C = 16.5 Hz, C5) (2nd isomer), 169.8 (t, 3JP,C = 6.4 Hz, C=S), 170.0(t, 3JP,C = 5.8 Hz, C=S) 2nd isomer.   31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = 19.7 (quin, 3JP,H = 13.6 Hz ), 20.3 (quin, 3JP,H = 13.6 Hz ) 2nd isomer, ratio = 1 :1.5.  IR [cm-1]: ṽ = 3387 (s), 2971 (w), 2939 (w), 1431 (m), 1382 (s), 1324 (s), 1160 (s), 1011 (s), 945 (s), 852 (s), 793 (m).  MS (EI, 70 eV): m/z (%) = 522.1 (70) [M].+, 315.0 (100) [C10H13N4P2S2].+.  HRMS m/z: theor./exp. for [C18H32N6P2S4]: 522.1046/522.1044.  EA [%]: theor./exp. C 41.36/41.25, H 6.17/5.83; N 16.08/16.19, S 24.53/23.98.  10.19.2 4,8-Bis(diethylamino)-1,3,5,7-tetraethyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d']bisimidazole-2,6-dithione-4,8-disulfide (27b) Yield: (2.29 g, 3.9 mmol, 70.9 %).  Appearance: light yellow solid  Melting Point: 245 °C 
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 1.03 (t, 12H, 3JH,H = 7.2 Hz, NCH2Me), 1.08 (t, 12H, 3JH,H = 7.2 Hz, NCH2Me) (2nd isomer), 1.51 (t, 12H, 3JH,H = 7.0 Hz, P-NCH2Me), 1.54 (t, 12H, 3JH,H = 7.0 Hz, P-
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NCH2Me) 2nd isomer, 3.27-3.44 (m, 8H, P-NCH2Me), 4.14-4.32 (m, 4H, NCH2Me), 4.47-4.64 (m, 4H, NCH2Me).   13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 13.1 (br,  P-NCH2Me), 13.3 (br, P-NCH2Me) 2nd isomer, 13.2 (br, NCH2Me), 39.3 (d, 2JP,C = 2.8 Hz, P-NCH2Me), 39.4 (d, 2JP,C = 2.9 Hz, P-NCH2Me) 2nd isomer, 42.7 & 42.8 (s, NCH2Me), 125.3 (dd, 1JP,C = 133.8 Hz, 2JP,C = 8.4 Hz C5), 125.5 (dd, 1JP,C = 133.8 Hz, 2JP,C = 8.7 Hz, C5) (2nd isomer), 168.5 (t, 3JP,C = 6.5 Hz, C=S).   31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = 20.1 (quin, 3JP,H = 13.8 Hz ), 20.5 (quin, 3JP,H = 13.9 Hz ) 2nd isomer, ratio = 1 :1.2.  IR [cm-1]: ṽ = 2974 (m), 2934 (w), 1440 (m), 1407 (s), 1309 (m), 1232 (s), 1162 (s), 1014 (s), 978 (s), 805 (s), 709 (s).  Pos-ESI-MS: for C22H40N6P2S4H theor./exp. 579.1751/ 579.1745.  EA [%]: theor./exp. C 45.65/45.29, H 6.97/6.75; N 14.52/14.56, S 22.16/22.57.  10.19.3 4,8-Bis(diethylamino)-1,3,5,7-tetra-n-butyl-4,8-dihydro[1,4]diphosphi-nine[2,3 -d:5,6-d']bisimidazole-2,6-dithione-4,8-disulfide (27c) Yield: (2.14 g, 3.1 mmol, 56.4 %)  Appearance: light yellow solid  Melting Point: 167 °C  
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 1.01 (t, 12H, 3JH,H = 6.9 Hz, NCH2CH2CH2Me) ,1.07 (t, 12H, 3JH,H = 6.7 Hz, P-NCH2Me), 1.38-1.51 (m, 8H, NCH2CH2CH2Me), 1.88-2.07 (m, 8H, NCH2CH2CH2Me), 3.25-3.37 (m, 8H, P-NCH2Me), 4.06-4.19 (m, 4H, NCH2CH2CH2Me), 4.35-4.49 (m, 4H, NCH2CH2CH2Me).  13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 13.3 (d, 3JP,C = 2.7 Hz,  P-NCH2Me), 13.7 (br, NCH2CH2CH2Me), 19.9 (s,NCH2CH2CH2Me), 29.2 (s, NCH2CH2CH2 Me), 39.3 (d, 2JP,C = 5.7 Hz, P-NCH2Me), 47.6 (s, NCH2CH2CH2Me), 125.2 (dd, 1JP,C = 134.1 Hz, 2JP,C = 16.3 Hz C4,5), 168.7 (t, 3JP,C = 6.6 Hz, C=S).   
31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = 19.9 (quin, 3JP,H = 13.5 Hz ), 20.2 (quin, 3JP,H = 13.5 Hz ) 2nd isomer, ratio = 15 :1.  IR [cm-1]: ṽ = 2959 (m), 2933 (w), 2870 (w), 1440 (m), 1407 (s), 1309 (m), 1216 (m), 1160 (s), 1016 (s), 947 (m), 707 (s).  
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Pos-ESI-MS: for C30H56N6P2S4H theor./exp. 691.3003/ 691.2997.  EA [%]: theor./exp. C 52.15/52.18, H 8.17/8.28; N 12.16/11.83, S 18.56/18.26.  10.19.4 4,8-Diphenyl-1,3,5,7-tetraethyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d']bisimidazole-2,6-dithione-4,8-disulfide (27d) Yield: 2.59 g (4.4 mmol, 80.0 %)  Appearance: white powder    Melting Point: 236 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.74 (t, 12H, 3JH,H = 7.1 Hz, N-CH2Me), 0.86 (m, 12H, 3JH,H = 7.1 Hz N-CH2Me) 2nd isomer, 3.94-4.46  (m, 8H, N-CH2Me),  7.17-8.13 (m, 10H, Ph ring protons). 13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 11.9 (s, N-CH2Me), 12.0 (s, N-CH2Me) 2nd isomer, 43.0 (br,  N-CH2Me), 123.7 (dd, 1JP,C = 115.9 Hz, 2JP,C = 13.6 Hz, C5), 124.1 (dd, 1JP,C = 115.0 Hz, 2JP,C = 13.3 Hz, C5) 2nd isomer, 127.2 (d,  1JP,C = 48.5 Hz, ipso-C), 128.4 (d,  1JP,C = 48.9 Hz, ipso-C) 2nd isomer, 130.0, 130.1, 130.2 & 130.3 (s, o-C of Ph ring), 132.2, 132.3, & 132.5 (s, m-C of Ph ring), 134.1 (br, p-C of Ph ring), 169.0 (t, 3JP,C = 6.3 Hz, C=S), 169.1 (t, 3JP,C = 6.3 Hz, C=S) 2nd isomer.  31P NMR (121.5 MHz, CDCl3Ȍ: δ = 1.5 (t, 3JP,H = 15.9 Hz) & 3.0 (t, 3JP,H = 16.1 Hz) ratio 1.3:1.  IR [cm-1]: ṽ = 2976 (w), 1436 (vs), 1372 (s), 1339 (m), 1263 (s), 1094 (s), 996 (m).  MS (EI, 70 eV): m/z (%) = 588.1 [M]+ (10), 255.8 [C10H12N2PS2]+ (100), 159.9 (50) [C8H5N2P]+. HRMS m/z: theor./exp. for [C26H30N4P2S4]: 588.0828/588.0827.  EA [%]: theor./exp. C 53.04/52.56, H 5.14/4.87; N 9.52/9.02, S 21.78/21.58.  10.19.5 4,8-Diphenyl-1,3,5,7-tetra-n-butyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d']bisimidazole-2,6-dithione-4,8-disulfide (27e) Yield: 2.89 g (4.1 mmol, 74.5 %)    Appearance: white powder  Melting Point: 162 °C  
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.19-0.35 (m, 4H, N-CH2CH2CH2Me),  0.68 (t, 12H, 3JH,H = 7.4 Hz, N-CH2CH2CH2Me), 0.91-1.03 (m, 4H, N-CH2CH2CH2Me), 1.09-1.22 (m, 4H, N-CH2CH2CH2Me), 1.67-1.82 (m, 4H, N-CH2CH2CH2Me),  3.97-4.31  (m, 8H, N-CH2CH2CH2Me),   7.61-8.15 (m, 10H, Ph ring protons).  13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 13.4 (s, N-CH2CH2CH2Me), 19.8 (s, N-CH2CH2CH2Me), 28.7 (s,  N-CH2CH2CH2Me) , 47.7 (s, N-CH2CH2CH2Me), 123.6 (dd, 1JP,C = 115.9 Hz, 2JP,C = 13.6 Hz, C5), 127.7 (d,  
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1JP,C = 93.4 Hz, ipso-C), 129.9 & 130.1 (s, o-C of Ph ring), 132.3 & 132.5 (s, m-C of Ph ring), 133.9 & 134.0 (s, p-C of Ph ring), 169.4 (t, 3JP,C = 5.9 Hz, C=S).  31P NMR (121.5 MHz, CDCl3Ȍ: δ = 1.4 (t, 3JP,H = 15.3 Hz) & 3.1 (t, 3JP,H = 16.1 Hz) ratio 10:1.  IR [cm-1]: ṽ = 2958 (w), 2930 (w), 2872 (w), 1407 (s), 1383 (s), 1357 (m), 1217 (s), 1158 (m), 1094 (s), 856 (s).  Pos-ESI-MS: for C34H46N4P2S4H theor./exp. 701.2158/ 701.2156.  EA [%]: theor./exp. C 58.26/57.98, H 6.61/6.56; N 7.99/7.86, S 18.29/17.92. 10.20 Oxidation of tricyclic 1,4-dihydro-1,4-diphosphinines with o-chloranil A solution of 4d-f (1.1 mmol) in methylene dichloride (15 ml) was treated with 2.2 mmol (2 equiv) of o-chloranil at room temperature. The reaction mixture was then allowed to stir for overnight to reach completion. Afterwards the reaction mixture was dried in vacuo (8×10-3 mbar) to get a dark brown residue. This crude product was later on washed once with diethyl ether (5 ml) to remove the coloring impurity, to get a light brown solid. This solid was then washed with n-pentane (2 × 5 ml) and dried in vacuo (8 × 10-3 mbar) to get a light brown powder. 10.20.1 4,8-Bis(diethylamino)-1,3,5,7-tetramethyl-4,8-dihydro[1,4]diphosphi-nine[2,3-d:5,6-d']bisimidazole-2,6-dithione-4,8-bis(tetrachlorobenzodioxaphospho-le) (28a) Yield: (0.85g, 0.9 mmol, 82.1 %) Appearance: light brown powder Melting Point: decomp. at 350 °C 
1H NMR (300.1 MHz, CD2Cl2, ʹͷ °CȌ: δ = 1.19 (t, 12H, 3JH,H = 6.9 Hz, P-NCH2Me), 1.21 (br, 12H, P-NCH2Me) (2nd isomer), 3.16 (br, 8H,  P-NCH2Me), 3.85 & 3.91 (s, 12H, N-Me).  13C{1H} NMR (75.5 MHz, CD2Cl2, ʹͷ °CȌ: δ = 14.1 (br, P-NCH2Me), 37.1 (br, N-Me), 44.4 (br, P-NCH2Me), 114.4 (s, o-chloranil ring C), 124.8 (s, o-chloranil ring C),   135.9 (dd, 1JP,C = 164.9 Hz, , 2JP,C = 24.9 Hz C5), 140.1 (s, o-chloranil ring C), 170.1 (t, 3JP,C = 7.3 Hz, C=S).   31P NMR (121.5 MHz, CD2Cl2, ʹͷ °CȌ: δ = -53.2 (quin, 3JP,H = 13.8 Hz ), -54.9 (br) 2nd isomer, ratio = 12:1.  IR [cm-1]: ṽ = 2968 (w), 1454 (s), 1383 (m), 1321 (m), 1156 (s), 1009 (s), 994 (s), 825 (s), 814 (s). 
Chapter 10: Experimental Section 
 165  
Pos-ESI-MS: for C30H32N6Cl8P2O4S2H theor./exp. 950.8929/950.8928.  EA [%]: theor./exp. C 37.92/36.91, H 3.39/3.72; N 8.84/8.23, S 7.75/7.72. 10.20.2 4,8-Bis(diethylamino)-1,3,5,7-tetraethyl-4,8-tetrahydro[1,4]diphosphi-nine[2,3-d:5,6-d']bisimidazole-2,6-dithione-4,8-bis(tetrachlorobenzodioxaphospho-le) (28b) Yield: (0.89 g, 0.88 mmol, 80.2 %)  Appearance: beige powder   Melting Point: decom. at 300 °C 
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 1.03 (t, 12H, 3JH,H = 7.0 Hz, NCH2Me), 1.19 (t, 12H, 3JH,H = 7.0 Hz, NCH2Me) (2nd isomer), 1.44 (t, 12H, 3JH,H = 6.3 Hz, P-NCH2Me), 1.47 (t, 12H, 3JH,H = 6.3 Hz, P-NCH2Me) 2nd isomer, 2.94-3.24 (m, 8H, P-NCH2Me), 4.31-4.68 (m, 4H, NCH2Me).   13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 13.4 (s,  NCH2Me), 13.8 (s, NCH2Me) 2nd isomer, 13.8 (br, P-NCH2Me), 14.4 (br, P-NCH2Me) 2nd isomer, 43.4 (s, NCH2Me), 44.2 (s, NCH2Me), 44.5 (br, P-NCH2Me), 114.6 & 114.9 (s, o-chloranil ring C), 125.4 & 125.8 (s, o-chloranil ring C), 134.6 (dd, 1JP,C = 167.1 Hz, 2JP,C = 22.9 Hz, C5), 135.9 (dd, 1JP,C = 175.5 Hz, 2JP,C = 24.6 Hz C5), (2nd isomer), 139.9 & 140.4 (s, o-chloranil ring C), 166.5 (t, 3JP,C = 8.1 Hz, C=S), 168.1 (t, 3JP,C = 7.5 Hz, C=S).  31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = -46.7 (quin, 3JP,H = 15.1 Hz ), -52.2 (quin, 3JP,H = 13.9 Hz ) 2nd isomer, ratio = 1 :2.5.  IR [cm-1]: ṽ = 2974 (w), 2936 (w), 1452 (s), 1405 (s), 1263 (m), 1154 (s), 1008 (s), 914 (s), 825 (s), 817 (s).  Pos-ESI-MS: for C34H40N6 Cl8O4P2S2H theor./exp. 1006.9555/ 1006.9556.  EA [%]: theor./exp. C 40.58/39.67, H 4.01/3.93; N 8.35/7.98, S 6.37/6.41. 10.20.2 4,8-Bis(diethylamino)-1,3,5,7-tetra-n-butyl-4,8-dihydro[1,4]diphosphi-nine[2,3-d:5,6-d']bisimidazole-2,6-dithione-4,8-bis(tetrachlorobenzodioxaphospho-le) (28c) Yield: 1.08 g (0.97 mmol, 88.1 %) Appearance: white powder      Melting Point: decom. at 260 °C 
1H NMR (300 MHz, CDCl3Ȍ: δ = 0.89 & 0.92 (t, 12H, 3JH,H = 7.6 Hz, N-CH2CH2CH2Me), 1.01 (t, 12H, 3JH,H = 6.3 Hz, P-NCH2Me), 1.20 (t, 12H, 3JH,H = 6.3 Hz, P-NCH2Me) 2nd isomer, 1.25-1.52 (m, 8H, N-CH2CH2CH2Me), 1.72-2.11 (m, 8H, N-CH2CH2CH2Me), 2.88-3.18 (m, 8H, P-NCH2Me), 4.11-4.55 (m, 8H, N-CH2CH2CH2Me). 
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13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 13.6 & 13.7 (s, N-CH2CH2CH2Me), 13.9 & 14.2 (br, P-NCH2Me), 20.3 & 20.4 (s, N-CH2CH2CH2Me), 29.5 & 29.9 (s, N-CH2CH2CH2Me), 43.9 & 44.4 (br, P-NCH2Me), 48.6 & 49.0 (s, N-CH2CH2CH2Me), 114.7 (m, o-chloranil ring C), 125.4 & 125.7 (s, o-chloranil ring C), 136.0 (dd, 1JP,C = 179.2 Hz, 2JP,C = 23.8 Hz, C4,5), 139.8 & 140.5 (s, o-chloranil ring C), 166.6 (t, 3JP,C = 8.1 Hz,  C=S), 168.7 (t, 3JP,C = 7.5 Hz, C=S) 2nd isomer.  31P NMR (121.5 MHz, CDCl3Ȍ: δ = -43.6 (quin, 3JP,H = 14.8 Hz ), -52.2 (quin, 3JP,H = 14.1 Hz ) 2nd isomer, ratio = 1 :1.  IR [cm-1]: ṽ = 2959 (m), 2871 (w), 1457 (s), 1403 (s), 1258 (s), 1217 (m), 1155 (m), 1009(s), 996 (s), 816 (s).  Pos-ESI-MS: for C42H56N6Cl8O4P2S2H theor./exp. 1119.0810/ 1119.0808.  EA [%]: theor./exp. C 45.10/44.70, H 5.05/4.93; N 7.51/7.32, S 5.73/6.12. 10.21 S-methylation of 1,4-dihydro-1,4-diphosphinines with methyl triflate 4d,f; 22b,c (1.1 mmol) in 20 mL of methylene dichloride were treated with 2.2 mmol of methyl triflate at room temperature. In the case of 4d a white precipitate slowly formed with time. This precipitate was separated by means of cannula filtration and washed with diethyl ether (2 × 2 ml) to get 29a. In other three cases the reaction mixtures were concentrated in vacuo to get the 29b-d. The products were finally washed with n-pentane (2 × 5 ml) and then dried under reduced pressure to remove traces of methylene dichloride. 10.21.1 4,8-Bis(diethylamino)-1,3,5,7-tetramethyl-4,8-dihydro[1,4]diphosphi-nine[2,3-d:5,6-d']bisimidazole-2,6-bis(imidazolium)trifluoromethanesulfonate (29a) Yield: (0.39 g, 0.5 mmol, 45.4 %)  Appearance: White powder   Melting Point: 223 °C 
1H NMR (300.1 MHz, DMSO-d6, ʹͷ °CȌ: δ = 0.91 (br, 12H, P-NCH2Me), 2.50 & 2.60 (br, S-Me) two isomers, 2.95 (br, 12H, P-NCH2Me), 4.02 & 4.08 (s, N-Me).  13C{1H} NMR (75.5 MHz, DMSO-d6, ʹͷ °CȌ: δ = 14.1 (br, P-NCH2Me), 17.6 & 17.7 (s, S-Me), 36.8(t, 3JP,C = 5.4 Hz, N-Me), P-NCH2Me signal was hidden under the solvent signal, 121.1 (q, 1JP,F = 332.1 Hz, CF3SO3-), 135.9 & 136.0 (d, 1JP,C = 5.9 Hz,  C4,5), 149.7 (br, C-SMe).   31P NMR (121.5 MHz, DMSO-d6, ʹͷ °CȌ: δ = 3.7 (quin, 3JP,H = 8.3 Hz) & 5.9 (br) 2nd isomer, ratio = 1:11. 
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IR [cm-1]: ṽ = 2982 (w), 2944 (w), 1444 (w), 1385 (w), 1257 (s), 1150 (s), 1058 (s), 941 (m), 838(s).  Pos-ESI-MS: for [C20H38N6P2S2]2+ theor./exp. 244.103/ 244.103,  Neg-ESI-MS: for [CF3SO3]- theor./exp. 148.9/148.9.  EA [%]: theor./exp. C 33.59/33.70, H 4.87/4.80; N 10.68/10.67, S 16.30/16.30. 10.21.2 4,8-Bis(diethylamino)-1,3,5,7-tetra-n-butyl-4,8-dihydro[1,4]diphosphi-nine[2,3-d:5,6-d']bisimidazole-2,6-bis(imidazolium)trifluoromethanesulfonate (29b) Yield: (0.96 g, 0.97 mmol, 88.1 %)  Appearance: orange oil     Melting Point: liq. at r.t.  1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 0.98 (br, 12H, P-NCH2Me), 1.06 (t, 12H, 3JH,H = 7.5 Hz, NCH2CH2CH2Me), 1.43-1.61 (m, 8H, NCH2CH2CH2Me), 1.81-1.99 (m, 4H, NCH2CH2CH2Me), 2.04-2.19 (m, 4H, NCH2CH2CH2Me), 2.69 & 2.71 (br, S-Me) two isomers, 2.91-3.32 (m, 8H, P-NCH2Me), 4.31-4.147 (m, 4H, NCH2CH2CH2Me), 4.56-4.78 (m, 4H, NCH2CH2CH2Me).  13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 13.2 & 13.8 (br, NCH2CH2CH2Me), 13.5 (br,  P-NCH2Me), 19.2 & 19.3 (S-Me), 19.9 & 20.0 (s, NCH2CH2CH2Me), 31.9 & 32.2 (br, NCH2CH2CH2Me), 45.0 (br, P-NCH2Me), 45.7 (d, 2JP,C = 18.3 Hz, P-NCH2Me) 2nd isomer, 48.6 & 49.7 (br, NCH2CH2CH2Me), 120.8 (q, 1JP,F = 321.2 Hz, CF3SO3-), 136.4 (dt, 1JP,C = 16.5 Hz, 2JP,C = 6.8 Hz C4,5), 147.5 (br, C=SMe), 147.8 (br, C=SMe) 2nd isomer.   
31P NMR (121.5 MHz, CDCl3, 25 °CȌ: δ = 2.2 (br) & 3.2 (br) two isomers, ratio = 2.4:1. IR [cm-1]: ṽ = 2966 (m), 2935 (w), 2876 (w), 1468 (m), 1382 (w), 1262 (s), 1146 (s), 1030 (s), 937 (m), 794 (m).  Pos-ESI-MS: for [C32H62N6P2S2]2+ theor./exp. 328.198/ 328.198  Neg-ESI-MS: for [CF3SO3]- theor./exp. 148.9/148.9.   EA [%]: theor./exp. C 42.76/41.65, H 6.54/6.35; N 8.80/8.22, S 13.43/13.39.  10.21.3 4,8-Diphenyl-1,3,5,7-tetraethyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d']bisimidazole-2,6-bis(imidazolium) trifluoromethanesulfonate (29c) Yield: 0.76 g (0.94 mmol, 85.6 %)    Appearance: white powder  Melting Point: 249 °C 
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1H NMR (300 MHz, CDCl3Ȍ: δ = 0.88 (t, 12H, 3JH,H = 7.2 Hz, N-CH2Me), 1.47 (m, 12H, 3JH,H = 7.3 Hz N-CH2Me) 2nd isomer, 2.63 & 2.69  (s, 6H, S-Me), 4.22-4.79 (m, 8H, NCH2Me),  7.17-7.89 (m, 10H, Ph ring protons).  
13C{1H} NMR (75.0 MHz, CDCl3Ȍ: δ = 14.2 (s, N-CH2Me), 15.5 (s, N-CH2Me) 2nd isomer, 18.9 & 19.1 (s, S-Me) two isomers, 45.4 (m, N-CH2Me), 45.9 (m, N-CH2Me) 2nd isomer, 120.6 (q, 1JP,F = 320.6 Hz, CF3SO3-), 128.1 (m, C4,5), 130.0 (t, JP,C = 3.8 Hz, Ph ring-C), 130.6 (m, Ph ring-C), 130.9 (s, Ph ring-C), 132.3 (m, Ph ring-C), 133.2 (s, Ph ring-C), 133.4 (d, 1JP,C = 8.1 Hz, ipso-C Ph ring), 136.1, 136.2 & 136.5 (s, Ph ring-C), 147.5 (br, C=SMe), 147.8 (br, C=SMe) 2nd isomer.  
31P NMR (121.5 MHz, CDCl3Ȍ: δ = -49.54 (br) & -55.84 (br), two isomers, ratio 1:1.3.  IR [cm-1]: ṽ = 2992 (w), 1472 (m), 1259 (vs), 1140 (s), 1087 (m), 1000 (m).  Pos-ESI-MS: theor./exp. for [C28H36N4P2S2]2+: 277.093/277.093  Neg-ESI-MS: for [CF3SO3]- theor./exp. 148.9/148.9.   EA [%]: theor./exp. C 42.25/41.94, H 4.26/4.26; N 6.57/6.30, S 15.04/14.89.  10.21.4 4,8-Diphenyl-1,3,5,7-tetra-n-butyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d']bisimidazole-2,6-bis(imidazolium) trifluoromethanesulfonate (29d) Yield: 1.01 g (1.06 mmol, 95.2 %)  Appearance: white powder   Melting Point: 187 °C 
1H NMR (300 MHz, CD2Cl2Ȍ: δ = 0.62-0.72 (m, 2H, N-CH2CH2CH2Me), 0.81 & 0.91 (t, 12H, 3JH,H = 7.5 Hz, N-CH2CH2CH2Me) two isomers, 1.14-1.23 (m, 2H, N-CH2CH2CH2Me), 1.25-1.35 (m, 4H, N-CH2CH2CH2Me), 1.35-1.45 (m, 4H, N-CH2CH2CH2Me), 1.62-1.73 (m, 2H, N-CH2CH2CH2Me), 1.85-1.95 (m, 2H, N-CH2CH2CH2Me), 2.61 & 2.68 (s, S-Me, two isomers), 4.16-4.55 (m, 8H, N-CH2CH2CH2Me), 7.43-7.89 (m, 10H, Ph ring protons).  
13C{1H} NMR (75.0 MHz, CD2Cl2Ȍ: Ɂ = ͳ͵.Ͳ & ͳ͵.ͳ ȋs, N-CH2CH2CH2Me), 18.9 & 19.1 (s, S-Me) two isomers, 19.8 & 19.9 (s, N-CH2CH2CH2Me), 31.1 & 31.9 (br N-CH2CH2CH2Me), 49.8 (m, N-CH2CH2 CH2Me), 50.4 (m, N-CH2CH2CH2Me) 2nd isomer, 120.8 (q, 1JP,F = 321.1 Hz, CF3SO3-), 128.3 (m, C4,5), 130.3 (t, JP,C = 4.4 Hz, Ph ring-C), 130.5 (m, Ph ring-C), 132.1 (s, Ph ring-C), 132.2 (s, Ph ring-C), 133.8 (m, Ph ring-C), 133.3 (d, 1JP,C = 8.1 Hz, ipso-C Ph ring), 136.0, & 136.3 (s, Ph ring-C), 146.7 (br, C=SMe), 147.1(br, C=SMe) 2nd isomer.  
31P NMR (121.5 MHz, CD2Cl2Ȍ: δ = -50.1 & -53.7 (br, two isomers, ratio 1.1:1).  
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IR [cm-1]: ṽ = 2960 (m), 2872 (w), 1469 (w), 1344(w), 1255 (s), 1151 (s), 1027 (s), 846 (m).   Pos-ESI-MS: theor./exp. for [C28H36N4P2S2]2+: 333.155/333.155  Neg-ESI-MS: for [CF3SO3]- theor./exp. 148.9/148.9.  EA [%]: theor./exp. C 47.30/46.91, H 5.43/5.40; N 5.81/5.65, S 13.29/13.91. 10.22 Synthesis of P-borane complexes of 1,4-dihydro-1,4-diphosphinines A solution of 4d-f (1.1 mmol) in methylene dichloride (10 ml) was treated with 2.4 mmol of borane-dimethyl sulfide adduct at room temperature. The reaction mixture was stirred for 2h and concentrated in vacuo (8×10-3 mbar) to get a yellow residue. This yellow residue was washed with n-pentane (3 × 5 ml) to remove the yellow coloring impurities and obtain a white powder. Finally, these white powders were dried in vacuo (8×10-3 mbar) to obtain pure 30a-c. 10.22.1 4,8-Bis(diethylamino)-1,3,5,7-tetramethyl-4,8-dihydro[1,4]diphosphi-nine[2,3-d:5,6-d']bisimidazole-2,6-dithione-4,8-diborane (30a) Yield: 0.45 g (0.94 mmol, 85.4 %) Appearance: white powder       Melting Point: decomp. at 210 °C 
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 1.08 (br, 12H, P-NCH2Me), 3.86 & 3.88 (s, 12H, N-Me).  13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 13.1 (br, P-NCH2Me), 34.8 & 35.1 (s, N-Me), 41.3 & 41.4 (br, P-NCH2Me), 123.2 (dd, 1JP,C = 87.6 Hz,  2JP,C = 9.4 Hz C5), 124.6 (dd, 1JP,C = 87.6 Hz, , 2JP,C = 7.9 Hz, C5) (2nd isomer), 170.6 (t, 3JP,C = 5.0 Hz, C=S), 170.7 (t, 3JP,C = 4.7 Hz, C=S) 2nd isomer.   31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = 34.4 (br).  IR [cm-1]: ṽ = 2974 (m), 2937 (w), 2410 (s), 2355 (w), 1424 (w), 1383 (s), 1328 (s), 1166 (s), 1057 (s), 1020 (s), 854(s).  MS (EI, 70 eV): m/z (%) = 472.2 (40) [M - BH3]+, 458.1 (70) [M - 2BH3]+, 315 (100) [C10H14N4P2S2].  EA [%]: theor./exp. C 44.46/43.81, H 7.88/7.76; N 17.28/16.53, S 13.19/13.45.  10.22.2 4,8-Bis(diethylamino)-1,3,5,7-tetraethyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d']bisimidazole-2,6-dithione-4,8-diborane (30b) Yield: 0.49 g (0.91 mmol, 82.3 %)  Appearance: White powder Melting Point: decom. at 180 °C 
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1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 1.07 (br, 12H, P-NCH2Me), 1.51 (t, 12H, 3JH,H = 6.9 Hz, NCH2Me), 1.54 (t, 12H, 3JH,H = 6.9 Hz, NCH2Me) 2nd isomer, 3.25 (br, 8H, P-NCH2Me), 4.17-4.32 (m, 8H, NCH2Me), 4.42-4.53 (m, 8H, NCH2Me) 2nd isomer. 13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 13.3 & 13.4 (s, NCH2Me), 13.3 (br, P-NCH2Me), 41.5 & 41.6 (br, P-NCH2Me), 43.2 & 43.4 (s, NCH2Me), 122.9 (dd, 1JP,C = 87.7 Hz, 2JP,C = 9.0 Hz C5), 124.4 (dd, 1JP,C = 85.9 Hz, 2JP,C = 7.6 Hz, C5) (2nd isomer), 169.0 (t, 3JP,C = 4.8 Hz, C=S), 169.1 (t, 3JP,C = 4.5 Hz, C=S) 2nd isomer.   
31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = 33.7 (br), 34.3 (br) 2nd isomer, ratio = 1.3:1.  IR [cm-1]: ṽ = 2975 (m), 2936 (w), 2873 (w), 2414 (w), 1444 (w), 1404 (s), 1307 (m), 1264 (s), 1202 (s), 1162 (s), 1059 (m), 1020 (s), 978 (m), 950 (m).  Pos-ESI-MS: for C22H43BN6P2S2H theor./exp. 529.2632/ 529.2635.  EA [%]: theor./exp. C 48.72/47.93, H 8.55/8.20; N 15.50/14.77, S 11.82/11.94.  10.22.3 4,8-Bis(diethylamino)-1,3,5,7-tetra-n-butyl-4,8-dihydro[1,4]diphosphi-nine[2,3-d:5,6-d']bisimidazole-2,6-dithione-4,8-diborane (30c) Yield: 0.43 g,(0.7 mmol, 63.6 %)   Appearance: white powder       Melting point: decomp. at 140 °C 
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 1.01 (t, 24H, 3JH,H = 7.1 Hz, NCH2CH2CH2Me & P-NCH2Me),  1.46 (br, 8H, NCH2CH2CH2Me), 1.95 (br, 8H, NCH2CH2CH2Me), 3.14 (br, 8H, P-NCH2Me), 4.03-4.15 (m, 4H, NCH2CH2CH2Me), 4.28-4.39 (m, 4H, NCH2CH2CH2Me).  13C{1H} NMR (75.5 MHz, CDCl3, 25 °CȌ: δ = 13.2 (br,  P-NCH2Me), 13.6 (s, NCH2CH2CH2Me), 19.9 (s,NCH2CH2CH2Me), 29.3 (s, NCH2CH2CH2 Me), 41.5 & 41.6 (s, P-NCH2Me), 48.3 (br, NCH2CH2CH2Me), 124.3 (dd, 1JP,C = 85.8 Hz, 2JP,C = 7.5 Hz C4,5), 169.3 (t, 3JP,C = 4.9 Hz, C=S).   31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = 33.3 (br).  IR [cm-1]: ṽ = 2967 (m), 2935 (w), 2872 (w), 2442 (w), 2410 (m), 2347 (w), 1441 (m), 1406 (s), 1200 (s), 1122 (s), 950 (s), 857 (s).  Pos-ESI-MS: for C22H59BN6P2S2H theor./exp. 641.3889/641.3890.  EA [%]: theor./exp. C 55.05/54.85, H 9.55/8.87; N 12.84/12.39, S 9.80/9.39. 
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10.23 Reductive cleavage of the P-Ph bonds in compound 22 To a THF (50 ml) solution of 22c (1.1 mmol, 0.71 g), 4.4 mmol (0.16 g) of potassium metal was added at r.t. and left stirring overnight. Upon adding the metal, the color of the solution slowly changed to orange and gradually an orange precipitate started to form. After ~12h the reaction mixture was cooled to –78 °C and 4.4 mmol of n-butyl iodide were added to quench the dianion 31, formed by reduction of 22c. The reaction mixture turned clear and light yellow after adding the electrophile. The reaction mixture was then concentrated under reduced pressure (8 × 10-3 mbar) and the residue taken up in 30 ml of toluene. This toluene solution was then filtered through a silica bed to filter off the KCl. This filtrate was then dried in vacuo and finally the residue was washed with n-pentane. After wards the washed solid was dried in vacuo (8 × 10-3 mbar) to get a beige powder. The product was finally confirmed as 25b by all analytical data. 10.24 Oxidative desulfurization of compound 22b A solution of 0.98 g (1.9 mmol) of 22b in 50 ml of chloroform was treated with 1,76ml of H2O2/H2O at room temperature and left stirring for overnight. After 12h the solvent was removed under reduced pressure and the remaining solid was washed with diethyl ether for three times (5 ml) and afterwards dried for 3 hours.  10.24.1 4,8-Diiphenyl-1,3,5,7-tetraethyl-4,8-dihydro[1,4]diphosphinine[2,3-d:5,6-d'] bisimidazole-4,8-dioxide-2,6-bis(imidazolium) hydrogensulfate (32) Yield: 1.18 g (1.7 mmol, 92.4 %)  Appearance: white powder   Melting point: 245 °C 
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 1.20 (t, 12H, 3JH,H = 7.25 Hz, N-CH2CH3) 1.26 (t, 12H, 3JH,H = 7.23 Hz, N-CH2CH3) (2nd isomer), 4.05-4.30  (m, 12H, N-CH2CH3), 7.75-8.05 (m, 10H, P-Ph), 9.96 (s, 2H, C2-H), 10.00 (s, 2H, C2-H) (2nd isomer). 
13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 14.8 (s, N-CH2CH3), 14.9 (s, N-CH2CH3) (2nd isomer), 46.1 (s, N-CH2CH3), 46.3 (s, N-CH2CH3) (2nd isomer), 123.9 and 124.1 (d, 1JP,C = 122.7 Hz, ipso-C), 133.5-136.1 (m, Ph ring carbons) , 146.8 (s, C2-H, both-isomers) 
31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = -5.4 (t, 3JP,H = 16.1 Hz) , -5.1 (t, 3JP,H = 15.6 Hz) ratio 1.2:1. IR [cm-1]: ṽ = 2988 (w), 1723 (w), 1439 (m), 1216 (vs), 1151 (vs), 1059 (vs), 997 (s). Pos-ESI-MS: for C26H34N4P2S2O10 theor./exp. 247.10/247.099. Neg-ESI-MS: for [HSO4]- theor./exp. 96.96 /96.96 
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EA [%]: theor./exp. C 45.35/45.15, H 4.98/5.27; N 8.14/7.42, S 9.31/8.40. 10.25 Synthesis of tricyclic 1,4-diphosphinines  Tris(n-butyl)phosphane (0.12 mL, 0.5 mmol) was added to a suspension of 24a (0.19 g, 0.5 mmol) in 5 mL of dichloromethane at room temperature. Then the reaction mixture was left stirring for 24h, until the whole orange suspension is converted into a red one. Then the solid was filtered and washed few times with DCM, followed by drying under reduced pressure to get the pure compound. In case of 24b, tris(n-butyl)phosphane (0.12 mL, 0.5mmol) was added to 24b (0.28 g, 0.5 mmol) in 5 mL of DCM at room temperature. After stirring for 1h the solvent was removed and the residue was filtered through a silica® bed with diethyl ether as the eluent to get the pure compound. 10.25.1 1,3,5,7-Tetramethyl-[2,3-d:5,6-d']diimidazole-2,6-dithione-4,8-[1,4]diph-osphinine (33a) Yield: 0.1 g (0.33 mmol, 65.1 %)  Appearance: Red solid   Melting Point: 220 °C 
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 4.00 (s, 12H).   13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 33.7 (t, 3JPC= 6.2 Hz, N-CH3), all ring carbon atom resonances could not be observed.  
31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = 76.2 (s).  IR [cm-1]: ṽ = 1428 (m), 1369 (s), 1352 (s), 1258 (s), 886 (s).  UV-Vis. (CH2Cl2): max [nm]/ (abs.) 282 (1.623), 497 (0.805).  MS (EI, 70 eV): m/z (%) = 313.9 (100) [M].+, 128.0 (60) [C5H8N2S]+ HRMS: theor./exp. for [C10H12N4P2S2]: 313.9979/313.9976.  EA [%]: theor./exp. C 38.21/37.96 , H 3.85/3.89; N 17.83/17.56, S 20.40/20.02.  10.25.2 1,3,5,7-Tetra-n-butyl-[2,3-d:5,6-d']diimidazole-2,6-dithione-4,8-[1,4]diphos-phinine (33b) Yield: 0.09 g (0.29 mmol, 58.3 %)    Appearance: Red solid  Melting Point: 165 °C  
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 1.02 (t, 12H, 3JH,H = 7.4 Hz, NCH2CH2CH2Me), 1.48-1.60 (m, 8H, NCH2CH2CH2Me ), 1.88-1.98 (m, 8H, NCH2CH2CH2Me), 4.53 (t, 8H, 3JH,H = 7.4 Hz NCH2CH2CH2Me). 
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13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 13.8 (s, NCH2CH2CH2Me), 20.1 (s, NCH2CH2CH2Me), 28.8 (s, NCH2CH2CH2Me), 46.8  (t, 3JP,C = 4.6 Hz, NCH2CH2CH2Me), 151.7 (t, 1JP,C = 22.5 Hz, P-C of the middle ring), 169.6 (t, 3JP,C = 2.3 Hz, C=S).  31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = 78.1 (s).  UV-Vis. (CH2Cl2) max [nm]/ (abs.) 286 (0.334), 498 (0.121).  IR [cm-1]: ṽ = 2956 (m), 2930 (m), 2870 (w), 1434 (m), 1398 (s), 1377 (s), 1217 (m), 1176 (m), 1016 (s), 926 (s). MS (EI, 70 eV): m/z (%) = 482.2 (85) [M].+,  HRMS: theor./exp. for [C22H36N4P2S2]: 482.1856/482.1859.  EA [%]: theor./exp. C 54.75/54.78 , H 7.52/7.61, N 11.61/11.40, S 13.29/13.19.  10.26 [4+2]-cycloaddition reactions of 1,4-diphosphinines A solution of 33b (0.48 g, 1 mmol) in toluene (20 ml) was heated with 0.12 ml of dimethyl acetylene dicarboxylate (for 34a; heated for 1 h at 50 °C) or N-phenylmaleimide (for 34b; heated at 110 °C for 3h) in a Schlenk tube. The color of the reaction mixture turned dark reddish brown for 34a and light red-orange for 34b. Afterwards the solvent was removed under reduced pressure (8× 10-3 mbar) and the residue was washed with n-pentane (3×5 ml). Finally it was dried under vacuum (8× 10-3 mbar) to get 34a,b in pure form. In case of 34c, a THF (10 ml) solution of compound 33b (0.48 g, 1mmol) was treated with a THF (5 ml) solution of 4-phenyl-1,2,4-triazoline-3,5-dione (0.18 g, 1 mmol) at -40°C. The color of the reaction mixture changed from dark red to bright yellow immediately upon addition of the triazoline derivative. Afterwards the reaction mixture was warmed up to the room temperature and concentrated under reduced pressure (8× 10-3 mbar). The crude product was then washed with diethyl ether (3 × 2 ml) at -30 °C to remove small amount of the impurity and to get compound 34c in pure form. 10.26.1 7,8-Bis(methyloxocarbonyl)-[2,3-d:5,6-d']bis(1,3-di-n-butyl-imidazole-2-thione)-1,4-diphospha-bicyclo[2.2.2]octa-2,5,7-triene (34a) Yield: 0.59 g (0.95 mmol, 95.0 %)   Appearance: Red solid   Melting Point: decomp. at 180 °C 
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1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 0.99 (t, 12H, 3JH,H = 7.3 Hz, NCH2CH2CH2Me), 1.39(tq, 8H, 3JH,H = 7.3 Hz = 14.9 Hz, 3JH,H = 7.49 Hz,  NCH2CH2CH2Me), 1.69-1.86 (m, 8H, NCH2CH2CH2Me), 3.87 (s, 6H, -CO2Me), 4.27 (t, 8H, 3JH,H = 7.4 Hz NCH2CH2CH2Me).  13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 13.8 (s, NCH2CH2CH2Me), 20.1 (s, NCH2CH2CH2Me), 31.6 (s, NCH2CH2CH2Me), 47.8  (dd, 3JP,C = 4.6 Hz, NCH2CH2CH2Me), 53.4 (s, -CO2Me), 128.6 (d, 1JP,C = 61.2 Hz, P-CO2Me),  142.5 (t, JP,C = 4.1 Hz, P-C of the middle ring), 160.5 (dd, 2JP,C = 14.1 Hz,  2JP,C = 11.9 Hz, -CO2Me) 164.3 (s, C=S), 166.1 (dd, 2JP,C = 16.8 Hz, -CO2Me). 31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = -87.3 (s).  IR [cm-1]: ṽ = 2957 (w), 2933 (w), 2873 (w), 1721 (s), 1435 (m), 1404 (s), 1245 (s), 1217 (s). MS (EI, 70 eV): m/z (%) = 624.1 (10) [M].+, 482.2 (100) [M-C6H6O4].+ HRMS: theor./exp. for [C28H42N4O4P2S2]: 624.2123/624.2123.  EA [%]: theor./exp. C 53.83/53.55 , H 6.78/6.73, N 8.97/8.82, S 10.26/9.84.  10.26.2 7,8-(N-Phenylmaleimide)-[2,3-d:5,6-d']bis(1,3-di-n-butyl-imidazole-2-thione)-1,4-diphospha-7,8-dihydro-bicyclo[2.2.2]octa-2,5-diene (34b) Yield: 0.59 g (0.91 mmol, 91.0 %)  Appearance: orange solid       Melting Point: decomp. at 160 °C  
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 0.89 (t, 6H, 3JH,H = 7.3 Hz, NCH2CH2CH2Me), 1.01 (t, 6H, 3JH,H = 7.3 Hz, NCH2CH2CH2Me), 1.29-1.49 (m, 8H, NCH2CH2CH2Me), 1.63-1.84 (m, 8H, NCH2CH2CH2Me), 3.72 (t, 2H, 3JP,H = 4.9 Hz, P-CH), 4.09-4.39 (m, 8H, NCH2CH2CH2Me), 6.75-7.45 (m, 5H, Ph ring protons). 13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 13.5 & 13.8 (s, NCH2CH2CH2Me), 19.9 & 20.1 (s, NCH2CH2CH2Me), 31.5 & 31.7 (s, NCH2CH2CH2Me), 44.5 (dd, 3JP,C = 8.4 Hz, P-CH), 47.3 (t, 3JP,C = 1.9 Hz, NCH2CH2CH2Me), 47.5 (t, 3JP,C = 2.1 Hz, NCH2CH2CH2Me), 126.3 (s, Ph ring C), 129.5 (s, Ph ring C), 129.6 (s, Ph ring C), 130.5 (s, Ph ring C), 133.0 (dd, JP,C = 6.4 Hz, P-C of the middle ring), 134.5 (dd, JP,C = 3.5 Hz, P-C of the middle ring), 167.4 (s, -C(O)-), 172.4 (t, 3JP,C = 3.3 Hz, C=S).  31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = -86.3 (t, 2JP,H = 4.9 Hz).   IR [cm-1]: ṽ = 2956 (w), 2930 (w), 2870 (w), 1768 (w), 1704 (s), 1404 (s), 1373 (s), 1217 (w), 1162 (s). Pos-ESI-MS: for C32H43N5O2P2S2H theor./exp. 656.2417/656.2406. 
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EA [%]: theor./exp. C 58.61/58.02 , H 6.61/6.76, N 10.68/10.12, S 9.78/9.10.  10.26.3 7,8-(4-Phenyl-1,2,4-triazoline-3,5-dione)-[2,3-d:5,6-d']bis(1,3-di-n-butyl-imidazole-2-thione)-1,4-diphospha-7,8-dihydro-bicyclo[2.2.2]octa-2,5-diene (34c) Yield: 0.39 g (0.6 mmol, 60.0 %)   Appearance: yellow solid   Melting Point: decomp. at 160 °C  
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 1.01 (t, 12H, 3JH,H = 7.3 Hz, NCH2CH2CH2Me), 1.36-1.48 (m, 8H, NCH2CH2CH2Me), 1.69-1.94 (m, 8H, NCH2CH2CH2Me), 4.14-4.44 (m, 8H, NCH2CH2CH2Me), 7.37-7.51 (m, 5H, Ph ring protons). 
13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 13.7 (s, NCH2CH2CH2Me), 20.1 (s, NCH2CH2CH2Me), 31.7 (s, NCH2CH2CH2Me), 47.6 (t, 3JP,C = 1.9 Hz, NCH2CH2CH2Me), 125.8 (s, Ph ring C), 128.9(s, Ph ring C), 129.3 (s, Ph ring C), 130.7 (s, Ph ring C), 131.8 (dd, JP,C = 2.2 Hz, P-C of the middle ring), 150.1 (dd, 2JP,C = 7.9 Hz, 3JP,C = 7.1 Hz,  -C(O)-), 166.3 (s, C=S).  31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = -49.6 (s).   IR [cm-1]: ṽ = 2957 (w), 2931 (w), 2872 (w), 1762 (w), 1717 (s), 1402 (s), 1387 (s), 1263 (m), 1217 (m). MS (EI, 70 eV): m/z (%) = 657.2 (10) [M].+, 482.2 (50) [M-C8H5N3O2].+ HRMS: theor./exp. for [C28H42N4O4P2S2]: 657.2238/657.2229.  EA [%]: theor./exp. C 54.78/54.30, H 6.28/6.27, N 14.91/14.72, S 9.75/9.26.  10.27 Reaction of 1,4-diphosphinines with Ph2E2 A solution of 33b (0.48 g, 1 mmol) in toluene (20 ml) was heated with 0.22 g of diphenyl disulfide (for 35a; heated for 2 days) or 0.31 g of diphenyl diselenide (for 35b; heated for 6h) at 110°C in a Schlenk tube. The color of the reaction mixture turned yellow in both cases from dark blood red during the course of the reaction. After the complete consumption of the starting materials the solvent was removed under reduced pressure (8× 10-3 mbar) and Afterwards the solvent was removed under reduced pressure (8× 10-3 mbar) and the residue was washed with n-pentane (3×5 ml). Finally it was dried under vacuum (8× 10-3 mbar) to get 35a,b in pure form as yellow powders.
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10.27.1 4,8-Bis(thiophenoxy)-1,3,5,7-tetra-n-butyl-4,8-dihydro[1,4]diphosphinine [2,3 -d:5,6-d']bisimidazole-2,6-dithione (35a) Yield: 0.55 g (0.78 mmol, 78.0 %)    Appearance: yellow solid  Melting Point: 195 °C  
1H NMR (300.1 MHz, CDCl3, ʹͷ °CȌ: δ = 1.06 (t, 12H, 3JH,H = 7.3 Hz, NCH2CH2CH2Me), 1.42-1.54 (m, 8H, NCH2CH2CH2Me), 1.58-1.73 (m, 4H, NCH2CH2CH2Me), 1.82-1.97 (m, 4H, NCH2CH2CH2Me), 3.98-4.08 (m, 4H, NCH2CH2CH2Me), 4.47-4.57 (m, 4H, NCH2CH2CH2Me), 6.33 (d, 4H, 3JH,H = 7.9 Hz, o-protons of Ph ring),  7.07 (t, 4H, 3JH,H = 7.5 Hz, m-protons of Ph ring),  7.29 (t, 2H, 3JH,H = 7.5 Hz, p-protons of Ph ring). 
13C{1H} NMR (75.5 MHz, CDCl3, ʹͷ °CȌ: δ = 13.8 (s, NCH2CH2CH2Me), 20.1 (s, NCH2CH2CH2Me), 31.1 (s, NCH2CH2CH2Me), 46.9 (t, 3JP,C = 3.4 Hz, NCH2CH2CH2Me), 125.4 (dd, , 3JP,C = 7.4 Hz, 3JP,C = 6.5 Hz, ipso-C of Ph ring ), 126.3 (t, JP,C = 4.1 Hz, P-C of the middle ring), 128.9 (s, Ph ring C) 129.2 (s, p-C of Ph ring), 134.9 (s, Ph ring C), 167.5 (t, 3JP,C = 1.6 Hz C=S).  31P NMR (121.5 MHz, CDCl3, ʹͷ °CȌ: δ = -34.2 (s).   IR [cm-1]: ṽ = 2958 (w), 2931 (w), 2871 (w), 1436 (s), 1398 (s), 1286 (s), 1216 (s), 1159 (s), 861 (s), 745 (s). Pos-ESI-MS: for C34H46N4P2S4H theor./exp. 701.2165/701.2153. EA [%]: theor./exp. C 58.26/58.01, H 6.61/6.66, N 7.99/7.83, S 18.29/17.43.  10.27.2 4,8-Bis(selenophenoxy)-1,3,5,7-tetra-n-butyl-4,8-dihydro[1,4]diphosphinine [2,3 -d:5,6-d']bisimidazole-2,6-dithione (35b) Yield: 0.59 g (0.75 mmol, 75.0 %)    Appearance: yellow solid  Melting Point: 188 °C  
1H NMR (300.1 MHz, C6D6, ʹͷ °CȌ: δ = 0.91 (t, 12H, 3JH,H = 7.2 Hz, NCH2CH2CH2Me), 1.25-1.35 (m, 8H, NCH2CH2CH2Me), 1.67-1.78 (m, 4H, NCH2CH2CH2Me), 1.92-2.03(m, 4H, NCH2CH2CH2Me), 4.01-4.08 (m, 4H, NCH2CH2CH2Me), 4.60-4.68 (m, 4H, NCH2CH2CH2Me), 6.42 (d, 4H, 3JH,H = 7.6 Hz, o-protons of Ph ring),  6.77 (t, 4H, 3JH,H = 6.8 Hz, m-protons of Ph ring),  6.91 (tt, 2H, 3JH,H = 7.5 Hz, 3JH,H = 1.2 Hz p-protons of Ph ring). 
13C{1H} NMR (75.5 MHz, C6D6, ʹͷ °CȌ: δ = 13.6 ( s, NCH2CH2CH2Me), 20.1 (s, NCH2CH2CH2Me), 30.9 (s, NCH2CH2CH2Me), 46.7 (t, 3JP,C = 3.8 Hz, NCH2CH2CH2Me), 124.1 (t, JP,C = 4.1 Hz, P-C of the middle 
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ring),  124.6 (dd, , 3JP,C = 9.5 Hz, 3JP,C = 7.9 Hz, ipso-C of Ph ring ), 128.7 (s, Ph ring C) 129.0 (s, p-C of Ph ring), 136.3 (s, Ph ring C), 168.9 (br, C=S). 
31P NMR (121.5 MHz, C6D6, ʹͷ °CȌ: δ = -44.6 (s).   IR [cm-1]: ṽ = 2957 (w), 2930 (w), 2871 (w), 1436 (s), 1396 (s), 1285 (s), 1216 (s), 1157 (s), 861 (s), 739 (s). Pos-ESI-MS: for C34H46N4P2Se2S2H theor./exp. 797.1052/797.1047.  EA [%]: theor./exp. C 51.38/50.71, H 5.83/5.83, N 7.05/6.92, S 8.07/8.12.  10.28 Nucleophilic 1,4-addition reaction of 1,4-diphosphinines A solution of compound 33b (0.48 g, 1mmol) in diethyl ether (20 ml) was treated first with 0.63 ml of nBuLi solution (for 36a; for 36b 0.21 g of KMHDS) at room temperature. During this addition the color of the reaction mixture changed from dark red to dark violet, which eventually turned bright orange. Then this solution was cooled down to –78 °C and 1 mmol of methyl iodide was added as the quenching agent. The color of the reaction mixture changed from orange to light yellow during the methyl iodide addition. The reaction mixture was allowed to slowly warmup to the room temperature. After this the reaction mixture was concentrated under vacuo (8× 10-3 mbar) to get a yellow residue which was again taken up into 30 ml toluene. This toluene solution was filtered through a silica bed to remove the salt (LiI) and some minor colored impurities. After concentrating this filtrate under reduced pressure, a white solid was obtained which was further dried (8× 10-3 mbar) to get pure 37a,b. 10.28.1 4-Bis(trimethylsilyl)amino-8-methyl-1,3,5,7-tetra-n-butyl-4,8-dihydro[1,4] diphosphinine[2,3-d:5,6-d']bisimidazole-2,6-dithione (37a) Yield: 0.53 g (0.8 mmol, 80.0 %)    Appearance: white solid  Melting Point: 139 °C  
1H NMR (300.1 MHz, C6D6, ʹͷ °CȌ: δ = -0.26 (s, 9H, N-SiMe3), 0.31 (t, 9H, 4JP,H = 2.7 Hz, N-SiMe3), 0.78 (d, 3JH,H = 5.1 Hz, P-Me), 0.84 (t, 6H, 3JH,H = 7.3 Hz, NCH2CH2CH2Me), 0.88 (t, 6H, 3JH,H = 7.5 Hz, NCH2CH2CH2Me), 1.24-1.48 (m, 8H, NCH2CH2CH2Me), 1.85-2.26 (m, 8H, NCH2CH2CH2Me), 3.55-3.63 (m, 2H, NCH2CH2CH2Me), 3.98-4.06 (m, 2H, NCH2CH2CH2Me), 4.61-4.68 (m, 2H, NCH2CH2CH2Me), 4.91-4.99 (m, 2H, NCH2CH2CH2Me). 
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13C{1H} NMR (75.5 MHz, C6D6, ʹͷ °CȌ: δ = 2.9 (s, N-SiMe3), 4.3 (t, 2JP,C = 14.7 Hz, N-SiMe3), 13.4 & 13.6 ( s, NCH2CH2CH2Me), 16.3 (dd, JP,C = 18.2 Hz, JP,C = 12.2 Hz, P-Me), 19.9 & 20.2 (s, NCH2CH2CH2Me), 30.6 (br, NCH2CH2CH2Me), 46.9 (d, 3JP,C = 5.7 Hz, NCH2CH2CH2Me), 47.3 (d, 3JP,C = 8.6 Hz, NCH2CH2CH2Me), 126.5 (d, JP,C = 1.5 Hz, P-C of the middle ring),  128.6 (dd, JP,C = 16.8 Hz , JP,C = 2.8 Hz, P-C of the middle ring),  168.5 (br, C=S). 
31P NMR (121.5 MHz, C6D6, ʹͷ °CȌ: δ = -72.4 (dq, 3JP,P = 15.7 Hz, 3JP,H = 5.2 Hz, P-Me); -5.1 (br. d, 3JP,P = 15.7 Hz, P-N(SiMe3)2).  IR [cm-1]: ṽ = 2956 (w), 2929 (w), 2861 (w), 1437 (m), 1402 (s), 1253 (m), 1217 (m), 887 (s), 871 (s), 842 (s). Pos-ESI-MS: for C29H57N5P2Si2S2H theor./exp. 658.3154/658.3142.  EA [%]: theor./exp. C 52.93/52.71, H 8.73/8.70, N 10.64/10.58, S 9.74/9.45.  10.28.2 4-n-Butyl-8-methyl-1,3,5,7-tetra-n-butyl-4,8-dihydro[1,4]diphosphinine[2,3 -d:5,6-d']bisimidazole-2,6-dithione (37b) Yield: 0.19 g (0.35 mmol, 35.0 %)    Appearance: white solid  Melting Point: 175 °C  
1H NMR (300.1 MHz, C6D6, ʹͷ °CȌ: δ = 0.73 (t, 3H, 3JH,H = 7.4 Hz, PCH2CH2CH2Me),  0.88 (t, 3H, 3JH,H = 6.7 Hz, PCH2CH2CH2Me) 2nd isomer, 0.98 (t, 3H, 3JH,H = 7.1 Hz, NCH2CH2CH2Me), 0.99 (t, 3H, 3JH,H = 7.2 Hz, NCH2CH2CH2Me) 2nd isomer, 1.11-1.16 (m, 2H, PCH2CH2CH2Me), 1.34-1.42 (m, 4H, PCH2CH2CH2Me),  1.40 (d, 2JP,H = 4.9 Hz, P-Me), 1.42-1.48 (m, 8H, NCH2CH2CH2Me), 1.50 (d, 2JP,H = 5.2 Hz, P-Me) 2nd isomer,  1.67-1.94(m, 8H, NCH2CH2CH2Me), 3.79-4.51 (m, 8H, NCH2CH2CH2Me). 13C{1H} NMR (75.5 MHz, C6D6, ʹͷ °CȌ: δ = 13.4 & 13.6 (s, PCH2CH2CH2Me of two isomers), 13.7 & 13.8 (s, NCH2CH2CH2Me of two isomers), 17.6 (dd, 1JP,C = 16.3 Hz, 3JP,C = 1.6 Hz, P-Me), 18.2  (dd, 1JP,C = 19.2 Hz, 3JP,C = 3.7 Hz, P-Me) 2nd isomer, 19.9 & 20.0 (s, NCH2CH2CH2Me), 23.3 & 23.4 (s, PCH2CH2CH2Me), 23.9 & 24.1 (s, PCH2CH2CH2Me) (2nd isomer), 25.6 (d, 3JP,C = 1.9 Hz,  PCH2CH2CH2Me), 28.3 (d, 3JP,C = 8.8 Hz,  PCH2CH2CH2Me) (2nd isomer),  28.8 (dd, 1JP,C = 20.0 Hz, 4JP,C = 5.2 Hz, PCH2CH2CH2Me), 30.3 (dd, 1JP,C = 7.8 Hz, 4JP,C = 2.5 Hz, PCH2CH2CH2Me) (2nd isomer),  30.7 (d, 3JP,C = 2.6 Hz, NCH2CH2CH2Me), 30.9 (d, 3JP,C = 2.6 Hz, NCH2CH2CH2Me), 32.8 (d, 3JP,C = 2.1 Hz, NCH2CH2CH2Me) (2nd isomer), 32.9 (d, 3JP,C = 2.1 Hz, NCH2CH2CH2Me) (2nd isomer),   46.7 (t, 3JP,C = 7.2 Hz, NCH2CH2CH2Me), 46.8 (t, 3JP,C = 6.5 Hz, NCH2CH2CH2Me), 47.5 (t, 3JP,C = 2.5 Hz, NCH2CH2CH2Me)(2nd isomer), 47.6 (t, 3JP,C = 3.5 Hz, NCH2CH2CH2Me)(2nd isomer), 122.7 (t, JP,C = 2.1 
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Hz, P-C of the middle ring), 127.1 (t, JP,C = 4.4 Hz, P-C of the middle ring) (2nd isomer), 128.1 (t, JP,C = 2.7 Hz, P-C of the middle ring), 128.3 (dd, JP,C = 7.1 Hz, JP,C = 4.3 Hz, P-C of the middle ring)(2nd isomer), 165.8 (br, C=S), 166.8 (br, C=S) 2nd isomer. 
31P NMR (121.5 MHz, C6D6, ʹͷ °CȌ: δ = -75.8 (dq, 3JP,P = 9.6 Hz, 3JP,H = 4.9 Hz, P-Me) & -69.4 (qd, 3JP,H = 5.2 Hz, 3JP,H = 4.8 Hz, P-Me);  -65.4 (br,  P-nBu) & -60.1 (br,  P-nBu).  Ratio of two isomers 1:3.5. IR [cm-1]: ṽ = 2955 (w), 2927 (w), 2859 (w), 1464 (w), 1434 (m), 1400 (s), 1361 (m), 1216 (m), 896 (m), 855 (m). Pos-ESI-MS: for C27H48N4P2S2H theor./exp. 555.2881/555.2868. EA [%]: theor./exp. C 58.46/57.86, H 8.72/8.75, N 10.10/9.74, S 11.56/12.19.  10.29 Oxidative hydrolysis of tricyclic 1,4-diphosphinine 33b A solution of compound 33b (0.48 g, 1 mmol) in 50 mL of diethyl ether was stirred for overnight in open atmospheric conditions. The red color of the compound vanished during this process and a light yellow solution was obtained. This solution was dried in vacuum to get a residue which was again washed with diethylether (2 × 2 ml) and n-pentane (2 × 5 ml). Finally it was dried under reduced pressure (8× 10-3 mbar) to get hands on pure 38. 10.29.1 1,3,5,7-Tetra-n-butyl-4,8-dihydro[1,4]bisphosphinicacid[2,3-d:5,6-d']bisimidazole-2,6-dithione (38b) Yield: 0.51 g (0.92 mmol, 92.0 %)    Appearance: white solid  Melting Point: 176 °C  
1H NMR (300.1 MHz, C6D6, ʹͷ °CȌ: δ = 1.01 (t, 12H, 3JH,H = 7.4 Hz, NCH2CH2CH2Me), 1.39-1.52 (m, 8H, NCH2CH2CH2Me), 1.87-1.98 (m, 8H, NCH2CH2CH2Me), 4.31-4.36 (m, 8H, NCH2CH2CH2Me). 13C{1H} NMR (75.5 MHz, C6D6, ʹͷ °CȌ: δ = 13.1 ( s, NCH2CH2CH2Me), 19.8 (s, NCH2CH2CH2Me), 30.0 (s, NCH2CH2CH2Me), 47.5 (s, NCH2CH2CH2Me), 125.4 (dd, 1JP,C = 167.4 Hz, 1JP,C = 21.6 Hz, P-C of the middle ring),  168.6 (t, 3JP,C = 7.6 Hz, C=S). 31P NMR (121.5 MHz, C6D6, ʹͷ °CȌ: δ = -6.9 (s).   IR [cm-1]: ṽ = 2956 (w), 2931 (w), 2872 (w), 2269 (m), 1516 (w), 1450 (m), 1419 (s), 1361 (m),  1213 (s), 1191 (s), 1143 (s),  960 (s). Pos-ESI-MS: for C22H38N4O4P2S2Na theor./exp. 571.1702/517.1721.  EA [%]: theor./exp. C 48.16/48.84, H 6.98/7.08, N 10.21/9.89, S 11.69/11.47. 
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Appendix 11.1 Crystal data and structure refinement for compound cis 4b 
 Identification code GSTR353, 3365 Z 8 Device Type                        Nonius KappaCCD ɏcalcg/cm3 
 
1.281 Empirical formula                  C18H32N6P2S2 Ɋ/mm-1 0.375 Moiety formula                     C18H32N6P2S2 F(000)                             1952 Formula weight                     458.56 Crystal size/mm 0.12 x 0.08 x 0.04 Temperature/K 293(2) ʹΘ range for data collection/° 
 
2.70 to 26.00 Wavelength/Å               0.71073  Limiting indices -ʹ  ͺ≤ h ≤ ʹ ,͵ -ͳ  ʹ≤ k ≤ ͳͷ, -ʹͲ ≤ l ≤ ͳ  ͺCrystal system Orthorhombic Reflections collected / unique     29973 / 8941 [R(int) = 0.0493] space group        P n a 21 Completeness to theta 0.998  a/Å 23.4008(7) Absorption correction              Semi-empirical from eq.s b/Å 12.3463(2) Max. and min. transmission         0.9852 and 0.9564 c/Å 16.4552(5) Refinement method                  Full-matrix least-squares on F2 σ/° 90 Goodness-of-fit on F^2             0.974 Ⱦ/° 90 Final R indices [I>2sigma(I)]      R1 = 0.0396, wR2 = 0.0903 ɀ/° 90 R indices (all data)               R1 = 0.0548, wR2 = 0.0958 Volume/ Å3 4754.1(2) Largest diff. peak and hole/ e Å-3          0.354 and -0.298  
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11.2 Crystal data and structure refinement for compound 3g  
 
 
 Identification code GSTR550,  ABK-38 Z 4 Device Type                        Bruker X8-KappaApexII ɏcalc g/cm  ͵
 
1.210 Empirical formula                  C20H35N4OPS2 Ɋ/mm-1 2.740 Moiety formula                     C20H35N4OPS2 F(000)                             952.0 Formula weight                     442.61 Crystal size/mm 0.24 × 0.15 × 0.13 Temperature/K 100(2) ʹΘ range for data collection/° 
 
8.402 to 135.464 Wavelength/Å               0.71073  Radiation CuKȽ ȋɉ = ͳ.ͷͶͳ͹ͺȌ Crystal system monoclinic Reflections collected / unique     4399 [Rint = 0.3466, Rsigma = 0.0697] space group        P21/n Completeness to theta 1.000 a/Å 11.9964(4) Absorption correction              Semi-empirical from eq.s b/Å 16.5050(6) Max. and min. transmission         0.18398; 0.753817 c/Å 13.3543(5) Refinement method                  Full-matrix least-squares on F2 σ/° 90 Goodness-of-fit on F^2             1.196 Ⱦ/° 113.292(2) Final R indices [I>  ʹσ ȋIȌ]      R1 = 0.1142, wR2 = 0.2434 ɀ/° 90 R indices (all data)               R1 = 0.1340, wR2 = 0.2560 Volume/ Å3 2428.66(15) Largest diff. peak and hole/ e Å-3        0.49/-0.74 
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11.3 Crystal data and structure refinement for compound 3i  
 
 
  Identification code GSTR465, ABK-92  ɏcalcg/cm3 1.177 Crystal Habitus clear colourless block Ɋ/mm-1 2.278 Device Type Bruker D8-Venture F(000) 2288.0 Empirical formula C28H43N4PS2 Crystal size/mm3 0.25 × 0.18 × 0.08 Moiety formula C28H43N4PS2 Absorption correction empirical Formula weight 530.75 Tmin; Tmax 0.3334; 0.7536 Temperature/K 123.01 Radiation CuKȽ ȋɉ = ͳ.ͷͶͳ͹ͺȌ Crystal system monoclinic ʹΘ range /° 6.986 to 135.496 Space group C2/c Completeness to theta 0.991 a/Å 29.1175(16) Index ranges -34 ≤ h ≤ ͵ Ͷ, -ͳ  ʹ≤ k ≤ ͳ ,ʹ -ʹ͸ ≤ l ≤ ʹ ͸ b/Å 10.9059(6) Reflections collected 76097 c/Å 21.7084(11) Independent reflections 5372 [Rint = 0.1435, Rsigma = 0.0514] Ƚ/° 90 Data/restraints/parameters 5372/261/407 Ⱦ/° 119.655(3) Goodness-of-fit on F2 1.051 ɀ/° 90 Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.1233, wR2 = 0.3190 Volume/Å3 5990.7(6) Final R indexes [all data] R1 = 0.1446, wR2 = 0.3409 Z 8 Largest diff. peak/hole / e Å-3 2.01/-1.51 
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11.4 Crystal data and structure refinement for compound 5f 
   Identification code GSTR443, ABK-247  ɏcalcg/cm3 1.309 Crystal Habitus clear colourless block Ɋ/mm-1 4.456 Device Type Bruker D8-Venture F(000) 624.0 Empirical formula C11H21N3PSCl Crystal size/mm3 0.11 × 0.06 × 0.04 Moiety formula C11H21ClN3PS Absorption correction empirical Formula weight 293.79 Tmin; Tmax 0.3776; 0.7536 Temperature/K 100.0 Radiation CuKȽ ȋɉ = ͳ.ͷͶͳ͹ͺȌ Crystal system monoclinic ʹΘ range for data collection/° 8.104 to 135.488° Space group P21/c Completeness to theta 0.997 a/Å 11.6794(7) Index ranges -ͳͶ ≤ h ≤ ͳͶ, -ͳͳ ≤ k ≤ ͳͳ, -ͳ͹ ≤ l ≤ ͳ͹ b/Å 9.3892(6) Reflections collected 20754 c/Å 14.5557(9) Independent reflections 2693 [Rint = 0.0872, Rsigma = 0.0492] Ƚ/° 90 Data/restraints/parameters 2693/0/160 Ⱦ/° 110.915(3) Goodness-of-fit on F2 1.066 ɀ/° 90 Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0465, wR2 = 0.1147 Volume/Å3 1491.01(16) Final R indexes [all data] R1 = 0.0550, wR2 = 0.1214 Z 4 Largest diff. peak/hole / e Å-3 0.40/-0.81 
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11.5 Crystal data and structure refinement for compound 4d  
   Identification code GSTR459, ABK-274  ɏcalcg/cm3 1.341 Crystal Habitus clear colourless block Ɋ/mm-1 0.392 Device Type Bruker D8-Venture F(000) 488.0 Empirical formula C18H32N6P2S2 Crystal size/mm3 0.3 × 0.27 × 0.26 Moiety formula C18H32N6P2S2 Absorption correction empirical Formula weight 458.55 Tmin; Tmax 0.4821; 0.7452 Temperature/K 100 Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Crystal system triclinic ʹΘ range/° 4.86 to 51.034° Space group P-1 Completeness to theta 0.992 a/Å 10.5879(15) Index ranges -ͳ  ʹ≤ h ≤ ͳ ,ʹ -ͳ  ͵≤ k ≤ ͳ ,͵ -ͳ  ͵≤ l ≤ ͳ  ͵b/Å 11.3529(15) Reflections collected 26099 c/Å 11.5102(15) Independent reflections 4205 [Rint = 0.0972, Rsigma = 0.0702] Ƚ/° 101.361(3) Data/restraints/parameters 4205/12/260 Ⱦ/° 116.339(3) Goodness-of-fit on F2 1.098 ɀ/° 103.068(3) Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0773, wR2 = 0.1581 Volume/Å3 1135.6(3) Final R indexes [all data] R1 = 0.1174, wR2 = 0.1778 Z 2 Largest diff. peak/hole / e Å-3 0.69/-0.56 
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11.6 Crystal data and structure refinement for compound 4f  
   Identification code GSTR531, ABK-339 ɏcalcg/cm3 1.147 Crystal Habitus clear colourless plate Ɋ/mm-1 2.365 Device Type Bruker D8-Venture F(000) 2720.0 Empirical formula C30H56N6P2S2 Crystal size/mm3 0.09 × 0.04 × 0.03 Moiety formula C30H56N6P2S2 Absorption correction empirical Formula weight 626.86 Tmin; Tmax 0.5634; 0.7536 Temperature/K 100.0 Radiation CuKȽ ȋɉ = ͳ.ͷͶͳ͹ͺȌ Crystal system tetragonal ʹΘ range /° 6.808 to 134.952° Space group I41/a Completeness to theta 0.954 a/Å 25.9652(8) Index ranges -͵ͳ ≤ h ≤ ͵ Ͳ, -ʹ  ͺ≤ k ≤ ͵ ͳ, -ͳ  ʹ≤ l ≤ ͳ  ʹb/Å 25.9652(8) Reflections collected 51235 c/Å 10.7734(4) Independent reflections 3121 [Rint = 0.1236, Rsigma = 0.0457] Ƚ/° 90 Data/restraints/parameters 3121/45/214 Ⱦ/° 90 Goodness-of-fit on F2 1.095 ɀ/° 90 Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0603, wR2 = 0.1428 Volume/Å3 7263.3(5) Final R indexes [all data] R1 = 0.0882, wR2 = 0.1552 Z 8 Largest diff. peak/hole / e Å-3 0.55/-0.31 
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11.7 Crystal data and structure refinement for compound 9a  
   Identification code dg-232, ABK-UBC-20 ɀ/° 92.645(4) Crystal Habitus clear colourless plate Volume/Å3 2546.5(7) Device Type Bruker APEX-DUO Z 4 Empirical formula C26H36N3PS ɏcalcg/cm3 1.183 Formula weight 453.61 Ɋ/mm-1 0.208 Temperature/K 90(2) Crystal size/mm3 0.06 × 0.1 × 0.19 Crystal system triclinic Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Space group P-1 ʹΘ rmax /°  60.19  a/Å 9.4412 (16) Completeness to theta 0.954 b/Å 15.818(3) Independent reflections 14925 c/Å 17.317(3) Goodness-of-fit on F2 1.008 Ƚ/° 99.675(4) Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0462, wR2 = 0.1121 Ⱦ/° 90.025(4) Largest diff. peak/hole / e Å-3 Ͳ.͹ͺ/−Ͳ.Ͷ  ʹ
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11.8 Crystal data and structure refinement for compound 9b  
   Identification code GSTR489, ABK-315  ɏcalcg/cm3 1.176 Crystal Habitus clear colourless needle Ɋ/mm-1 0.191 Device Type Bruker D8-Venture F(000) 1104.0 Empirical formula C29H43N4PS Crystal size/mm3 0.14 × 0.05 × 0.04 Moiety formula C29H43N4PS Absorption correction empirical Formula weight 510.70 Tmin; Tmax 0.6294; 0.7456 Temperature/K 150 Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Crystal system monoclinic ʹΘ range for data collection/° 4.506 to 55.998° Space group P21/c Completeness to theta 0.998 a/Å 11.7230(6) Index ranges -ͳͷ ≤ h ≤ ͳͷ, -͵ͻ ≤ k ≤ ͵ ͻ, -ͳͳ ≤ l ≤ ͳͳ b/Å 29.7836(16) Reflections collected 118005 c/Å 8.5162(4) Independent reflections 6940 [Rint = 0.0923, Rsigma = 0.0307] Ƚ/° 90 Data/restraints/parameters 6940/0/327 Ⱦ/° 103.9668(17) Goodness-of-fit on F2 1.169 ɀ/° 90 Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0853, wR2 = 0.2340 Volume/Å3 2885.5(3) Final R indexes [all data] R1 = 0.0957, wR2 = 0.2394 Z 4 Largest diff. peak/hole / e Å-3 1.64/-0.46 
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11.9 Crystal data and structure refinement for compound 10  
   Identification code dg-311, ABK-UBC-5 ɀ/° 90 Crystal Habitus clear colourless plate Volume/Å3 2613.18(40)  Device Type Bruker APEX-DUO Z 4 Empirical formula C26H37BN3PS ɏcalcg/cm3 1.183 Formula weight 465.42 Ɋ/mm-1 0.203 Temperature/K 90(2) Crystal size/mm3 0.11 × 0.12 × 0.28 Crystal system monoclinic Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Space group P21/c ʹΘ max /°  60.20  a/Å 11.5715(10) Completeness to theta 0.954 b/Å 13.5369(12) Independent reflections 7687 c/Å 16.9067(15) Goodness-of-fit on F2 1.020 Ƚ/° 90 Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0360, wR2 = 0.0940 Ⱦ/° 99.317(2) Largest diff. peak/hole / e Å-3 Ͳ.Ͷ͵/−Ͳ.ʹ ͻ 
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11.10 Crystal data and structure refinement for compound 21a   
   Identification code GSTR484, ABK-323  ɏcalcg/cm3 1.450 Crystal Habitus clear colourless plate Ɋ/mm-1 0.579 Device Type Bruker X8 Kappa Apex F(000) 280.0 Empirical formula C11H12N2PSCl Crystal size/mm3 0.22 × 0.2 × 0.09 Moiety formula C11H12N2PSCl Absorption correction empirical Formula weight 270.71 Tmin; Tmax 0.6578; 0.7459 Temperature/K 150.0 Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Crystal system triclinic ʹΘ range for data collection/° 4.574 to 56° Space group P-1 Completeness to theta 1.000 a/Å 8.3058(5) Index ranges -ͳͲ ≤ h ≤ ͳͲ, -ͳ  ʹ≤ k ≤ ͳ ,ʹ -ͳ  ͵≤ l ≤ ͳ  ͵b/Å 9.1140(9) Reflections collected 29551 c/Å 9.9160(7) Independent reflections 2990 [Rint = 0.0621, Rsigma = 0.0280] Ƚ/° 63.984(3) Data/restraints/parameters 2990/0/147 Ⱦ/° 78.086(2) Goodness-of-fit on F2 1.039 ɀ/° 66.898(2) Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0294, wR2 = 0.0724 Volume/Å3 619.94(9) Final R indexes [all data] R1 = 0.0374, wR2 = 0.0767 Z 2 Largest diff. peak/hole / e Å-3 0.41/-0.39 
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11.11 Crystal data and structure refinement for compound 22a  
  Identification code GSTR483, ABK-324  ɏcalcg/cm3 1.399 Crystal Habitus clear colourless block Ɋ/mm-1 0.401 Device Type Bruker D8-Venture F(000) 976.0 Empirical formula C22H22N4P2S2 Crystal size/mm3 0.24 × 0.12 × 0.08 Moiety formula C22 H22 N4 P2 S2 Absorption correction empirical Formula weight 468.49 Tmin; Tmax 0.4015; 0.7449 Temperature/K 123 Radiation MoKȽ ȋɉ = Ͳ.͹1073) Crystal system monoclinic ʹΘ range for data collection/° 4.648 to 47.61° Space group P21/c Completeness to theta 0.746 a/Å 13.390(8) Index ranges -ͳͷ ≤ h ≤ ͳͷ, -ͳ͹ ≤ k ≤ ͳ͹, -ͳͳ ≤ l ≤ ͳͲ b/Å 15.743(9) Reflections collected 29748 c/Å 10.566(6) Independent reflections 3262 [Rint = 0.2943, Rsigma = 0.1727] Ƚ/° 90 Data/restraints/parameters 3262/173/340 Ⱦ/° 93.25(2) Goodness-of-fit on F2 1.047 ɀ/° 90 Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.1518, wR2 = 0.3602 Volume/Å3 2224(2) Final R indexes [all data] R1 = 0.2285, wR2 = 0.4184 Z 4 Largest diff. peak/hole / e Å-3 0.88/-0.84 
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11.12 Crystal data and structure refinement for compound 22c  
  Identification code GSTR560, ABK-476 ɏcalcg/cm3 1.250 Crystal Habitus clear colourless block Ɋ/mm-1 0.282 Device Type Bruker D8-Venture F(000) 1360.0 Empirical formula C34H46N4P2S2 Crystal size/mm3 0.23 × 0.18 × 0.17 Moiety formula C34H46N4P2S2 Absorption correction empirical Formula weight 636.81 Tmin; Tmax 0.5234; 0.7459 Temperature/K 99.99 Radiation MoKȽ ȋɉ = 0.71073) Crystal system triclinic ʹΘ range for data collection/° 4.264 to 55.998° Space group P-1 Completeness to theta 0.992 a/Å 14.250(2) Index ranges -ͳ  ͺ≤ h ≤ ͳ ,ͺ -ʹͲ ≤ k ≤ ͳͻ, -ʹ  ͵≤ l ≤ ʹ  ͵b/Å 15.1496(18) Reflections collected 132335 c/Å 17.733(3) Independent reflections 16255 [Rint = 0.1491, Rsigma = 0.0769] Ƚ/° 71.768(6) Data/restraints/parameters 16255/53/785 Ⱦ/° 70.775(7) Goodness-of-fit on F2 1.098 ɀ/° 75.242(6) Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.1561, wR2 = 0.4133 Volume/Å3 3383.7(8) Final R indexes [all data] R1 = 0.1917, wR2 = 0.4350 Z 4 Largest diff. peak/hole / e Å-3 2.91/-1.14 
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11.13 Crystal data and structure refinement for compound 23b  
 Identification code GSTR514, ABK-MK-08 ɏcalcg/cm  ͵ 1.165 Crystal Habitus clear colourless block Ɋ/mm-1 0.308 Device Type Bruker X8-KappaApexII F(000) 912.0 Empirical formula C19H34N3Si2PS Crystal size/mm3 0.18 × 0.16 × 0.08 Moiety formula C19H34N3Si2PS  Absorption correction empirical Formula weight 423.70 Tmin; Tmax 0.6563; 0.7459 Temperature/K 100 Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Crystal system orthorhombic ʹΘ range for data collection/° 4.676 to 55.998° Space group P212121 Completeness to theta 0.995 a/Å 7.9723(5) Index ranges -ͳͲ ≤ h ≤ ͹, -ʹ  ʹ≤ k ≤ ʹ Ͳ, -ʹ  ʹ≤ l ≤ ʹ  ʹb/Å 17.3933(11) Reflections collected 20496 c/Å 17.4227(9) Independent reflections 5819 [Rint = 0.0415, Rsigma = 0.0406] Ƚ/° 90 Data/restraints/parameters 5819/0/244 Ⱦ/° 90 Goodness-of-fit on F2 1.080 ɀ/° 90 Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0352, wR2 = 0.0765 Volume/Å3 2415.9(2) Final R indexes [all data] R1 = 0.0394, wR2 = 0.0787 Z 4 Largest diff. peak/hole / e Å-3 0.29/-0.22 Flack parameter 0.39(9)   
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11.14 Crystal data and structure refinement for compound 25b 
   Identification code GSTR542, ABK-470 ɏcalcg/cm  ͵ 1.177 Crystal Habitus clear orange plank Ɋ/mm-1 0.278 Device Type Bruker D8-Venture F(000) 1296.0 Empirical formula C30H54N4P2S2 Crystal size/mm3 0.18 × 0.1 × 0.08 Moiety formula 2(C15H27N2PS) Absorption correction empirical Formula weight 596.83 Tmin; Tmax 0.5517; 0.7459 Temperature/K 100.01 Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Crystal system monoclinic ʹΘ range for data collection/° 4.738 to 56° Space group P21/c Completeness to theta 0.989 a/Å 17.997(2) Index ranges -ʹ  ͵≤ h ≤ ͳͻ, -ʹͷ ≤ k ≤ ʹ ͷ, -ͳ  ʹ≤ l ≤ ͳ  ʹb/Å 19.612(2) Reflections collected 43984 c/Å 9.6079(11) Independent reflections 8059 [Rint = 0.1400, Rsigma = 0.1106] Ƚ/° 90 Data/restraints/parameters 8059/0/349 Ⱦ/° 96.652(4) Goodness-of-fit on F2 1.030 ɀ/° 90 Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0549, wR2 = 0.1071 Volume/Å3 3368.2(7) Final R indexes [all data] R1 = 0.1069, wR2 = 0.1261 Z 4 Largest diff. peak/hole / e Å-3 0.74/-0.49 
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11.15 Crystal data and structure refinement for compound 26a  
  Identification code GSTR475, ABK-286  ɏcalcg/cm3 1.310 Crystal Habitus clear colourless plate Ɋ/mm-1 3.609 Device Type Bruker D8-Venture F(000) 1602.0 Empirical formula C109H194Cl2N36O12P12S12 Crystal size/mm3 0.16 × 0.14 × 0.08 Moiety formula CH2 Cl2, 6(C18H32N6O2P2S2) Absorption correction empirical Formula weight 3028.25 Tmin; Tmax 0.2969; 0.7536 Temperature/K 123 Radiation CuKȽ ȋɉ = ͳ.ͷͶͳ͹ͺȌ Crystal system triclinic ʹΘ range for data collection/° 4.368 to 135.498° Space group P-1 Completeness to theta 0.998 a/Å 9.2983(3) Index ranges -ͳͳ ≤ h ≤ 11, -ʹͷ ≤ k ≤ ʹ ͷ, -ʹ͸ ≤ l ≤ ʹ ͸ b/Å 20.5513(8) Reflections collected 117863 c/Å 21.2034(8) Independent reflections 13876 [Rint = 0.1808, Rsigma = 0.0877] Ƚ/° 100.916(2) Data/restraints/parameters 13876/312/882 Ⱦ/° 102.062(2) Goodness-of-fit on F2 1.083 ɀ/° 96.821(2) Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.1245, wR2 = 0.2866 Volume/Å3 3837.4(2) Final R indexes [all data] R1 = 0.1538, wR2 = 0.3012 Z 1 Largest diff. peak/hole / e Å-3 1.47/-0.94 
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11.16 Crystal data and structure refinement for compound 26d  
  Identification code GSTR533, ABK-MK-13 ɏcalcg/cm3 1.405 Crystal Habitus clear colourless plate Ɋ/mm-1 0.490 Device Type Bruker X8-KappaApexII F(000) 2672.0 Empirical formula C27H32Cl2N4O2P2S2 Crystal size/mm3 0.09 × 0.08 × 0.03 Moiety formula C26H30N4O2P2S2, CH2Cl2 Absorption correction empirical Formula weight 641.52 Tmin; Tmax 0.6666; 0.7459 Temperature/K 100 Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Crystal system monoclinic ʹΘ range for data collection/° 3.036 to 56° Space group P21/n Completeness to theta 0.998 a/Å 16.7459(15) Index ranges -ʹ  ʹ≤ h ≤ ʹ ,ʹ Ͳ ≤ k ≤ ʹ ,͵ Ͳ ≤ l ≤ ʹ ͸ b/Å 17.9798(17) Reflections collected 17853 c/Å 20.1929(19) Independent reflections 17853 [Rint = 0.1970, Rsigma = 0.1954] Ƚ/° 90 Data/restraints/parameters 17853/1014/721 Ⱦ/° 94.071(3) Goodness-of-fit on F2 1.149 ɀ/° 90 Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.3242, wR2 = 0.5993 Volume/Å3 6064.5(10) Final R indexes [all data] R1 = 0.3897, wR2 = 0.6355 Z 8 Largest diff. peak/hole / e Å-3 2.68/-2.67 
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10.17 Crystal data and structure refinement for compound 27a  
   Identification code GSTR513, ABK-MK-36 ɏcalcg/cm3 1.342 Crystal Habitus clear colourless plate Ɋ/mm-1 0.444 Device Type Nonius KappaCCD F(000) 326.0 Empirical formula C25H40N6P2S4 Crystal size/mm3 0.18 × 0.06 × 0.04 Moiety formula C18 H32 N6 P2 S4, C7 H8 Absorption correction multi-scan Formula weight 614.81 Tmin; Tmax 0.8771; 1.0511 Temperature/K 100 Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Crystal system triclinic ʹΘ range for data collection/° 5.898 to 55.988° Space group P-1 Completeness to theta 0.999 a/Å 7.5153(4) Index ranges -ͻ ≤ h ≤ ͻ, -ͳ  ʹ≤ k ≤ ͳ ,ʹ -ͳͷ ≤ l ≤ ͳ  ͵b/Å 9.3062(8) Reflections collected 8843 c/Å 11.8949(9) Independent reflections 3645 [Rint = 0.0814, Rsigma = 0.1013] Ƚ/° 95.800(3) Data/restraints/parameters 3645/31/192 Ⱦ/° 100.379(4) Goodness-of-fit on F2 1.029 ɀ/° 109.282(4) Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0579, wR2 = 0.1097 Volume/Å3 760.76(10) Final R indexes [all data] R1 = 0.1024, wR2 = 0.1256 Z 1 Largest diff. peak/hole / e Å-3 0.47/-0.44 
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10.18 Crystal data and structure refinement for compound 27d  
   Identification code GSTR532, ABK-MK-23 ɏcalcg/cm3 1.221 Crystal Habitus clear colourless block Ɋ/mm-1 0.418 Device Type Bruker X8-KappaApexII F(000) 924.0 Empirical formula C26H30N4P2S4 Crystal size/mm3 0.11 × 0.1 × 0.06 Formula weight 588.72 Absorption correction empirical Temperature/K 100 Tmin; Tmax 0.6086; 0.7459 Crystal system trigonal Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Space group P3121 ʹΘ range for data collection/° 4.558 to 55.96° a/Å 15.0072(6) Completeness to theta 0.990 b/Å 15.0072(6) Index ranges -ʹͲ ≤ h ≤ ͳͻ, -ʹͲ ≤ k ≤ ʹ Ͳ, -ͳ͸ ≤ l ≤ ͳ͹ c/Å 12.3126(6) Reflections collected 28461 Ƚ/° 90 Independent reflections 3833 [Rint = 0.1350, Rsigma = 0.1145] Ⱦ/° 90 Data/restraints/parameters 3833/0/166 ɀ/° 120 Goodness-of-fit on F2 1.028 Volume/Å3 2401.5(2) Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0548, wR2 = 0.1213 Z 3 Final R indexes [all data] R1 = 0.0773, wR2 = 0.1322 Flack parameter 0.02(18) Largest diff. peak/hole / e Å-3 0.49/-0.49 
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10.19 Crystal data and structure refinement for compound 29d  
    Identification code GSTR553, ABK-521 ɏcalcg/cm3 1.450 Crystal Habitus clear colourless block Ɋ/mm-1 0.519 Device Type Bruker X8-KappaApexII F(000) 1176.0 Empirical formula C40H56Cl4F6N4O6P2S4 Crystal size/mm3 0.24 × 0.16 × 0.14 Moiety formula 2(CH2Cl2), 2(C18H26N2PS), 2(CF3O3S) Absorption correction empirical Formula weight 1134.86 Tmin; Tmax 0.5986; 0.7459 Temperature/K 100 Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Crystal system triclinic ʹΘ range for data collection/° 1.966 to 55.996° Space group P-1 Completeness to theta 0.997 a/Å 10.5491(12) Index ranges -ͳ  ͵≤ h ≤ ͳ ,͵ -ͳ͸ ≤ k ≤ ͳ͸, -ʹ  ͺ≤ l ≤ ʹ  ͺb/Å 12.4821(14) Reflections collected 72578 c/Å 21.887(3) Independent reflections 12414 [Rint = 0.0615, Rsigma = 0.0533] Ƚ/° 73.686(6) Data/restraints/parameters 12414/109/630 Ⱦ/° 76.144(8) Goodness-of-fit on F2 1.104 ɀ/° 72.404(6) Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0720, wR2 = 0.1384 Volume/Å3 2598.6(5) Final R indexes [all data] R1 = 0.1029, wR2 = 0.1521 Z 2 Largest diff. peak/hole / e Å-3 1.21/-0.68 
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10.20 Crystal data and structure refinement for compound 30a  
   Identification code GSTR557, ABK-320 ɏcalcg/cm3 1.327 Crystal Habitus clear colourless block Ɋ/mm-1 0.607 Device Type Nonius KappaCCD F(000) 688.0 Empirical formula C20H42B2Cl4N6P2S2 Crystal size/mm3 0.25 × 0.2 × 0.1 Moiety formula 2(CH2Cl2), C18H38B2N6P2S2 Absorption correction empirical Formula weight 656.07 Tmin; Tmax 0.6786; 0.7459 Temperature/K 123 Radiation MoKȽ ȋɉ = Ͳ.͹ͳ073) Crystal system monoclinic ʹΘ range for data collection/° 3.916 to 55.998° Space group P21/c Completeness to theta 0.995 a/Å 10.0982(8) Index ranges -ͳ  ͵≤ h ≤ ͳ ,͵ -ͳͲ ≤ k ≤ ͻ, -ʹ  ͺ≤ l ≤ ʹ  ͺb/Å 7.8176(6) Reflections collected 22733 c/Å 21.2936(18) Independent reflections 3945 [Rint = 0.0648, Rsigma = 0.0445] Ƚ/° 90 Data/restraints/parameters 3945/1/195 Ⱦ/° 102.342(3) Goodness-of-fit on F2 1.039 ɀ/° 90 Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0403, wR2 = 0.0894 Volume/Å3 1642.1(2) Final R indexes [all data] R1 = 0.0583, wR2 = 0.0976 Z 2 Largest diff. peak/hole / e Å-3 0.35/-0.28 
Appendix 
 207  
10.21 Crystal data and structure refinement for compound 33a  
   Identification code GSTR360, 3460f ɏcalcmg/mm3 1.573 Empirical formula C10H12N4P2S2 m/mm-1 0.628 Formula weight 314.30 F(000) 324.0 Temperature/K 123.15 Crystal size/mm3 0.18 × 0.16 × 0.02 Crystal system monoclinic Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Space group P21/c ʹΘ range for data collection 6.66 to 55.98° a/Å 4.3829(8) Index ranges -ͷ ≤ h ≤ ͷ, -ʹͳ ≤ k ≤ ʹ Ͳ, -ͳͳ ≤ l ≤ ͳ  ʹb/Å 16.111(3) Reflections collected 6828 c/Å 9.5606(16) Independent reflections 1592 [Rint = 0.0898, Rsigma = 0.1127] Ƚ/° 90.00 Data/restraints/parameters 1592/0/84 Ⱦ/° 100.562(7) Goodness-of-fit on F2 1.150 ɀ/° 90.00 Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0750, wR2 = 0.1823 Volume/Å3 663.7(2) Final R indexes [all data] R1 = 0.1447, wR2 = 0.2107 Z 2 Largest diff. peak/hole / e Å-3 1.19/-0.70 
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10.22 Crystal data and structure refinement for compound 33b  
   Identification code GSTR526, ABK-340B ɏcalcg/cm3 1.225 Crystal Habitus clear red plate Ɋ/mm-1 0.323 Device Type Bruker X8-KappaApexII F(000) 558.0 Empirical formula C49H84N8P4S4 Crystal size/mm3 0.09 × 0.05 × 0.02 Moiety formula 2(C22H36N4P2S2), C5H12 Absorption correction empirical Formula weight 1037.36 Tmin; Tmax 0.6480; 0.7459 Temperature/K 100 Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Crystal system triclinic ʹΘ range for data collection/° 6.01 to 56° Space group P-1 Completeness to theta 0.997 a/Å 9.3810(11) Index ranges -ͳ  ʹ≤ h ≤ ͳ ,ʹ -ͳ͸ ≤ k ≤ ͳ͸, -ͳ͹ ≤ l ≤ ͳ͹ b/Å 12.2140(13) Reflections collected 48495 c/Å 13.1530(16) Independent reflections 6764 [Rint = 0.1641, Rsigma = 0.1376] Ƚ/° 90.957(7) Data/restraints/parameters 6764/57/322 Ⱦ/° 109.757(7) Goodness-of-fit on F2 1.004 ɀ/° 96.772(7) Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0624, wR2 = 0.1339 Volume/Å3 1405.9(3) Final R indexes [all data] R1 = 0.1621, wR2 = 0.1707 Z 1 Largest diff. peak/hole / e Å-3 0.62/-0.44 
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10.23 Crystal data and structure refinement for compound 34b  
  Identification code GSTR548, ABK-445 ɏcalcg/cm3 1.262 Crystal Habitus clear colourless block Ɋ/mm-1 0.313 Device Type Bruker X8-KappaApexII F(000) 2868.0 Empirical formula C129H174Cl2N20O8P8S8 Crystal size/mm3 0.18 × 0.12 × 0.07 Moiety formula 4(C32H43N5O2P2S2), CH2Cl2 Absorption correction empirical Formula weight 2708.01 Tmin; Tmax 0.6894; 0.7459 Temperature/K 100 Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Crystal system monoclinic ʹΘ range for data collection/° 6.332 to 56° Space group C2/c Completeness to theta 0.996 a/Å 27.7111(12) Index ranges -ʹ͹ ≤ h ≤ ͵ ͸, -ͳͻ ≤ k ≤ ͳͻ, -ʹͻ ≤ l ≤ ʹ ͳ b/Å 14.5378(7) Reflections collected 48634 c/Å 21.9682(16) Independent reflections 8586 [Rint = 0.0533, Rsigma = 0.0439] Ƚ/° 90 Data/restraints/parameters 8586/64/439 Ⱦ/° 126.3663(11) Goodness-of-fit on F2 1.062 ɀ/° 90 Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0729, wR2 = 0.2022 Volume/Å3 7126.5(7) Final R indexes [all data] R1 = 0.0981, wR2 = 0.2277 Z 2 Largest diff. peak/hole / e Å-3 1.26/-0.51 
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10.24 Crystal data and structure refinement for compound 35a  
  Identification code GSTR558, ABK-465 ɏcalcg/cm3 1.264 Crystal Habitus clear yellow plate Ɋ/mm-1 0.374 Device Type Bruker X8-KappaApexII F(000) 1488.0 Empirical formula C34H46N4P2S4 Crystal size/mm3 0.18 × 0.14 × 0.05 Moiety formula C34H46N4P2S4 Absorption correction empirical Formula weight 700.93 Tmin; Tmax 0.4664; 0.7459 Temperature/K 100 Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Crystal system monoclinic ʹΘ range for data collection/° 2.266 to 56° Space group P21/c Completeness to theta 0.998 a/Å 18.465(3) Index ranges -ʹͶ ≤ h ≤ ʹ ,͵ -ͳ͹ ≤ k ≤ ͳ͹, -ͳ͹ ≤ l ≤ ʹ Ͳ b/Å 13.1095(18) Reflections collected 50325 c/Å 15.633(2) Independent reflections 8895 [Rint = 0.0776, Rsigma = 0.0589] Ƚ/° 90 Data/restraints/parameters 8895/0/401 Ⱦ/° 103.230(5) Goodness-of-fit on F2 1.078 ɀ/° 90 Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0466, wR2 = 0.0901 Volume/Å3 3683.8(9) Final R indexes [all data] R1 = 0.0630, wR2 = 0.0975 Z 4 Largest diff. peak/hole / e Å-3 0.54/-0.40 
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10.25 Crystal data and structure refinement for compound 35b  
  Identification code GSTR549, ABK-466 ɏcalcg/cm3 1.408 Crystal Habitus clear yellow block Ɋ/mm-1 2.197 Device Type Bruker X8-KappaApexII F(000) 1632.0 Empirical formula C34H46N4P2S2Se2 Crystal size/mm3 0.24 × 0.12 × 0.08 Moiety formula C34H46N4P2S2Se2 Absorption correction empirical Formula weight 794.73 Tmin; Tmax 0.5809; 0.7459 Temperature/K 100 Radiation MoKȽ ȋɉ = Ͳ.͹ͳͲ͹͵Ȍ Crystal system monoclinic ʹΘ range for data collection/° 4.348 to 55.998° Space group P21/c Completeness to theta 0.997 a/Å 18.5972(7) Index ranges -ʹͶ ≤ h ≤ ͳͷ, -ͳ͹ ≤ k ≤ ͳ͹, -ʹͲ ≤ l ≤ ʹ Ͳ b/Å 13.2665(5) Reflections collected 61648 c/Å 15.6185(6) Independent reflections 9047 [Rint = 0.0775, Rsigma = 0.0563] Ƚ/° 90 Data/restraints/parameters 9047/18/401 Ⱦ/° 103.2796(13) Goodness-of-fit on F2 1.007 ɀ/° 90 Final R indexes [I>=ʹσ ȋIȌ] R1 = 0.0353, wR2 = 0.0629 Volume/Å3 3750.4(2) Final R indexes [all data] R1 = 0.0725, wR2 = 0.0754 Z 4 Largest diff. peak/hole / e Å-3 0.39/-0.40 
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